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ABSTRACT 
The in vivo metabolism of some "model" compounds, i. e. 
benzoic acid, phenol and aniline was investigated in the sheep, the pig 
and the rat. Using anaesthetised ureter cannulated rats a preliminary 
examination was made of the time course of the urinary metabolic profile 
following intraduodenal administration. Some in vitro metabolism 
studies of these model compounds were also investigated using isolated 
cells from various organs (liver, kidney and intestine) from various 
laboratory animal species (rat, dog and ferret). 
Following an oral dose of these "model" compounds 
urinary elimination in all three species was very rapid and some 80-100% 
of the dose was recovered in the urine during the first 24 hours. For 
aniline, the pig was an exception in that only 56% of the dose (50 mg kg-1) 
was eliminated in the urine in 24 hours. Faecal excretion of these 
compounds in all three species was < 2% of the dose. 
In vivo metabolism of benzoic acid (50 mg kg-1) in all 
three species produced hippuric acid (> 90%) as the major 24 hour urinary 
metabolite and benzoylglucuronide as a minor metabolite (< 5%). 
The major 8 hour urinary metabolites from phenol 
(25 mg kg-1) metabolism were phenylglucuronide and phenylsulphate. 
In the sheep, the pig and the rat, the glucuronide was 49%, 83% and 
42% of the total urinary metabolites respectively, while the sulphate 
represented about 32%, 1% and 55% respectively. O-Conjugates of quinol 
were minor urinary metabolites (, r, 7%) in all three species. In the 
sheep alone some 12% of the urinary metabolite was conjugated with 
phosphate. 
N kkcetylated derivatives were identified as the major 
24 hour urinary metabolites of aniline (50 mg kg-1) representing 82%, 
85% and 76% of the urinary metabolites from the sheep, the pig and the 
rat respectively. The double conjugate N-acetyl-p-aminophenylglucuronide 
was the major metabolite in the sheep and the pig (60% and 66% respectively) 
while N-acetyl-p-aminophenylsulphate was the major metabolite in the 
rat (56%). Minor urinary metabolites included 0-conjugates of o-, and 
p-aminophenol (- 2O%), acetanilide (=3%) and N-acetyl-P-aminophenol 
(=10%) . 
First order kinetics were observed in the metabolism 
of these compounds in the anaesthetised ureter cann 
70-80% of an intraduodenal dose of phenol (12.5 and 
benzoic acid (50 and 100 mg kg-1) was eliminated in 
whereas only about 50% of a dose of aniline (25 and 
ulated rat and some 
25 mg kg-1) and 
about 2 hours, 
50 mg kg-1) was 
eliminated in about 3 hours. Different rates of elimination of individual 
metabolites were observed and this was reflected in the changes in the 
ratio of metabolite with time. 
Benzoic acid was conjugated extensively with glycine 
by isolated liver and kidney cells from the rat, whereas, the kidney 
cells but not the liver cells carried out this reaction in the dog and 
the ferret. Liver cells from these animals showed a limited ability 
to form benzoylglucuronide. Phenol was O-conjugated and aniline was 
N-acetylated by isolated intestinal mucosal cells from the rat. Isolated 
liver cells from the rat were shown to be able to metabolise phenol and 
aniline giving metabolic patterns similar to those obtained from in 
vivo metabolism studies. 
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FOREWORD 
The environment has always contained a wide variety of 
substances which are considered foreign to the animal body. These 
substances are usually consumed as a consequence of their presence in 
the normal diet and as man becomes more dependent on synthetic chemicals 
in the form of drugs, food additives, pesticides and herbicides, etc. 
for his well-being, other animal species, in particular, species of 
agricultural and economic importance will also be subjected to continuous 
increase in exposure to additional foreign compounds. To many chemicals 
lipophilic membranes present no barrier, thus it is apparent that large 
numbers of foreign compounds are being absorbed through ingestion in 
food and drink, in the inspired air and through the skin continuously 
and it is therefore important to know the fate of these foreign compounds 
in the animal body. 
Probably all these foreign compounds are capable of 
evoking pharmacologic and toxicologic responses in animals which have been 
exposed to them and although animals in general are protected from the 
noxious effects of these foreign compounds by detoxication mechanisms 
present in the animal body, nevertheless, it is important to know and 
to understand the functional significance of these biochemical mechanisms, 
how they work and what are their limitations as protective systems. To 
this end the study of the biochemistry of foreign compounds has made 
tremendous advances in recent years and numerous scientific publications 
and treatise have been produced, so much so that it has become a basic 
scientific discipline of pharmacology, toxicology and pathology. 
Detoxication is a biochemical defence mechanism of the 
body which limits the duration and intensity of a response evoked by 
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the exposure to foreign compounds and it is a complex dynamic function 
of the body. Metabolism is generally regarded as the most important 
process in detoxication, however, other processes such as absorption, 
distribution and excretion are also important in the detoxication and 
elimination of foreign compounds from the animal body. Thus to consider 
one process to the exclusion of another over simplifies the dynamic 
interactions involved so that an understanding of the mechanism of 
detoxication is necessarily only approximate. It is important to bear 
this in mind when considering the role of metabolism in detoxication. 
The metabolic fate of many foreign compounds has been 
extensively investigated, but few studies have been conducted concerning 
the interaction of metabolism with other processes involved in detoxication. 
The role of metabolism in detoxication of drugs has been studied for nearly 
a century, and it is apparent that metabolism plays an important role 
in rendering an active foreign compound biologically inert or altering 
the properties of that compound so that other processes of detoxication 
such as renal or biliary excretion can remove that compound more readily 
from the body. The extent to which any one process plays a role in 
detoxication depends largely on the foreign compound, the animal 
species and route of administration. It is generally accepted that 
metabolism is mediated principally by the liver and relatively little 
significance has been attributed to metabolism by other organs even 
though it is known that they may be involved in the metabolism of 
foreign compounds. However, recent studies have shown that extrahepatic 
metabolism of foreign compounds does have functional significance in 
the detoxication of foreign compounds. Extrahepatic tissues which are 
being extensively studied include, the intestines, lungs, kidneys, 
blood, brain and placenta. 
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In the following thesis a comprehensive review on the 
metabolism of foreign compounds will not be attempted, but rather only 
those concepts pertinent to the understanding and discussions of the 
thesis will be considered. 
CHAPTER I 
INTRODUCTION 
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1.1 BIOTRANSFORMATION OF FOREIGN COMPOUNDS 
1.1.1 Mechanisms of Biotransformation of Foreign Compounds 
In the animal body foreign compounds undergo a wide 
range of biotransformations which in general are carried out in two 
phases and the reactions involved may be classified into oxidation, 
reduction, hydrolysis and synthesis or conjugation. Oxidation, reduction 
and hydrolysis constitute what are termed the phase I reactions while 
synthesis or, conjugation constitute the phase II reactions (Williams 
1959, Williams 1967, Parke 1968). In general most foreign compounds in 
the body undergo a phase I reaction and the products of the phase I 
reaction are metabolised further by a phase II reaction, to form more 
water soluble materials which are then eliminated from the body. Not 
all foreign compounds are metabolised by the two phase process, some 
compounds are metabolised mainly by just a phase I or a phase II reaction. 
Most foreign compounds are metabolised in the liver of 
animals and the metabolising enzymes can occur in the soluble, mitochrondrial 
or microsomal fractions of the hepatic tissues. A drug may be metabolised 
by more than one metabolic pathway, and indeed very often a foreign 
compound may be subjected to several competing pathways of metabolism 
simultaneously so that the L. -. tent of formation of the various metabolites 
will depend on the relative rates of the various pathways involved. 
However, enough information is available at present so that by analogy, 
the major route of metabolism of most foreign compounds may be anticipated, 
but it has not yet been possible to predict precisely the pathway of 
metabolism of a given compound in a given species. 
This section will deal primarily with metabolic pathways 
of biotransformation of foreign compounds which are relevant to the 
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present investigation. However, for the purpose of completeness a 
list of characteristic drug metabolising reactions are given in tabulated 
form in the following subsections. 
1.1.1.1 Phase I Reactions 
Metabolic reactions which may be classified as phase I 
reactions are carried out by enzymes of the normal metabolic pathways 
of the body and by the so-called "drug metabolising enzymes" or "mixed 
function monooxygenases". Most compounds are metabolised by the latter 
which are enzymes associated with the endoplasmic reticulum of cells. 
Although the liver is the major site of metabolism of most foreign compounds, 
recent studies have shown that drug metabolising activities are also 
present in the microsomal fraction of cells of extrahepatic tissues. 
The subcellular location of typical phase I reactions is summarized 
in Table 1.1. 
The phase I reactions which are most relevant to this 
thesis are aromatic hydroxylation and N-oxidation and it is perhaps 
significant that these are probably the most studied phase I oxidative 
reactions. 
Most aromatic compounds are hydroxylated by the hepatic 
microsomal cytochrome P450 dependent enzymes to yield phenols. The 
hydroxylation of benzene to phenol is perhaps the classical example 
of aromatic hydroxylation affording a striking illustration of the 
reactivity of the monooxygenase system of enzymes. Numerous mechanisms 
of hydroxylation of aromatic compounds have been proposed and it is now 
well established that the insertion of molecular oxygen to give an 
epoxide (arene oxide) is the first step in the majority of aromatic 
hydroxylations. Figure 1.1 shows that an arene oxide intermediate can 
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Table 1.1 
Typical Phase I Reactions 
Chemical Reactions Location of &izymes 
Mic. Mit. Cyt. 
OXIDATIONS : - 
Hydroxylatiou 
Dealkylation 
aliphatic 
aromatic 
0- 
N- 
S- 
Epoxidation 
Oxide formation N- 
S- 
Aromatizatiou 
Alcohol oxidation 
Aldehyde oxidation 
Desulphuration 
Dehalogenation 
Oxidative deamination 
REDUCTION : - 
Nitroreduction 
Azoreduction 
Aldehyde reduction 
Oxide reduction 
HYDROLYSIS : - 
Deesterification 
Deamination 
Mic. - Microsomes 
Mit. - Mitochrondria 
Cyt. - Cytosol 
+ 
+ 
} 
+ 
+ 
+ 
+ 
+ 
t 
4 
+ 
} 
+ 
-I- 
+ 
+ 
+ 
f 
t 
+ 
+ 
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FIGURE 1"1 
MECHANISMS OF ENZYMIC AROMATIC HYDROXYLATION 
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give rise to a number of metabolites: phenols, dihydrodiols and 
mercapturic acids. The nature and distribution of these metabolites 
are dependent on a number of factors including the stability of arene 
oxides with regard to isomerization to the phenols, suitability as a 
substrate for epoxide hydratase and its affinity to nucleophilic groups 
of tissue macromolecular components. The relative stability of arene 
oxides is a function of the number and type of substituents present in 
the oxiran ring, and electron donating substituents will tend to decrease 
while electron withdrawing substituents will tend to increase the 
stability of the arene oxide. Thus the life time of the arene oxides, 
which may leave the microsomal enzymes prior to further metabolism and 
have a high affinity for tissue macromolecular components in vivo, may 
have important significance in tissue response to the parent aromatic 
compounds. Other factors which are important include the susceptibility 
of arene oxides to epoxide hydratase and glutathione-S-epoxide transf erase 
activity and the availability of glutathione. 
The isomerization of arene oxides to phenols is a reaction 
which occurs nonenzymically and in neutral and basic environments it is 
a spontaneous rearrangement while at pH <6, the arrangement is an acid 
catalysed isomerization. In both cases, the rate limiting step is 
believed to be the opening of the epoxide to form either the zwitterion 
or the protonated derivative. This isomerization is accompanied by 
intramolecular displacement of an aromatic substituent (e. g. isotopic 
hydrogen, halogen and methyl group) from the place of the final location 
of the phenolic group to a neighbouring carbon atom. This phenomenon is 
known as the "N. I. H. shift" (Guroff et al 1967) and has now been accepted 
as providing a priori evidence for the intermediacy of arene oxides in 
enzymic aromatic hydroxylation. The mechanism of isomerization to phenols 
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involving the "N. I. H. shift" has been considered by many authors and 
an authoritative review on the subject has been published recently 
(Daly et al 1972). Under physiological pH conditions, the proposed 
mechanism may be summarized in the following simplified scheme: - 
RRRR 
. 
MIXED DI RECTT> 
FIýVCTION HR LOSS 
X OXIDASE XX 0' >l OH 
NIH 
SHIFT 
RR 
H 
XX 0H 
The synthesis of trans-dihydrodiols is a reaction which 
is catalysed by the enzyme epoxide hydratase. It has been studied in 
great depth and a comprehensive review on the subject has been published 
recently (Oesch 1973). The enzyme is localised in the microsomal fraction 
and shows a close relationship with the microsomal mixed function mono- 
oxygenase system of enzymes. The liver is the main site of epoxide 
hydratase activity and low levels of epoxide hydratase have also been 
found in the kidney, lungs, intestines and skin, but apparently no 
activity was detectable in the brain, heart, spleen and muscle. The 
dihydrodiols formed by epoxide hydratase are either conjugated with 
glucuronic acid and/or converted to catechols by soluble hepatic 
hydrogenase and the catechols are subsequently metabolised by catechol- 0- 
methyltransferase or other conjugations. Formation of dihydrodiols is 
also evidence for the involvement of epoxides in enzymic aromatic 
hydroxylation. 
Arene oxides are also readily opened by nucleophiles, 
especially those containing sulphur and the addition of the thiol group 
of glutathione to arene oxides can lead to glutathione conjugates. This 
conjugation proceeds either spontaneously or is catalysed by soluble 
hepatic glutathione-S-epoxide transferase(s). The glutathione conjugates 
formed are converted to premercapturic acids in vivo and subsequently 
to mercapturic acids under acid conditions. Arene oxides are also found 
covalently bound to tissues, probably through nucleophilic moieties 
in tissue macromolecules. 
Other mechanisms for aromatic hydroxylations have also 
been postulated and it is likely that they may be involved in specific 
cases. The conversion of aniline to p-aminophenol and benzene to phenol 
has been shown to proceed via hydroxymethylation to give intermediates 
of p-aminobenzylalcohol (Sloane 1964, Sloane and Heinemann 1967) and 
benzylalcohol (Sloane 1965) respectively. This is a relatively minor 
pathway and the mechanism is unknown but a firmly bound form of an 
active folate derivative may be the carbon donor for the hydroxymethylation 
reaction (Sloane and Heinemann 1970). 
Aromatic hydroxylation is generally catalysed by microsomal 
enzymes, but recently aniline hydroxylase activity in rat and human 
placenta was found in the cytosol and the catalytic activity was observed 
to be associated with haemoglobin (Juchau and Symms 1972). The 
o-hydroxylation of 2-acetyl-aminofluorene via an enzyme catalysed isomeri- 
zation of the N-hydroxylated intermediate, N-hydroxy-2-acetylaminofluorene 
12 
(Gutmann and Erickson 1969,1970) offers another mechanism of aromatic 
hydroxylation. The reaction appears to be restricted to arylhydroxamic 
acids. It is catalysed by enzymes of the soluble fraction of the liver 
and it has been suggested that hydroxylamines may be intermediates in 
o-hydroxylation of aromatic amines (Booth and Boyland 1964). It is 
usually only a minor pathway, but amines in which the p-position is 
blocked are more readily metabolised by this route (Von Jagow et a] 
1966, Kampffineyer and Kiese 1964). 
Because of the common occurrence of nitrogen in many 
drugs and foreign compounds, much interest has been directed towards 
the interrelationships of various biological oxidation reactions 
involving the nitrogen in organic molecules. There are at least two 
microsomal enzyme systems which are involved in the enzymic oxidation 
of organic nitrogen and a relationship has been suggested between the 
pKa's of the organic nitrogen and the enzyme system involved, namely 
that the basic amines with pKa 8-11 are oxidised by a flavineadenosine 
nucleotide (FAD) - dependent enzyme system while nonbasic nitrogen 
containing compounds such as those with adjacent carbonyl groups whose 
pKa's are 1 or less are oxidised by a cytochrome P450 dependent system. 
Furthermore intermediate compounds with pKa 1-7 are substrates of both 
enzyme system which would yield the same products but by different 
processes (Gorrod 1973). This concept has however been strongly 
challenged by Hlvica (Personal Communication). A mixed function amine 
oxidase has been solubilised from pig hepatic microsomal fraction with 
detergent, which is capable of oxidising some secondary and tertiary 
amines with "intermediate" and "basic" pKa nitrogens (Zieglar and 
Mitchell 1972). 
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Oxidation of organic nitrogen gives rise to N-hydroxy 
or N-oxide metabolites depending on whether the nitrogen is primary, 
secondary or tertiary. Thus it has been shown that many aromatic 
primary amines, secondary amides and some carbamates are metabolised by 
N-oxidation to give N-hydroxy metabolites while tertiary amines are 
metabolised to N-oxides (Gorrod 1973). Typical examples of nitrogen 
oxidation include the N-hydroxylation of 2-acetyl-aminofluorene to give 
N-acetyl-N-2-fluorenylhydroxylamine (Cramer et al 1960), this reaction 
is probably essential for the carcinogenic properties of 2-acetylamino- 
fluorene, and the synthesis of phenylhydroxylamine from aniline (Kiese 
1959). From the point of view of aromatic amines, N-oxidation to give 
arylhydroxylamine results in the synthesis of potentially toxic 
metabolites and arylhydroxylamines are implicated in ferrihaemoglobin 
formation in many species after administration of the parent amines 
(Kiese 1966). 
1.1.1.2 Phase II Reactions 
Phase II reactions or conjugations are biosynthetic reactions 
by which foreign compounds and their metabolites are conjugated to 
endogenous substrates. In general conjugation involves the transfer 
of a readily available endogenous substrate from a donor to the foreign 
compound containing functional groups (e. g. OH, SH, COOH, NH2) which 
act as the acceptors. 
A conjugation requires, amongst other things, an "active" 
intermediate, usually a nucleotide and a transferring enzyme and from 
the point of view of the mechanism, there are two kinds of conjugation 
reactions: one in which the conjugating agent forms part of the active 
intermediate (e. g. glucuronic acid conjugation) and the other in which 
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Table 1.2 
Chemical 
Reactions 
Glucuronic acid 
conjugation 
5u1phate 
conjugation 
Acetylation 
Amino acid 
conjugation 
Glycine 
Mercapturic 
acid 
Methylation 
Typical Phase II Reactions 
Donor Major Acceptors 
UDPGA -0H, -C 00H , 
NT 29 NH 9 -SH 
PAPS 
Acetyl-CoA 
Glycine 
C GASH 
Glutathione 
S-adenoarl -= 
methionine 
Mic. - Microsomes 
Mit. - Mitochrondria 
Cyt. - Cytosol 
ArOH, ArNH2 9 
ROH 
ArNH2 9 Rvi i2 
1 
2' 
ArSO2NH2 
ArC OOH, 
ArCHý)COOH 
-Cl, -Br. -NO 
Epoxides, 
Axomatic 
hydrocarbons 
ArOH9 -NH 2 
NH, N, -SH 
En, 'rjýme T, nea+i nn 
Mic. Mit. Cyt. 
4 
+ 
+ 
+ 
+ 
+ 
0 
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the drug or its phase I metabolite forms part of the active intermediate 
(e. g. amino acid conjugation). Conjugation reactions are by no means 
restricted to foreign compounds and conjugates of endogenous compounds 
are also found. For example, they are important in the metabolism of 
bile pigments and bile salts and they are also involved in the synthesis, 
deactivation and transport of certain hormones. Typical conjugation 
reactions are summarized in Tablel. 2. 
Glucuronic acid conjugation: - 
Conjugation reactions involving carbohydrates as the donor 
are very common and in mammals glucuronic acid conjugation is one of the 
more common routes of metabolism of foreign compounds in most species. 
Other carbohydrates such as glucose, N-acetylglucosamine and ribose 
have also been shown to be conjugated, but these are formed only in either 
specific species of animals or occurring with specific foreign compounds 
(Williams 1967). 
The pathway of glucuronic acid conjugation involves a 
condensation reaction between "activated" glucuronic acid and the 
foreign compound or its biotransformation product and may be summarized 
in the following scheme: 
Glucose-l-phosphate + UTP o UDP-glucose + pyrophosphate 
pyrophosphorylase 
UDP-glucose + 2NAD+ + H2O 0 UDP-glucuronic acid + 2NADH + 2H+ 
UDPG-dehydrogenase 
UDP-glucuronic acid + RXH ) RX-glucuronic acid + UDP 
UDP-glucuronyl transferase. 
NH or S. 
I- 
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e. g. 
OH 
OH + OH QH 
N H2-0 -0-P-C PHENOL p. ý a00 
o "I 
COOH 
0 
OH 
C 
H 
PHENYLGLUCURONIDE 
1H 
+ 
COOH 
OH 
UDP 
H 
The biosynthesis of glucuronides has been the subject of 
a detailed monograph (Dutton 1966). It should be noted that as the 
result of the condensation reaction, the C-1 atom of glucuronic acid is 
changed from the L )L configuration to a (3 configuration. The transfer of 
glucuronic acid from UDPGA to the acceptor drugs or foreign compounds is 
probably catalysed by a family of glucuronyltransferases (although the 
data could equally well be interpreted as one enzyme existing in a 
number of different microenvironments), which are microsomal enzymes 
found not only in the liver, but also widely distributed in a number of 
tissues including the lungs, small intestines, kidneys, brain placenta 
and skin (Miettinen and Leskinen 1970, Aitio 1973 a, b). Potentially 
compounds with OH, COOH, NH2 or SH groups are capable of acting as 
glucuronic acid acceptors in glucuronide formation and give rise to 
o-glucuronides (ether and ester types), N-glucuronides and S-glucuronides 
(Smith and Williams11966, Williams 1967). 
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Sulphate Conjugation: - 
Conjugation with inorganic sulphate to give sulphoconjugates 
constitutes a very common biochemical reaction and sulphate conjugates 
are found widely distributed in the animal world. By far the most 
widely distributed sulphoconjugates are the sulphuric acid esters in 
which the C-O-SO3 linkage is present. However, other conjugates exist 
in which sulphate is covalently attached to other linkages, e. g. 
P-O-SO 3, N-SO 3, N-O-SO3 and S-SO 3. The subject of sulphoconjugation 
and sulphohydrolysis has been recently reviewed by Dodgson and Rose (1970). 
The pathway of sulphate conjugation requires the activation 
of inorganic sulphate in a series of reactions involving ATP to form 
31 -phosphoadenosine-5ý-phosphosulphate (PAPS) which is the "active" 
sulphate donor. The sequence of events leading to sulphate conjugation 
is summarized in the following scheme: 
SO4 + ATP o Adenosine-5ý-phosphosulphate (APS)+ pyrophosphate 
ATP-sulphateadenyltransferase 
APS + ATP --' 3I-phosphoadenosine-5I-phosphosulphate (PAPS) + ADP 
APS-sulphokinase 
PAPS + RXH --i RX-SO3H + 3-phosphoadenosine 5ý-phosphate (PAP) 
sulphokinase. 
X=0 or NH. 
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e. g. 
OH NH 2 
N 
CH2O-P'-0-503H 
PHENOL 
N 
OH 
0 
PAPS 
X=-0--CH 
OH 
OSO3H 
PHENYL- 
SULPHATE 
PAP 
These reactions occur in the soluble fraction of cells 
and the transfer of inorganic sulphate from PAPS to the acceptor molecule 
is catalysed by a family of enzymes known as sulphokinases (sulphotrans- 
ferases). Several sulphokinases have been described and they are 
widely distributed in various tissues including the liver, kidneys and 
intestine (Dodgson and Rose 1970). Foreign compounds such as phenols, 
certain aliphatic alcohols and some aromatic amines are metabolised by 
sulphate conjugation and are excreted as etheral sulphates and sulphamates. 
Acetylation: - 
Acetylation of amino, hydroxyl and sulphydryl groups can 
occur in the intact animal, but only a few examples of acetylation of 
OH group (e. g. choline to acetylcholine) and SH groups (e. g. synthesis 
of acetyl-CoA) are known to occur in the body and no example of acetylation 
of these groups in drugs or other foreign compounds appears to be known. 
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Acetylation of amino groups on the other hand is comparatively common 
and the reaction involved may be illustrated by the acetylation of 
sulphanilamide to N4-acetylsulphanilamide. 
NHZ 
2NH2 
SULPHANILAMIDE 
CH3 CC-S-CoA 
0 
CH3 C- H 
1+ 
NHZ 
N4ACETYL - SULPHANILAMIDE 
CoASH 
There are at least 5 types of amino groups which may be 
acetylated and these include: aromatic amino groups (ArNH2); aliphatic 
amino groups (RNH2); o. amino acids (R. CH. NH2.000H); hydrazino groups 
(R. NH. NH2) and suiphonamido groups (Ar. SO2NH2) (Williams 1967). The 
enzymes involved in these reactions are collectively known as 
N-acetyltransferases and evidence for the multiplicity of N-acetyltransferase 
is being accumulated. A review on the acetylation of drugs has appeared 
recently and it summarizes some of the available information regarding 
N-acetylation (Weber 1973). 
N-Acetylation reactions occur in the soluble fraction of 
cells and it is believed that acetylation reactions take place in the 
reticulo endothelial rather than the parenchymal cells of the liver 
(Govier 1965). Acetylation of foreign compounds has been known to 
occur in tissues other than the liver and tissue distribution studies 
showed that acetylation reactions occur in most of the tissues of 
the body (Weber 1973). 
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Amino acid conjugation: - 
Conjugation with amino acids represents another pathway 
in phase II metabolism and the well known conjugations involving amino 
acids include the synthesis of hippuric acids (glycine conjugation) and 
synthesis of mercapturic acids (glutathione conjugation). 
Glycine is probably the most important amino acid involved 
in phase II reactions with foreign compounds. It is a reaction which 
occurs usually with aromatic acids and also with some aliphatic acids 
(Williams 1963). The pathway of glycine conjugation may be summarized 
as follows: 
Ar-COOH + ATP o Ar-CO-AMP + pyrophosphate 
acyl synthetase 
Ar-CO-AMP + CoASH ---ý. Ar-CO-S-CoA + AMP 
acyl kinase. 
Ar-CO-S-CoA + NH2-CH2-COOH > Ar-CO-NH-CH2-COOH + CoASH 
transacylase 
e. g. 
c OOH + 
BENZOIC 
ACID 
NI-ý- C H2 COO H 
GLYCINE 
CoASH 
CT CO-NH-CH2 COOH 
HIPPURIC ACID 
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This reaction occurs in the mitochrondrial fraction of 
cells and glycine is not the only amino acid capable of undergoing such 
a reaction, for in some species glycine may be replaced or supplemented 
by glutamine, ornithine, arginine or taurine (Williams, 1967, Smith 
1968). 
Mercapturic acid synthesis involves a conjugation reaction 
with glutathione catalysed by glutathione-S-transferase enzymes. The 
formation of mercapturic acids has been studied in considerable detail 
in animals and the pathway of biosynthesis of mercapturic acids and the 
nature and distribution of the enzymes catalysing the conjugation of 
glutathione with foreign compounds have been reviewed recently (Boyland 
and Chasseaud, 1969, Wood. 1970, Chasseaud, 1973). The biosynthesis of 
mercapturic acids which are derivatives of N-acetylcysteine is summarized 
in the following pathway: - 
RX + HSCH2-CHCONHCH2000H 
I 
NHCOCH2CH2-CHCOOH 
I 
NH2 
glutathione-S-transferase 
R-S-CH 2-CHCONHCH2000H 
NHCOCH2CH2-CHCOOH 
NH2 
'-glutamyl transferase 
R-S-CH 2-CHCONHCH2000H I 
NH2 
cysteinylglycinase 
R-S-CH 2-CHCOOH 
R- ''H2-CHCOOH 
NH 2 NH 
acetylase I 
COCH 3 
mercapturic acic 
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Unlike other conjugation mechanisms glutathione conjugation 
does not appear to require an "activated" intermediate (Chasseaud 1973), 
although in the case of epoxide conjugates, the epoxide may be considered 
to be an activated intermediate. The enzymes involved in mercapturic 
acid synthesis are found to be widely distributed in the soluble fraction 
of many tissues including the liver and the kidneys and foreign compounds 
which are conjugated with glutathione include aromatic hydrocarbons, 
hydrocarbons containing 'active' halogen and nitro groups, epoxides and 
many others (Chasseaud 1973). Interestingly aromatic amines have also 
been shown to be precursors of mercapturic acids (Boyland et al 1962). 
Another conjugation mechanism in which an amino acid 
participates is methylation. This involves the transfer of a methyl group 
from donor methionine via S-adenosylmethionine to an acceptor molecule 
catalysed by methyltransferase(s). This reaction is a very common 
pathway for methylation of many endogenous compounds, but represents 
a relatively minor pathway for foreign compounds and drugs. Some foreign 
polyhydric phenols are metabolised by this pathway to a very limited 
extent. 
1.1.2 Factors Affecting Biotransformation of Foreign Compounds 
It has already been stated that the metabolism of a 
foreign compound may be carried out by several different pathways of 
biotransformation simultaneously resulting in many different metabolites. 
The rate at which these biotransformations proceed and their relative 
importance in determining the metabolic profile and biological activities 
of foreign compounds are affected by a number of factors. These factors 
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may be genetic, physiological and environmental in origin (Parke 1968, 
Vesell et al 1976, Max Lang and Vesell 1976) and in the study of 
foreign compound metabolism these factors must be taken into consideration, 
particularly in areas where comparisons between species of animals 
including man are concerned, as in the testing and safety evaluation 
of foreign compounds for use in man. In this section, a brief summary 
of some of the factors affecting metabolism of foreign compounds in 
animals together with the implications of these factors will be discussed 
in terms of the present investigation. 
1.1.2.1 Genetic Factors 
Genetic factors which affect the biotransformation of 
foreign compounds may be classified as those affording species differences 
and strain differences, i. e. genetic polymorphism and the study of intra- 
species differences has given rise to the relatively new science of 
pharmacogenetics. 
In all species the metabolism of foreign compounds follows 
a common biphasic pattern of reaction as discussed in the preceding 
section. These reactions are mediated by enzymes and the nature and 
distribution of these enzymes which are subject to genetic controls are 
the main contributory factors in the inter- and intra-species 
differences in foreign compound metabolism (Kalow, 1965, Williams, 1967, 
Hathway, 1970, Hucker, 1970, La Du, 1972, Vesell, 1972,1973, Nebert and 
Felton, 1976). The enzymes which are involved in the metabolism of foreign 
compounds may vary qualitatively and quantitatively so that species 
differences may arise as the result of qualitative or quantitative 
differences in the actual pathways of metabolism. Differences may 
arise due to the presence or absence of particular enzymes in different 
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species, the amount and localization of drug metabolising enzymes, 
the presence of natural inhibitors of these enzymes and the possible 
presence of enzymes which compete for the same foreign compounds. 
Furthermore, the presence of enzymes which are capable of reversing 
the reaction of biotransformation of a particular foreign compound 
and its metabolites may have a significant role in the observed 
differences in foreign compound metabolism between species. 
Thorough investigations on the species variation in 
the actual enzymes involved in foreign compound metabolism have yet to 
be carried out, but based on our knowledge of pathways of drug metabolism 
and the observed metabolic profile, some insight into the factors 
contributing towards species variation has been obtained. Thus aromatic 
hydroxylation, one of the most studied reactions in phase I metabolism 
has been shown to occur in most species studied including insects, fish 
birds, reptiles and mammals, but the extent to which this reaction occurs 
in the metabolism of a given compound and the orientation of the resultant 
hydroxylated derivatives varies considerably from species to species so 
that in the case of aniline, which is hydroxylated both at the o- and 
p- positions, the ratio of the p-hydroxylated to the o-hydroxylated 
urinary metabolites shows considerable species variaton (Parke 1960). 
This has been interpreted to be due to the presence of two aniline 
hydroxylases in different amounts in different species so that the 
activity of o-aniline hydroxylase is greater in species with low p: o 
ratios while species with high p: o ratios may have very active p-aniline 
hydroxylase. 
Many observations of species differences have been made 
with regards to phase I and phase II metabolism, but systematic 
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investigations on species variation have generally been restricted to 
phase II reactions. For example, glucuronic acid conjugation is found 
to be present in most animal species, but is absent in insects where 
it is replaced by ß -glucoside synthesis (Smith, 1968) and in the cat 
and the Gunn rat there appear to be some deficiencies in glucuronyl- 
transferase activities. Deficiencies in other conjugating mechanisms 
are also observed in some "common" species. Thus the pig has been 
shown to have a deficiency in sulphate conjugation with respect to 
some phenols while the dog and hen are believed to be deficient in 
acetylation of aromatic amines and glycine conjugation of aromatic acids 
respectively (Williams 1967). 
In the animal body there are several mutually antagonistic 
enzyme systems, e. g. glucuronyltransf erase-: --glucuronidase (Miettinen 
and Leskinen, 1970), sulphotransferase-sulphatase (Dodgson and Rose, 1970) 
and acetylase-deacetylase (Weber, 1973), but unfortunately the functional 
significance of these enzyme systems are as yet unexplained. However, 
their presence suggests that they may contribute to species variation in 
foreign compound metabolism in that the excretion of a particular 
conjugate may be an expression of the relative activities of conjugation 
and deconjugation enzymes. 
1.1.2,2 Physiological Factors 
Factors which may affect the biotransformation of"foreign 
compounds from a physiological standpoint are numerous and they may 
alter the metabolism of foreign compounds both qualitatively and quantitat- 
ively. Age is an important factor for consideration (Wilson, 1972, Yaffe 
and Juchau, 1973, Neims, et al, 1976), since it affects not only the 
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development of enzyme systems involved in metabolism as in the neonatal 
development of glucuronyltransferase (Dutton 1966), but also the hormonal 
state of the animal which plays an important part in the maintenance of 
the homeostatic regulation of the animal. Thus in the rat the marked 
sex differences in drug metabolism observed are apparently controlled 
by the production of androgens and although such differences are also 
observed in some other species (e. g. the mouse), sex differences in the 
metabolism of foreign compounds are generally small or absent in most 
species studied (Parke, 1968, Hathway, 1970, Gillette, 1971). 
Changes in the availability of endogenous constituents 
such as co-factors in foreign compound metabolism will also alter the 
metabolic profile and perhaps the toxicity of the administered foreign 
compound. Thus the availability of endogenous conjugating substrates 
such as inorganic sulphate and amino acids, which depends on the nutritional 
status of the animal may be altered by changes in the diet of the animal 
(Arnstein and Neuberger, 1951, Bray, et al, 1952b, Miettinen and Leskinen, 
1970, Campbell and Hayes, 1974). Indeed the dose level and the frequency 
of the exposure of an animal to foreign compounds will also have important 
implications on their metabolism since metabolic reactions may be 
saturated by high levels of foreign compounds either because of the 
limiting capacity of the metabolising enzyme or because of the readily 
exhaustible supply of co--factors. Where metabolism is mediated by more 
than one pathway, such factors will have important significance in 
the competition between pathways of metabolism, resulting in changes 
in metabolic profile with changes in the dose level of the foreign 
chemical. 
When a foreign compound is administered to an animal, 
numerous factors are involved in the transport of the compound and its 
27 
metabolites to and from it's site of metabolism. These factors will 
have important roles in the rate of metabolism of the compound, the 
duration of the compound in the animal and hence the potential hazards 
of the compound in the animal. Such factors may include absorption, 
plasma protein binding, tissue distribution, biliary and urinary excretion 
and entrohepatic circulation. Furthermore, these factors are influenced 
by the nature of the foreign compound, blood flow to and from the site 
of metabolism and the activities of the drug metabolising enzymes 
(Gillette, 1971a, Vesell, et al, 1976). The route of administration also 
serves as an important factor for consideration (Dollery, et al, 1971, 
Conolly et al, 1972, George, et al, 1974), since compounds administered 
orally may be subjected to the actions of the gastrointestinal micro- 
organisms, intestinal secretions, enzymes of the intestinal wall, all 
of which are by passed by an intraperitoneal injection and the absorption 
of the compounds may be influenced by factors such as gastric emptying 
and intestinal mobility (Dent, 1975). Other physiological factors which 
may influence metabolism of foreign compounds include seasonal variation 
and circadian rhythm (Moore Ede, 1973, Romero, 1976). 
The disease state of the animal will also influence 
the metabolism of foreign compounds. It is well known that human patients 
with severe liver damage show an increased sensitivity to a wide variety 
of drugs. This phenomenon has been attributed to the impairment of 
the detoxicating function of the liver (Parke, 1968). However, other 
organs are also involved in the metabolism of foreign compounds so 
that physiological abnormalities due to diseases, which result in 
tissue redistribution of administered foreign compounds and functional 
alteration of organs with specific roles in the metabolism of foreign 
compounds will also affect the metabolic profiles of the foreign compounds. 
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1,1.2,3 Environmental Factors 
Environmental factors which may affect the metabolism of 
administered foreign compounds include stress due to adverse conditions, 
changes in the atmospheric conditions and exposure to ionising radiation, 
but perhaps the most studied environmental factor is the interaction 
with other foreign compounds either administered deliberately or 
accidentally. These interactions may result in alteration in the 
metabolism of not only foreign compounds, but also normal body constituents 
(Parke, 1968, Conney, 1971, Brown, 1970; 1972; 1975, Fouts, 1976) . 
The administration to animals of numerous drugs and 
environmental chemicals can inhibit or potentiate the pharmacological 
and toxicological action of the drugs and this may be achieved by a 
variety of mechanisms apart from direct effects on drug metabolising 
enzymes, including the alteration in drug distribution as in the competition 
for receptor sites and the displacement of protein bound drugs by other 
administered drugs (Dayton and Perel, 1971). However, alteration in the 
activities of the drug metabolising enzyme system is probably the most 
important medium by which affects of environmental factors are manifested 
(Gillette, 1976) and furthermore, steroid hormones are substrates of the 
same liver microsomal enzyme system that metabolises foreign compounds 
so that environmental factors which affect drug metabolism may also affect 
the hormonal status of the animals concerned. 
The activation of the metabolism of foreign compounds by 
the chronic administration of other foreign compounds such as drugs, 
pesticides and polycyclic hydrocarbons is well known and has been studied 
extensively because of their possible association with carcinogenesis and 
drug tolerance (Conney, 1967,1971). This activation of the enzymes 
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involved in metabolism of foreign compounds is due to an increase in 
the amount of drug metabolising enzymes resulting from enzyme induction 
which probably requires the de novo synthesis of enzyme protein (Gelboin 
1971). 
The inhibition of metabolism of foreign compounds by 
other foreign compounds has also been observed and unlike induction, 
inhibition does not require repeated administration of the effecting 
agent. The mechanism of inhibition is not fully understood and several 
inhibitory mechanisms may exist, including competitive inhibition for 
the enzyme systems by acting as alternative substrates, non-competitive 
inhibition by "allosteric" modification, uncoupling of the oxidative 
mechanisms involved in hepatic microsomal drug metabolism and alteration 
of the properties of the hepatic microsomal enzymes (Anders 1971, Leibman 
and Ortiz 1973). 
Many foreign compounds and environmental contaminants are 
inducers and inhibitors of drug metabolism and interestingly administration 
of sub-optimal levels of different inducers concurrently gives rise to 
additive effects of induction. The classical inducers of drug 
metabolising enzymes are phenobarbital and 3-methylcholanthrene while 
SKF525A ((3 -diethylaminoethyldiphenylpropylacetate) and metyrapone 
are classic inhibitors of drug metabolism in animals. 
Inducers and inhibitors may have considerable effects on 
the metabolism of other foreign compounds leading to changes in the 
toxicity and the intensities of pharmacological activities of these 
compounds. Thus in the presence of an inhibitor the therapeutic action 
of a drug may be potentiated because the inhibitor functions as a 
synergist, but this will also prolc-ng any possible toxic effect of the 
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parent drug, if detoxication of the drug is mediated by metabolism. 
On the other hand the presence of inducers may accelerate the metabolism 
of the drug and hence reduce its therapeutic value. Moreover, many drugs 
such as phenobarbital will also induce their own metabolism so that 
repeated dosage of the drug will lead to the development of tolerance 
as a result of increase in detoxication of the drug due to increase 
in metabolism. 
1.1.3 Consequences of Biotransformation of Foreign Compounds 
The biological activities of foreign compounds in an 
animal are usually governed by the rate at which these compounds are 
eliminated from the body, and although there are numerous routes by 
which foreign compounds may be removed from the body, by far the most 
important are the renal and biliary excretory routes. Other routes 
of excretion include pulmonary excretion, secretions in the saliva, 
milk, sweat and gastrointestinal tract (Stowe and Plaa, 1968, Werner 
1976, Chasseaud, 1971, P1aa, 1971). 
In general, the renal elimination of foreign compounds 
is governed by a number of factors including those which affect the rate 
of glomerular filtration and tubular transport of foreign compounds 
(Cafruny, 1971, Rennick, 1972), but by far the most important factor is 
the polarity of the foreign compound. Thus the elimination of lipid 
soluble substances by the kidneys is slow because such substances are 
likely to diffuse from the glomerular filtrate back into the plasma 
until the concentrations in the plasma and the urine are virtually 
identical, whereas in general, polar and ionized compounds are not 
reabsorbed in the renal tubules. The renal excretion of some polar 
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metabolites may be enhanced by active transport mechanisms, thus 
many acidic and basic foreign compounds are actively secreted in the 
proximal tubules of mammalian kidneys. It can be seen then, that 
detoxication occurs as a consequence of the change in polarity of the 
foreign compound following biotransformation thus permitting a subsequent 
improvement in its renal excretion rate. 
The increased polarity and hence water solubility of an 
administered foreign compound, although involving both phase I and phase 
II metabolism is normally primarily due to the conjugation reactions 
(Parke, 1968). The two most important properties of a bioactive molecule 
are its biochemical activity and its lipid solubility. The former 
often shows a high degree of molecular structural dependency so that 
subsequent to conjugation reactions considerable structural alteration 
results and this may be expected to result in the loss of bioactivity. 
The lipid solubility on the other hand gives a measure of the ability 
to penetrate biomembranes to potential sites of action and as a 
consequence of conjugation reactions, the lip. ophilicity of the compound 
may be altered so as to result in limited bioavailability and hence 
detoxication. Conjugations, however, do not necessarily increase the 
water solubility of foreign compounds and their metabolites, thus 
acetyl metabolites of many sulphonamides are very insoluble in water 
and cause kidney damage as a result of their intratubular crystallization 
(Mandel, 1971). 
Although most foreign compound metabolites are less 
biologically active than their parents, in quite a few instances, 
metabolism is capable of increasing the pharmacological or toxicological 
activities of the parent compounds. Classic examples of metabolic 
<<oý activation of pharmacologically inactive compounds include the 
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of prontosil to sulphanilamide (antibacterial agent) and the deethylation 
of phenacetin to N-acetyl-p-aminophenol (analgesic). Numerous examples 
of metabolic activation of foreign compounds to toxic metabolites are 
known. Thus bioactivation may be involved in the carcinogenesis of 
some polycyclic hydrocarbons, hepatotoxicity of some commonly used drugs 
and methaemoglobinemia produced by some aromatic amines. Such activations 
generally result in the formation of "active" intermediates which may 
undergo nonenzymic irreversible reactions with tissue macromolecular 
constituents leading to toxic responses. Other foreign compounds are 
sufficiently similar to normal endogenous compounds that they participate 
in the pathways of intermediary metabolism causing interference with their 
functioning in what has been termed "lethal synthesis". Indeed such 
selective mechanisms of lethal synthesis are often utilised in the action 
of insecticides and pesticides. 
From this very brief discussion it can be seen that metabolism 
generally affords increased polarity and water solubility of foreign 
II 
compounds so as to facilitate their elimination from the body and hence 
detoxication. However, metabolism may also give rise to active intermediates 
which may have toxicological and pharmacological activities. The 
understanding of these reactions will give some insight into the 
biochemical basis of toxicology and pharmacology. 
1.2 TECHNIQUES USED FOR STUDYING 
BIOTRANSFORMATION OF FOREIGN COMPOUNDS 
The fate of foreign compounds has been studied by both 
in vivo and in vitro techniques. The choice of techniques depends largely 
on the scope and objective of the studies and the level of cellular 
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organization at which the studies are designed. Thus foreign compound 
metabolism may be investigated at a molecular level to study enzyme 
mechanisms, at cellular and tissue levels and at the level of the 
intact animal for studying metabolism and disposition of foreign compounds. 
In this section a brief comment on the various techniques used in drug 
metabolism from the standpoint of "level of organization" will be 
considered in terms of the advantages and limitations of each technique 
in the overall understanding of metabolism of foreign compounds. 
1.2.1 In Vivo Investigations 
Since the products of metabolism of foreign compounds 
are finally excreted by the animal, the classic method for investigating 
metabolism of foreign compounds involves the most unequivocal, but 
exacting techniques of feeding experiments. Living animals are dosed 
with foreign compounds and the metabolites and their conjugates are 
isolated from the animal excreta which is followed by chemical 
characterization of the excreted metabolites by various standard 
analytical techniques. 
In vivo experiments also allow for investigations 
into disposition of foreign compounds within living animals and 
summarize a complex sequence of events in which an administered foreign 
compound is handled by the body. Disposition includes not only metabolism, 
but also absorption, distribution and excretion of foreign compounds. 
Thus studies on the disposition of foreign compounds in the living 
animal provides information on the kinetics of absorption and excretion, 
the length of time a foreign compound remains in the body, route of 
elimination from the body, the pharmacological and toxicological activities 
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of the foreign compound in relation to its site of localization and the 
concentration of the foreign compound and its metabolites in various 
body fluids such as blood, bile and urine and tissues such as liver, 
kidney, spleen, lung, heart, muscle, brain and adipose tissues, which 
reflect the bioactivity of the foreign compound. Furthermore from the 
point of view of interspecies differences in foreign compound metabolism, 
in vivo studies give an overall picture of the factors affording species 
variation such as the disposition of administered foreign compounds which 
may be related to differences in the role of gastrointestinal microorganisms, 
differences in diet between carnivorous and herbivorous animals or genetic 
deficiencies in pathways of metabolism and many other genetic and 
physiological factors as described in Section 1.1.2. In vivo experiments 
will also give important information regarding changes in metabolic 
profile due to route of administration of the compound or changes in 
dose levels. Enteral and parenteral routes of administration may give 
rise to differences in metabolic profile particularly if metabolism of 
the foreign compounds is carried out extensively by other organs as well 
as the liver (Dollery, et al, 1971). Differences in the route of 
administration may illicit differences in the pharmacological responses 
due to metabolism and possibly also the concentration of the active 
compound at the site of action. In vivo dose response studies may also 
indicate changes in metabolic profile due to saturation of mechanisms 
involved in metabolism. They may give information regarding the 
therapeutic and toxic levels of the foreign compound and the effect of 
chronic dosage on metabolism and metabolic profiles of the foreign compounds. 
Many other factors affecting the metabolism of foreign 
compounds are studied by in vivo techniques and from this short 
discussion 
it can be seen that following the identification and characterization of 
metabolites of a particular foreign compound, it is possible to elucidate 
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the pathways of metabolism of that compound and the factors which control 
its metabolism in the living animal by means of in vivo investigations. 
1.2.2 In Vitro Investigations 
In the study of foreign compound metabolism, in vitro 
investigations are frequently undertaken to supplement in vivo investigations. 
The advantages offered by in vitro investigations are numerous. They 
provide a more controlled means whereby the mechanism of biotransformation 
may be investigated so that information regarding the site of metabolism, 
pathways in the formation of metabolites, the enzyme systems that catalyse 
the various steps in the production of metabolites, the components of the 
enzyme systems involved and the biochemical properties of these components 
together with mechanisms which control the enzymic reactions involved 
in biotransformation of foreign compounds may be obtained and correlated 
with those observed in the intact animal. 
Correlation of in vitro results with in vivo observations 
can only be made provided the limitations of the in vitro techniques 
are realised and taken into account. There are a variety of in vitro 
techniques and tissue preparations which may be used for the investigation 
of foreign compound metabolism and each will have inherent advantages 
and disadvantages. However, they are able to provide some information 
regarding factors involved in metabolism of foreign compounds at different 
cellular levels of organization. Understanding of these various factors 
will provide an insight into the overall metabolism of foreign compounds 
in the intact animal. 
In the intact organ, metabolism of foreign compounds may 
be studied by perfusion of drugs and other foreign chemicals through the 
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organ in question under conditions closely resembling those which occur 
in the living animal (Evans et al, 1963). Indeed such organ perfusion 
experiments may be carried out in situ in the intact animal. Organ 
perfusion experiments provide information concerning the function of 
that organ in the metabolism of foreign chemicals and include the rates 
and pathways of metabolism which occur in the organ being perfused, the 
possibility of the formation of stable intermediate metabolites which 
are subsequently metabolised by other organs and the limiting factors in 
metabolism which may be the activities of the enzyme systems or the rate 
at which foreign compounds are conveyed from the blood to the site of 
metabolism. Unfortunately organ perfusion provides little or no information 
regarding the mechanism of formation of metabolites or properties of the 
enzyme systems involved. Indeed for the identification of principle 
metabolites it frequently offers no advantages over studies of urinary 
and/or biliary metabolites, but for evaluating specific organ function, 
organ perfusion offers considerable advantages and provides a means for 
studying the contribution of various organs in the overall metabolism of 
a foreign compound (Gillette, 1971b). 
Because of the relatively complex methodology involved in 
organ perfusion experiments, tissue slices have been used as an alternative 
for studying foreign compound metabolism in different tissues. The 
methodology of tissue slice experiments is relatively simple, but because 
the transfer of foreign compounds and nutritional material from the 
incubation medium depends solely on passive diffusion, the concentration 
of substances between the inner and outer areas of the slices may not 
be identical so that very thin slices must be used and for this reason 
tissue slices may not provide the best technique for obtaining information 
representative of drug metabolism within the cells of the tissue in 
37 
question, in particular the transport of foreign compounds to and its 
metabolites from, the cells. Nevertheless some knowledge regarding 
the transport of foreign compounds into tissues and pa`-hways of metabolism 
may be obtained from tissue slice experiments. 
With the currently improving methodology in the isolation 
and culturing of large numbers of functional and viable cells from various 
tissues, such in vitro preparations are gaining ascendancy as a tool 
for the study of foreign compound metabolism in its various aspects 
(Schindler, 1969, Fry and Bridges, 1977). Among the obvious advantages 
of this type of preparation are that cells are constantly bathed in the 
medium containing the nutrients so that the diffusion barrier to oxygen, 
nutrients and foreign compound substrates is minimal. Moreover isolated 
cells provide a preparation in which various mechanisms involved in the 
intra cellular homeosta sis are intact, so that study of the metabolism 
of foreign compounds which are metabolised by more than one pathway 
may be investigated concurrently and understanding of the functional 
significance and the factors affecting the various metabolic pathways 
may be achieved. Indeed such isolated cell preparations may have wide- 
spread application as a mid point in the various in vivo and in vitro 
comparative studies. 
Other in vitro techniques which are currently employed 
in the study of drug metabolism include the use of tissue homogenates, 
subcellular fractions of tissues and solubilised and purified preparations 
of enzymes involved in foreign compound metabolism. Such techniques 
that are used are directed towards the obtaining of information regarding 
the enzymes involved in biotransformation of foreign compounds and its 
relationship to the metabolism of various endogenous materials, the 
mechanism of the enzymic reaction, the components of the enzyme systems 
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and factors affecting the properties of these components. 
f 
In the use of tissue homogenates and subcellular fractions 
it must be realised that once cells are broken, intracellular control 
mechanisms, compartmentalization and interrelationship between various 
intracellular organelles are lost and intracellular components may be 
damaged so that steady state levels of intracellular substrates and co- 
factors will not correlate with those observed in vivo. Furthermore, 
the process of homogenization of tissues often causes apparent inactivation 
of certain enzymic activities, frequently as a result of inactivation 
of co-factors involved in the enzyme system. Thus a great deal of care 
must be taken before correlation between such in vitro observations and 
in vivo observations can be made (Gillette, 1971b). However, the use of 
tissue subcellular fractions has demonstrated that many subcellular 
particles contain enzyme systems which are important in the metabolism 
of foreign compounds. Thus hepatic microsomal fractions have been 
demonstrated to carry out many oxidative metabolic reactions involving a 
wide variety of lipid soluble foreign compounds and steroids which 
require molecular oxygen and NADPH as co-factor, glucuronic acid 
conjugation reactions and the reduction of many azo- and nitro- compounds. 
The mitochrondrial fraction, on the other hand has been shown to catalyse 
the oxidation of amines, formation of amino acid derivatives and the 
oxidation of fatty acids. The soluble subcellular fraction also 
contains many enzymes capable of metabolising foreign compounds and 
indeed it can be demonstrated that microsomal enzymes convert many 
foreign compounds to intermediates which in turn are converted to other 
metabolites by enzymes in the soluble fraction as in the synthesis of 
sulphates, mercapturates and acetyl derivatives. 
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Although much has been learnt regarding the enzyme 
systems involved in the metabolism of foreign compounds, the actual 
mechanisms of enzymic reaction remain elusive and in order to elucidate 
the mechanisms of enzymic reaction, attempts are being made to solubilise 
and purify these enzymes. Some investigations using partially purified 
enzymes have been carried out and although information ranging from the 
sequences of the catalysed reactions, nature of the enzyme and number 
of enzymes catalysing similar reactions has been obtained, the significance 
of these findings is limited in their correlation with the mechanism 
of reaction of these enzymes in the intact animal. Solubilization and 
purification of membrane bound multienzymes invariably alters the 
interrelationship of the components of the enzymes and the environment 
in which the enzyme system normally functions so that reactions which 
occur with enzymes purified from subcellular particles may not have a 
direct bearing on the mechanism of the reaction in the living animal. 
Nevertheless, studies on partially purified enzyme preparations have provided 
valuable information on possible mechanisms of foreign compound metabolism, 
the kinetics of the reaction and factors affecting the metabolism of 
these compounds at the molecular level. 
Thus it can be seen that study of foreign compound metabolism 
requires the complementary use of both in vivo and in vitro techniques 
and the information obtained can then be correlated so as to lead to a 
better overall understanding of the biotransformation of foreign compounds 
and their consequences in the living animal. 
1.3 OBJECTIVE OF THIS THESIS 
A brief survey of the current literature on the comparative 
metabolism of foreign compounds in various animal species showed that 
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relatively few systematic studies have been carried out in this area. 
Some investigations on species variation in the metabolism of organic 
compounds which include benzoic acid (Baldwin et al 1960, Bridges, et al 
1970), phenylacetic acid (James, et al, 1972), indoleacetic acid (Bridges, 
et al , 
1974) , aniline (Parke, 1960) , quinic acid (Adamson yet al, 
1970a) , 
amphetamine (Dring, et al 1970), sulphadimethoxine (Adamson, et al, 1970b), 
phenol (Capel, et al, 1972), disodium cromoglycate (Ashton, et al, 1973) and 
phenacetin (Smith and Timbrell, 1974) have been reported. However, 
although these compounds were examin(. in a broad range of vertebrate 
species including fish, amphibians, mammals and birds, small animals 
have generally been employed and detailed metabolic studies on large 
animals have been very limited. Apart from work in the monkey, some 
very preliminary foreign compound metabolism studies have been conducted 
in the pig (Bridges, et al, 1970, Capel, et a1,1972) and the use of the 
sheep as an animal model for the study of drug detoxication in vivo has 
been the subject of a PhD thesis (Maylin, 1971) . 
There are a number of reasons for studying metabolism of 
foreign compounds in farm animal species. They are important food 
producing species and in view of the economic importance of the development 
of drugs and therapeutic agents for the maintenance and growth promotion 
of these animals which are used for the production of food and other 
products of economic value, comparative study on the metabolic capabilities 
of these species becomes an important aspect of the development of 
veterinary products. In this context the problem of drug residues in 
the edible tissue of these species is a key factor for consideration and 
since the identification of drug residues requires a knowledge of the 
metabolic fate of the drug in the animal species in question, a study of 
the major pathways of drug detoxication and elimination in these animals 
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is therefore desirable. Furthermore, the role of gut microorganisms 
in the metabolism of orally administered drugs in ruminants such as the 
sheep may give rise to new and unidentified pathways of metabolism and 
metabolites. 
Although various aspects of species variation in foreign 
compound metabolism have been considered by many authors, and considerable 
amounts of data exist in the literature on the major pathways of drug 
detoxication and elimination in laboratory animals, very little is 
known about the metabolism of drugs in farm animals. In fact, very few 
systematic studies on drug metabolism have been carried out in these 
species. However, the pharmacology and pharmacokinetics of a number of 
drugs have been studied in animals of agricultural interest and some 
of these are summarized in Table 1.3. 
It is a general belief that large animals tend to 
metabolise drugs slower than small laboratory animals, this view however 
lacks good experimental verification and a study on this aspect of drug 
metabolism may prove to be significant. From the point of view of the 
pig, a knowledge of its metabolic capabilities is valuable in view of the 
potential use of this species in toxicological studies. 
In order to elucidate the principle pathways of metabolism 
in these animals, it is necessary to obtain background information on the 
metabolism of some "model" organic molecules by these animals and 
compare it with that observed in laboratory animals. In the present 
investigation, the metabolism of benzoic acid, phenol and aniline was 
investigated in the sheep and the pig and the results compared with 
those obtained in the laboratory rat. Benzoic acid was chosen for the 
study of amino acid conjugation, in particular glycine conjugation, 
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Table 1.3 
Some Investigations Involving Animal Species of Agricultural Interest 
Foreign Compounds Species Nature of References 
Studies 
Alcohol Horse Metabolism Plapp (1973) 
Aflatoxins Pig Metabolism Patterson (1973) 
Sheep 
Goat 
Cow 
Amphetamine Goat Pharmacok. netics Baggot et al (1973) 
Horse Metabolism Chapman & Marcroft (19731 
Antihelmintics Domestic Pharmacology Dunlop (1967) 
animals 
Acetyl- Goat Renal Jorgensen et al (1974) 
sulphanilamide excretion 
Benzoic acid Pig Metabolism Bridges et al (1970) 
Sheep Metabolism Matin (1966,1975) 
Benomyl Sheep Metabolism Douch (1973) 
Fungicide 
Chloramphenicol Cow Pharmacology Sisodia et al (1973a, b) 
Pig Pharmacokinetics Davies et al. (197.. )) 
ý Goat 
Horse 
Digoxin Goat Mammary Rasmussen et al (1975) 
excretion 
Haloperiol Cow Distribution Ziv et al (1974) 
Sheep 
Histamine Pig Metabolism Eliaseen (1973a, b, c) 
Goat 
Cow 
Sheep 
Horse 
2-Methyl-4,6- Sheep Pharmacology Froslie (1973,1974) 
dinitrophenol 
Naphthol Pig Metabolism Capel et al 1974a) 
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Table 1.3 cont. 
Foreign. Compounds 
Phenol 
Phenylbutazone 
Quinidine 
Sulphadiazine 
Sulphadioxin 
Sulphonamides 
Tetracycline 
analogues 
Trimethoprim 
Miscellaneous 
Species Nature of 
Studies 
Sheep Metabolism & 
Pharmacokinetics 
Pig Metabolism 
Pig 
Vari ous 
species 
Goat 
Cow 
Pharmacokinetics 
Pharmacokinetics 
Metabolism 
Pharmacokinetics 
Ruminants 
Cow 
Sheep 
Disposition 
Metabolism 
Pharmacokinetics 
Pig Urinary 
Goat elimination 
Cow Pharmacokinetics 
'moat Distribution 
Raninants 
Vari ous 
species 
Cow 
Absorption 
Pharmacology 
Excretion 
(in tears 
References 
Maylin (1971) 
Capel et al (1972,1974b1 
Hvidberg & Rasmussen 
(1975) 
Neff et al (1972 
Atef & Nielsen (1975) 
Davitiyananda & 
Rasmussen (1974) 
Austin (1976) 
Nielsen (1973a, b) 
Ziv & Sulman (1974) 
Nielsen & Rasmussen 
(1972,1975a) 
Davitiananda & 
Rasmussen (197i) 
Nielsen & Rasmussen 
(1975b) 
Phillipson (1967) 
Stowe (1976) 
Dunlop (1976) 
Pedersen (1973 
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phenol for sulphate and glucuronide conjugation and aniline for 
aromatic hydroxylation and conjugation reactions. 
An examination of the literature revealed that although 
some aspects of metabolism of these "model" compounds have been 
investigated in the rat, nevertheless studies regarding the site of 
metabolism of these "model" compounds and the kinetics of in vivo 
metabolism which may reveal information regarding possible influences 
of some factors in the metabolism and disposition of these compounds 
such as species variation have not been investigated satisfactorily. 
In an attempt to investigate such problems, ureter cannulated rats 
were used in some metabolism studies and the metabolism of these "model" 
compounds was also investigated in isolated cells prepared from rat liver, 
kidney and small intestine in an attempt to establish, not only the 
site of metabolism of these compounds, but also the ability of these cell 
preparations to metabolise foreign compounds and hence the ability of 
these various organs to metabolise foreign compounds and their consequences 
in the intact animal. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 MATERIALS 
2.1.1 Radiochemicals 
FU-14C]-Aniline 
hydrogen sulphate, 6OmCi mmol-1; 
[Ring-U-14Cj- 
Benzoic acid, 36.3 mCi mmol-1 and 
CU-14CJ-Phenol, 
34 mCi mmol-1 were 
obtained from The Radiochemical Centre (Amersham, Bucks. ). 
The radiochemical purity of these compounds was checked 
by standard thin-layer chromatographic methods and found to be at least 
98% in all cases. 
2.1.2 Chemicals 
Chemicals used in liquid scintillation counting were 
obtained from Packard Instruments Ltd. (Caversham, Berks. ). p-Bis 
(o-methylstyryl)-benzene (bis-MSB) was from Koch-Light Laboratories 
(Colnbrook, Bucks. ). 1: 4 Dioxan was purchased in bulk from Maybridge 
Chemicals (Tintagel, Cornwall). The toluene used for scintillation 
counting was low in sulphur and was supplied by Fisons (Loughborough, 
Leics. ). 
Chemicals used in metabolic studies were of analar grade 
from British Drug Houses (Poole, Dorset). Saccharic acid 1: 4 lactone 
and N-acetyl-p-aminophenol were from Sigma (London). Phenyl-$-D-glucuronide 
monohydrate was from Koch Light Laboratories and N-phenylsulphamic acid 
was from ICN Pharmaceuticals (Horsham, Surrey). 
All other solvents and chemicals were from BDH and were 
of analar or laboratory reagent grades. 
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Benzoylglucuronide was obtained from the excretion products 
of a turkey dosed with benzoic acid. The isolation of benzoylglucuronide 
was essentially as described by Baldwin et al, (1960). 
A turkey (6 Kg) was starved for 12 hours before the oral 
administration of benzoic acid (5 g). The excreta were collected in 
galvanized metal trays placed below the cage. Benzoic acid was 
administered as a solution of its sodium salt by means of a stomach tube. 
The bird was allowed free access to drinking water which contained 
glucose (1% w/v). 
After 24 hours the excreta was collected and acidified 
with a few drops of conc. HCl. It was homogenised, centrifuged to 
remove solid debris and continuously extracted with ether for 2-3 days. 
A small amount of isoamyl alcohol was added to break up emulsions. 
The ether extract was evaporated in vacuo and the residue 
was dried overnight in a vacuum desiccator containing P205 and anhydrous 
Na2CO3. The dried residue was taken up in a minimum amount of ethanol 
and 10 vols of chloroform added. On keeping at approximately -40C a 
white material (benzoylglucuronide) precipitated out. 
The precipitate gave a positive naphthoresorcinol test. It 
ran as a single spot on thin layer chromatography. The spot was located 
under UV light and identified using naphthoresorcinal spray. The spot 
did not correspond to benzoic acid, hippuric acid or glucuronic acid, 
which were co-chromatojraphed. The dried precipitate had a melting point 
of 1790-181°C and it was hydrolysed by ß-glucuronidase (ketodase) to give 
benzoic acid. The benzoylglucuronide so prepared w, is used as a 
chromatographic standard without further purification. 
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Phenylsulphate was prepared according to the method of 
Hawkins and Young (1954). 
Carbon disulphide (70 ml) and dimethylaniline (14.5 ml) 
were stirred and cooled in ice water. Chlorosulphonic acid (2.0 ml) was 
added followed by phenol (2.8 g) with stirring. The mixture was stirred 
for 1 hour and allowed to stand overnight. Aqueous KOH (50% w/v, 12 ml) 
was added slowly, the separated dimethylaniline was poured off and 
removed by washing with ether (3 x 100 ml). 
The resultant potassium salt was dissolved in a minimum 
quantity of water at 70-800c and the hot solution filtered. The filtrate 
was cooled and the white crystalline material formed was dried and 
washed with ether. 
Thin layer chromatography of an aqueous solution of the 1-1 
crystalline material ran as a single spot and it did not correspond to 
phenol or phenylglucuronide which were co-chromatographed. It was 
hydrolysed by arylsulphatase to give phenol. This potassium salt of 
phenylsulphate was used as a chromatographic standard without further 
purification. 
2.2 METHODS 
2.2.1 Measurement of Radioactivity 
Nuclear Chicargo MK. II, LKB Wallac 1210 and Packard 
Tricarb 3320 scintillation counters were used throughout this work. 
Counting efficiencies were determined using external 
standard channel ratio techniques from quench curves prepared using cd 4 
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as the quenching agent and n-(1-14C) - hexadecane (The Radiochemical 
Centre, Amersham) as the standard. Different curves were prepared for 
the different scintillant and counting conditions used and in all cases 
the validity of the external standard channel ratio results were checked 
by internal standardization of a randomly selected range of samples: 
Agreement between the two methods of counting was in the order of ±2%. 
Counting efficiencies were in the order of 70%-90%. 
Several scintillant mixtures were used, they included: - 
1. Instagel (Packard Instruments Ltd. ) 
2. Dioxan based scintillant 
Naphthalene 60 g 
2.5 Diphenyloxazole (PPO) 4g 
p-Bis- 2- (4-methyl-5-phenyloxazciyl) 
benzene (dimethyl POPOP) 0.2 g 
Methanol (analar) 100 ml 
1: 2 ethandiol 40 ml 
and 1: 4 dioxan to give 1000 ml 
3. Toluene based scintillant 
PPO 5g 
Bis MSB 0.25 g 
Toluene 1000 ml 
4. Dioxan/Toluene based scintillant 
Naphthalene 100 g 
PPO 5 g 
Dimethyl POPOP 0.3 g 
Dioxan 800 ml 
Toluene 200 ml 
For the counting of urine samples (0.1-0.5 ml), Instagel 
and dioxan based scintillants were used while for the counting of homogenised 
faecal samples (1% w/v, 0.5 ml) a dioxan based scintillant containing a 
thixotropic gel powder (5% w/v), Cab-o-sil (Packard Instruments Ltd. ) was 
used. 
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Freeze dried faecal samples (50 mg) were counted in the 
Dioxan/Toluene based scintillant after combustion in a Packard Tricarb 
oxidizer to determine the radioactivity of the resultant 
14CO2 
which was 
trapped in a solution of ethanolamine: ethyleneglycol monomethylether: 
toluene (1: 8: 10 v/v) (Jaffay and Alvarez, 1961). 
Sections of paper chromatograms were counted in the toluene 
based scintillant while sections of silica gel thin layer chromatograms were 
counted in the toluene based scintillant containing Cab-o-sil. 
Aliquots (0.5 ml) of hydrolysates, ether extracts, and 
aqueous residues from enzymic hydrolysis experiments were counted in the 
dioxan based scintillant while crystalline material from reverse isotope 
dilution analysis experiments were first dissolved in dimethylformamide 
(0.5 ml) before being counted in the dioxan based scintillant. 
In all cases 10 ml scintillant was used and counting was 
carried out at 4 
°C 
after storage at 4°C in the dark to avoid possible 
errors due to chemiluminescence. 
2.2.2 In vivo Investigations 
2.2.2.1 Animal and Animal Dosing Procedures 
Details of animals used throughout this research project 
are summarized below: - 
Species Sheep (mixed breed) 
Sex male 
Age 2-3 months 
Weight 30-40 kg 
Diet Ewe and Lamb Diet 
(Pauls Feeds Ltd. ) 
and hay 
Pig (large white) 
male 
2-3 months 
15-20 kg 
Commercial Pig 
Weaner Rations 
(Pauls Feeds Ltd. ) 
Rat (Wistar albir, 
male 
5-6 weeks 
0.2-0.3 kg 
Spillers No. 1 3 
TEXT CUT 
OFF IN 
ORIGINAL 
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The animals were kept in metabolism cages appropriate 
to their size. The sheep and the pig were kept in metal metabolism 
cages at Pfizer (Central Research) Ltd., Sandwich, Kent, while the rats 
were kept in all glass small animal metabolism cages - "Metabowl" (Jencons, 
Scientific Supplies, London). The animals were allowed free access to 
food and water at all times throughout the experiments. 
In all cases radiolabelled compounds under investigation 
were administered orally. The pig was dosed by means of a stomach tube 
while the rat and the sheep were dosed by a syringe. 
The radiolabelled compounds were administered as an aqueous 
solution of their salts. (For the sheep and the pig 15-20 ml, for the rat 
1 ml). In the case of the sheep and the pig, small aliquots of the dosing 
solutions were taken for the determination of its 
14C 
content. The actual 
amount of radioactivity received by the animals was calculated as the 
difference between the 
14C 
level in the dosing solution and the residual 
washings after administration. In the case of the rat, a stock dosing 
solution of known specific radioactivity was prepared and 1 ml aliquots 
were taken for oral administration. 
2.2.2.2 Collection and Treatment of Excreta 
Urine from the animals was collected in suitable receptacles, 
at regular intervals during the first 24 hours after administration of the 
compound. In the case of the sheep and the pig, the urine was collected 
almost as soon as it was voided. 
All urine samples were kept frozen after collection until 
14 
needed, but were assayed for C immediately after collection. 
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Faeces from the large animals were collected in bags worn 
as a harness by the animals. These samples were homogenised, freeze dried 
and analysed for 
14C 
after combustion. Faeces from the rat were homogenised, 
diluted and small aliquots were taken for 
14C 
determination. 
The radioactivity of all urine samples (0.5 ml for the sheep 
and pig, 0.1 ml for the rat) was counted in duplicate at 40C after storage 
at 4°C in the dark to avoid possible errors due to chemiluminescence as 
described previously. Triplicate samples (= 50 mg) of freeze dried faeces 
were counted as described after combustion to determine the radioactivity 
of the resultant 
14CO2. 
Quadruple samples of homogenised rat faeces 
(0.5 ml) were counted as described. 
2.2.2.3 Identification of Urinary Metabolites 
General scheme used for metabolite identification: - 
Urine 
enzyme hydrolysis 
TLC and PC 
(overnight) 
14C 
determination < Hydrolysate ---ý TLC 
ether extraction 
14C determination Aqueous residue ether extract 
14C 
determination! 
TLC and reverse isotope 
dilution analysis. 
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Studies on Urine Samples 
a) Chromatography of Urine Samples 
Both descending paper chromatography and thin layer 
chromatography were employed. Whatman No. 1 paper was used for the 
descending method while silica gel 60 F254 precoated thin layer plates, 
0.25 mm (Merck, Darmstadt, West Germany) were used for thin layer 
chromatography. 
The following solvent systems were used in the 
chromatographic investigation of urine: - 
For descending paper chromatography: - 
A Butan-l-ol : Acetic acid (glacial) : Water (4: 1: 2 v/v) 
B Butan-l-ol : Ethanol : Acetic acid (glacial) : Water 
(3: 1: 0.1: 1 v/v) 
C Butan-l-ol saturated with equal volumes of 1.5 M 
ammonia and 1.5 M amm oniam carbonate. 
D Propan-l-ol : Ammonia (880 s. g. ) (7: 3 v/v) 
E Butan-l-ol : Ammonia (880 s. g. ) : Water (10: 1: 1 v/v) 
F Butan-l-ol : Benzene : Pyridine : Water (5: 1: 3: 2 v/v) 
For thin layer chromatography: - 
G Butan-l-ol : Acetic acid (glacial) : Water (4: 1: 1 v/v) 
B Butan-l-ol : Ethanol : Acetic acid (glacial) : Water 
(3: 1: 0.1: 1 v/v) 
H Propan-l-ol : Butan-l-ol : Ammonia (0.1N) (2: 1: 1 v/v) 
Urine from the experimental animals was applied as a band 
(2 cm for TLC and 4 cm for PC) and the chromatograms were developed in 
the above solvent systems. Where possible authentic metabolites were 
co-chromatographed with the urine samples. 
Several methods were employed in the location and detection 
of the radiolabelled metabolites on the radiochromatograms and 
they are 
summarized below: - 
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1. Quenching of background fluorescence under UV light. 
I 
2. Preparation of radiochromatogram scans on a Berthold 
Camlab Radiochromatogram Scanner. 
3. Thin layer radiochromatogram autoradiography using 
Kodak blue brand medical X-ray films. Autoradiography 
was carried out for 5-10 days and the films were 
developed using Kodak universal developer and fixed 
using "Kodafix" in the manner recommended by the 
manufacturer. Areas corresponding to the dark spots 
on the autoradiographs were marked on the chromatograms 
and these areas were cut out, placed into scintillation 
vials and counted as described. 
4. "Strip counting". 
Radiochromatograms were cut into sections (0.5 cm) 
and the associated 
14C 
was determined by liquid 
scintillation counting. 
5. Colour reaction with the following spray reagents 
a) Naphthoresorcinol in acetone (1% w/v) to which 
phosphoric acid (10% v/v) was added just before 
use (4: 1 v/v) followed by heating the chromatogram 
to 1400C (Bridges et al 1965). 
b) p-Dimethylaminobenzaldehyde in acetic anhydride 
(4% w/v) containing a little sodium acetate 
followed by gentle heating of the chromatogram. 
(Bridges et al 1970). 
c) p-Dimethylaminocinnamaldehyde in acetic anhydride 
(0.05% w/v) followed by heating the chromatogram 
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to 1200C (Bridges et al 1970). 
d) Freshly diazotized p-nitroaniline followed by 
O. 5M potassium hydroxide in ethanol (Copius- 
Peereboom 1960). 
e) Equal volumes of freshly prepared potassium 
ferricyanide (1% w/v) and ferric chloride (2% w/v) 
followed by 2N HC1 (Barton et al 1952). 
f) Ninhydrin in acetone (0.2% w/v) followed by heating 
the chromatogram at 950C for 10-15 minutes. 
g) 0.1M Potassium dichromate in acetic acid (0.1M) 
followed by O. 1M silver nitrate after 5 minutes 
(Knight and Young 1958). 
h) p-Dimethylaminobenzaldehyde in ethanol (0.5% w/v) 
containing concentrated HC1 (1% v/v). 
i) Sodium nitrite in O. 1N HC1 (0.2% w/v) followed 
by ammonium sulphamate (5% w/v) after 3 minutes 
and after a further 3 minutes by an aqueous 
solution of N-1-naphthylethylenediamine hydrochloride 
(1% w/v) (modified Bratton and Marshall 1937). 
j) 0.5N HC1 followed by heating to 100°C for 10-20 
minutes and the chromatogram sprayed with reagents 
d, h and i. 
b) Enzymic Hydrolysis and Ether Extraction 
Enzymes 
Enzymic hydrolysis of urine samples (3-5 ml) was carried 
out and the following hydrolyses were conducted: - 
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ß-glucuronidase hydrolysis: 
The enzyme used was Ketodase (15,000-20,000 Fishman units) 
ox liver ý-glucuronidase (Warner and Chilcolt) and overnight hydrolysis 
was carried out at pH 5.0 in 0.1M acetate buffer at 370 C in a shaking 
water bath. Incubations carried out undLr the same conditions but in the 
absence of enzyme were taken as controls. Ketodase is essentially free 
of sulphatase activity. 
Arylsulphatase hydrolysis: 
The enzyme used was arylsulphatase (3,000-5,000 units), a 
partially purified powder from Helix pomatia (Sigma Type 1) and overnight 
hydrolysis was carried out at pH 5.0 in a O. 5M acetate buffer at 37°C in 
a shaking water bath. Saccharic acid 1: 4 lactone (Sigma) 20 mM was used to 
inhibit the p-glucuronidase activity present in the enzyme preparation. 
Incubations carried out under the same conditions but in the absence of 
enzyme were taken as controls. 
Acid phosphatase hydrolysis: 
The enzyme used was a crude preparation of acid phosphatase 
(15-20 units) from wheat germ (Sigma type 1). It also contains lipase 
activity. Overnight hydrolysis was carried out at pH 4.8 in a O. 1M 
citrate buffer at 370C in a shaking water bath. Saccharic acid 1: 4 lactone 
was used to inhibit the ß-glucuronidase activity present in the enzyme 
preparation. Incubations carried out under the same conditions, but in the 
absence of enzyme were taken as controls. 
The definitions of the enzyme activity units mentioned above 
are summarized below: - 
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Ketodase - one Fishman unit will liberate 1.0 ý. g 
phenophthalein from phenolphthalein glucuronide per hour at 37°C at 
pH 5.0. 
Arylsulphatase - one unit will hydrolyse 1.01Wnole 
p-nitrocatechol sulphate per hour at pH 5.0 at 37 
°C. 
Acid phosphatase - one unit will hydrolyse 1.0pmole 
p-nitrophenyl phosphate per minute at pH 4.8 at 37 
°C. 
The specificity of the enzymes used were checked using 
p-nitrophenylglucuronide (25mM); p-nitrophenylsulphate (25 mM) and 
_p-nitrophenylphosphate 
(25 mM) as substrates for the three enzymes used. 
It was found that Ketodase shows essentially only 
p-glucuronidase activity while arylsulphatase, besides causing the hydrolysis 
of p-nitrophenylsulphate will also hydrolyse p-nitrophenylphosphate. Acid 
phosphatase, on the other hand, hydrolysed 2-nitrophenylphosphate, showed 
little or no sulphatase activity, but caused some hydrolysis of 
p-nitrophenylglucuronide. However, the p-glucuronidase activity present 
in acid phosphatase from wheat germ was found to be inhibited by saccharic 
acid 1: 4 lactone (20 mm) and saccharic acid 1: 4 lactone does not appear 
to affect the hydrolysis of n-nitrophenyl phosphate by acid phosphatase. 
After overnight incubation, aliquots of the hydrolysate 
were taken and chromatographed on Silica gel 60 F254 pre-coated thin 
layer plates in solvent systems B and G. 
Ether Extraction 
After overnight incubation, the pH of the hydrolysates 
from enzyme hydrolysis were suitably adjusted and aliquots (5-10 ml) taken 
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and extracted with diethyl ether (10-15 ml) two or three times. Isoamyl 
alcohol (1% w/v) was added to prevent emulsion formation during extraction 
and in some cases extraction was facilitated by saturation of the 
hydrolysate with sodium chloride. Following ether extraction, aliquots 
(0.1-0.5 ml) of the different fractions, i. e. hydrolysate, ether extract 
and aqueous residue were suitably diluted and taken for 
14C 
determination 
as previously described. 
The efficiency of the ether extraction after enzymic 
hydrolysis was also investigated. In the case of phenol and phase I 
metabolites of phenol, ether extraction was carried out at pH 5.0 and it 
was found that under these conditions phenol was quantitatively extracted 
into ether. Quinol (pKa 9.9 and 11.4) which has pKas similar to that of 
phenol (pKa 10) was assumed to have similar extraction properties. For 
aniline and phase I metabolites of aniline, ether extraction was carried 
out at pH 7-8 after saturation of the hydrolysate with sodium chloride. 
Aniline and acetanilide were extracted quantitatively while p-aminophenol 
(pKa 10.3) was extracted to about 90%. o-Aminophenol and m-aminophenol with 
pKas of 9.9 and 9.8 respectively were assumed to be extracted similarly. 
N-Acetyl-p-aminophenol on the other hand was extracted with an efficiency 
of about 80%. 
A range of concentrations of authentic materials were 
used in these extraction experiments. Authentic metabolites were dissolved 
in control urine to give a range of concentration (0.1-2.0 mm) and 
extracted with ether as described above. The amount of material extracted 
into the ether fraction was determined colourimetrically or by liquid 
scintillation counting and compared with standard curves prepared by 
dissolving authentic metabolites in ether . Thus the efficiency of the 
extraction procedure was determined. The amount of metabolites found in 
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the urine of the experimental animals were within the range of 
concentrations used. 
Studies on Ether Extracts of Hydrolysed Urine Samples 
a) Chromatography 
Thin layer chromatography was carried out on silica gel 
60 F254 pre-coated thin layer plates. (Merck, Darmstadt, West Germany) 
and Silica gel G1500/LS254 pre-coated thin layer plates (Schleicher and 
Schüll, Dassel, West Germany). 
The following solvent systems were used in the chromatographic 
investigation of the ether extracts: - 
I Benzene : Dioxan : Acetic acid (glacial) (90: 25: 4 v/v) 
J Benzene : Methanol : Acetic acid (glacial) (90: 16: 8 v/v) 
K Chloroform : Methanol : Acetic acid (glacial) (80: 20: 1 v/v) 
L Chloroform : Methanol : Ammonia (880 s. g. ) (80: 20: 1 v/v) 
M Chloroform : Ethylacetate : Formic acid (50: 40: 10 v/v) 
N Chloroform : Ethylacetate : Acetic acid (glacial) (50: 40: 10 v/v) 
0 Toluene : Methanol (90: 10 v/v) 
P Toluene : Methanol : Acetic acid (glacial) (90: 10: 1 v/v) 
The ether extracts were dried over anhydrous sodium 
sulphate and concentrated either in vacuo or over a stream of nitrogen. 
The concentrated extracts were applied as a band (1.5-2.0 cm) and 
chromatograms developed in the above solvent systems. Authentic 
metabolites were co-chromatographed with the ether extracts. 
Methods for the location and detection of the radiolabelled 
metabolites were as described for the chromatographic investigation of 
urine samples. 
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b) Reverse Isotope Dilution Analysis 
The basic principle of reverse isotope dilution analysis 
depends on the fact that if a radioactive compound is added to the 
corresponding unlabelled compound and mixed homogeneously, the amount of 
radioactivity per unit of mass of the substance (i. e. specific radioactivity) 
will be reduced. That is, the radioactive material will be diluted by 
the nonradioactive material. If the reduction in the specific radioactivity 
can be measured, the amount of diluting non-radioactive material added 
can be calculated. Thus it can be seen that if isolation and purification 
procedures are incorporated with the radioactive isotope dilution analysis, 
this method may be used to determin the amount of one component in the 
presence of several others, by the addition of a radioactive tracer, of 
known specific radioactivity, of the component in question. 
The isolation and purification can be carried out by any 
suitable procedures such as recrystallization, distillation and 
chromatography. Since accurate specific radioactivity determination 
depends on the purity of the sample and is independent of the amount of 
material used, the yield is relatively unimportant and rapid, but wasteful 
methods of purification can be used. Also, derivatives of the compound 
can be prepared, isolated and measured if this assists in the purification 
of the material; the principle of the method remains unchanged. 
In reverse isotope dilution analysis the principle is 
essentially the same, except that a known weight of non-radioactive 
material is added to a mixture of radioactive materials, *- hence, reverse 
isotope dilution. 
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The principles of reverse isotope diluti, Jn may be 
summarized as follows: - 
If An is the total radioactivity in a mixture of several 
radioactive compounds whose radioactivities are Aa, Ab, Ac..... and whose 
mass are Wa, Wb, Wc..... respectively. 
If the corresponding non-radioactive compounds are ao, 
bo, c0..... are added to fractions of the mixture so that the mass of the 
radioactive compounds is negligible compared with the mass Wa°, Wb°, We°.... 
of the non-radioactive compounds, i. e. Wa° = Wa° + Wa, etc. 
If compounds a, b, c are now isolated and purified from 
the various fractions of the mixture to constant specific radioactivities 
Sa, Sb, Sc..... respective; where 
Sa = Aa , Sb = Ab , Sc = Ac ............. Wa Wb We 
Thus knowing Sa, Sb, Sc..... and Wa°, Wb°, We°..... and An, then Aa, Ab, 
Ac..... may be calculated and hence the amounts of a, b, c ..... in the 
mixture may be determined. 
In the identification of urinary metabolites by reverse 
isotope dilution, authentic metabolites (200-500 mg) were added to 
separate portions of the ether extracts (5-10 ml), dissolved or refluxed 
for a few minutes and evaporated to dryness in vacuo on a rotary 
evaporator. The residues were either recrystallised to constant specific 
radioactivity and constant melting point or in some cases, they were 
derivatized and the derivatives were recrystallized to constant specific 
radioactivity and constant melting point. 
In the study of the metabolism of phenol, toluene-4-sulphonyl 
derivatives of phenol and quinol were prepared during the reverse isotope 
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dilution experiments for the identification of metabolites. Catechol 
was recrystallized successfully from hot water to constant specific 
radioactivity and melting point (1050C). 
Toluene-4-sulphonyl derivatives were prepared by dissolving 
the phenol and quinol residues in NaOH (10%, 2.5 ml), toluene-4-sulphonyl 
chloride (1.0 g for phenol, 2.0 g for quinol) in acetone (4 ml) was 
added and stirred vigorously for 15-20 minutes. The mixture was cooled 
and the crystalline precipitate formed was poured into water (25 ml), 
stirred and filtered at the pump. The precipitate was washed with water 
and the resultant crystalline material was recrystallized from industrial 
methylated spirit successively to constant specific radioactivity and 
constant melting point. The melting point of toluene-4-sulphonyl 
derivatives of phenol and quinol were 960C and 1590C respectively. 
In the study of the metabolism of aniline, ON-dibenzoyl 
derivatives of aminophenols were prepared during the reverse isotope 
dilution experiments for the identification of metabolites. Acetanilide 
and N-acetyl-p-aminophenol were recrystallized successively from water 
containing industrial methylated spirit (1% v/v) and hot water respectively, 
to constant specific radioactivity and constant melting point. The 
melting points of acetanilide and N-acetyl-p-amiJophenol were 1140C and 
1680 C respectively. 
The ON-dibenzoyl derivatives of aminophenols were prepared 
by the Schotten and Baumann reaction. The aminophenol residues were 
dissolved in NaOH (10%, 25 ml) and benzoyl chloride (2 ml) was added drop 
by drop with stirring. Stirring was continued for 15 minutes and the 
resultant QN-dibenzoyl derivatives were filtered and washed with O. 1M HCl, 
water and recrystallized. 
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QN-p. ibenzoyl-o-aminophenol was recrystallized successively 
from ethanol, ethylacetate and ethanol to constant specific radioactivity 
and constant melting point (1830C). The ON-dibenzoyl derivative of 
m-aminophenol was recrystallized successively from ethanol, ethylacetate 
and toluene to constant specific radioactivity and melting point (1530C) 
while the derivative of p-aminophenol was recrystallized from methanol, 
ethylacetate and methanol to constant specific radioactivity and melting 
point (2340 C). 
The radioactivity associated with the crystalline material 
was monitored during reverse isotope dilution analysis at each stage of the 
recrystallization. Crystals (15-50 mg) were dissolved in dimethylformamide 
(0.5 ml) and the radioactivity was determined by liquid scintillation 
counting in a dioxan based scintillant (10 ml) as described. 
2.2.3 Ureter Cannulation Experiments 
2.2.3.1 Surgical Procedure 
Male, Wistar albino rats weighing about 250 g were used 
throughout the ureter cannulation experiments. 
Animals were anaesthetised with sodium pentobarbitone by 
intraperitoneal injection of Nembutal (0.25-0.3 ml per animal) (Abbott 
Laboratories Ltd. Kent). 
The animals were laid ventral side uppermost and a mid- 
ventral line incision made through the muscle of the abdominal wall 
between the xiphisternum and the pubic region. Care was taken to avoid 
cutting the underlying organs. 
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The abdominal viscera were exposed and the bulk of the 
intestine was displaced to the left of the animal. The right ureter 
was located by its pulsing movement caused by urine passing down the 
ureter to the bladder. 
The right ureter was ligated at a position just anterior 
to the bladder and the bulk of the intestine was displaced to the right 
of the animal and the left ureter was located and ligated in a similar 
manner. 
Ligation of the ureter allows urine to be retained in the 
ureters, causing a slight distension which facilitates the introduction 
of the ureter cannulae (polyethylene cannula PP1O, Portex Ltd. ), and 
delinearates the ureters. 
Fatty tissue around the ureters was removed using forceps, 
a small incision was made anterior to the ligature and the cannula 
introduced through the incision and directed towards the kidney. Care 
was taken not to sever the ureter when making the incision. The cannula 
was gently eased along the ureter towards the kidneys. Extreme care was 
taken to avoid damaging the ureters and urine in the ureters appears to 
facilitate this process by acting as a lubricant. The final position of 
the tips of the cannulae was several millimeters posterior to the kidneys 
and the cannulae were sutured into place. 
It was found that the initial flow of urine along the 
polyethylene cannulae was facilitated if the cannulae were partially 
filled with isotonic saline before being introduced into the ureters. 
this also helped in preventing blockage of the cannulae during the 
operation. 
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The cannulae from both ureters were exteriorized, cut to 
appropriate lengths and the intestine replaced. Isotonic saline (5-10 ml) 
at 370C was introduced into the abdominal cavity to facilitate the 
production of urine and urine was collected from the cannulae at timed 
intervals. 
Throughout the surgical procedure care was taken to avoid 
damaging blood vessels and major organs and disturbance of the abdominal 
viscera was kept to a minimum. 
The animals were kept anaesthetised throughout the surgical 
procedure and the subsequent experiments by periodic administration of 
Nembutal (0.05-0.1 ml) into the opened abdominal cavity. It was found 
that the rats may be kept in this anaesthetised state for as long as 
4-6 hours and urine flow along the cannulae was maintained throughout 
this time. At the end of the experiments the animals were killed by 
cervical dislocation. No experiments were conducted on conscious, post- 
operative animals. 
2.2.3.2 Dosing Procedure for Anaesthetised and Ureter Cannulated Rats 
In all cases the administration of radiolabelled compounds 
was by intraduodenal injection and the compounds were administered as a 
solution of their salts in isotonic saline (3-5 ml) at 370C. 
The dosing procedure was as follows: - 
The deuodenum of the experimental animal was located and 
the bile duct identified. Intraduodenal injections were made at a point 
distal to the junction between the bile duct and the duodenum. The 
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needle of the syringe was introduced directly into the intestinal lumen 
through the gut wall and the duodenum was ligated just behind the needle 
point but in front of the point of entry of the needle. The dose solution 
was injected into the lumen of the intestine and the ligature was secured 
as the needle was withdrawn so that leakage of the dose solution was 
prevented. After securing the ligature, the duodenum was carefully 
replaced into the abdominal cavity. 
Throughout this procedure, extreme care was taken to avoid 
damage to the intestine distal to the point of injection and the intestine 
was kept moist during the procedure by periodic wetting with isotonic 
saline at 37 
°C. 
2.2.3.3 Collection and Assay of Urine and Identification of 
Urinary Metabolites from Ureter Cannulated Rats 
Urine (100-200 t1) was collected from the ureter cannulae 
at timed intervals (usually 10 minutes) after intraduodenal injection of 
radiolabelled compounds. Urine was assayed for 
14C 
in the dioxan based 
scintillant as described. 
Qualitative and quantitative estimation of urinary 
metabolites was by thin layer chromatography of urine samples followed by 
radiochromatogram autoradiography and scintillation counting. The methods 
used were as described previously for the identification of urinary 
metabolites. 
2.2.4 Isolated Cell Preparation Experiments 
2.2.4.1 Isolated Rat Hepatocytes 
Suspensions of isolated rat hepatocytes were supplied by 
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Dr. J. Fry and the method for the isolation of rat hepatocytes was 
according to Fry, et a1 , 
(1976) 
. 
Essentially the method consists of washing rat liver 
slices in Dulbecco's Ca2+ and Mg2+ free phosphate buffer saline at 370C, 
followed by incubation with ethylglycol-bis-(P-amino-ethylether)N, N'- 
tetraacetic acid (EGTA). After treatment with EGTA, the liver slices 
are digested with collagenase/hyaluronidase (0.05%/0.01% w/v Sigma type 
I and II) in Hank's Mg2+ free balanced salt solution containing 
CaCl2(5mM) at 370C in a shaking water bath. 
The resultant enzymic digest was filtered through a layer 
of Boulting Cloth (15O, ýtm pore size Henry Simon Ltd., Stockport) and the 
filtrate centrifuged at approximately 200g 
av 
for 2 minutes. The cell 
pellet was washed and resuspended in Hank's balanced salt solution 
without Ca2+ and Mg2+ The total yield of cells was determined by 
counting in an improved Neubauer counting chamber and the viability of 
the cells was determined on the basis of the ability of the cells to 
exclude the dye trypan blue. 
The cells were finally resuspended in L15 Leibovitz medium 
with glutamine (Gibco, Scotland) containing tryptose phosphate broth 
(10% w/v) and foetal calf serum (10% w/v). The cell density was 
6-8 x 106 viable cells ml-1. Viability of cells was in the order of 
80-90%. 
Protein content of the hepatocytes was estimated by the 
following procedure. The cell suspension was centrifuged and the 
resultant cell pellet disrupted in a solution of Triton X-100 (1% v/v) 
and digested in O. 5M NaOH. The protein was estimated according to the 
method of Lowry et al (1951). 
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2.2.4.2 Isolated Rat Intestinal Mucosal Cells 
Suspensions of isolated rat intestinal mucosal cells 
were supplied by R. Shirkey and the method for the isolation of rat 
intestinal mucosal cells was according to Shirkey (1976). 
Intestinal mucosal cells were isolated from the upper 
third of the small intestine. This section of the small intestine was 
flushed with Kreb's Ca2+ and Mg 
2+ 
free phosphate buffer pH 7.4 containing 
0.1% glucose (Kreb's CMF buffer), everted and filled with Kreb's CMF 
buffer containing albumin (0.5% w/v bovine serum albumin fraction V, 
Sigma). The everted gut was incubated in Kreb's CMF buffer containing 
0.5% w/v ethylene diamine tetraacetic acid (EDTA 1mM) with a bacterial 
protease (1% w/v Sigma type VII) for 45 minutes at 37°C in a shaking 
water bath. 
The resultant enzymic digest was filtered through a layer 
of Boulting cloth (150um pore size, Henry Simon Ltd., Stockport) and the 
filtrate centrifuged at approximately 200g av 
for 1 minute. The cell 
pellet was washed with Kreb's phosphate buffer pH 7.4 containing glucose 
(0.1% v/w) and albumin (0.5% w/v) and resuspended in L15 Leibovitz medium 
with glutamine (Gibco, Scotland) containing foetal calf serum (10% w/v). 
Total cell count and cell viability were calculated as described for rat 
hepatocytes. The cell density was 7-9 x 106 viable cells ml-1. Viability 
of cells was in the order of 90-95%. 
2.2.4.3 Isolated Rat Kidney Cells 
Suspensions of isolated kidney cells were supplied by 
Dr. J. Fry and the method for their isolation was essentially as described 
for rat hepatocytes. 
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Kidney slices were prepared from rat kidneys from which 
surrounding fatty tissue and the medulla had been excised and the slices 
were washed, incubated and enzymically digested as described for rat 
hepatocytes. 
The cells thus obtained, which also contained nephrons 
and tubules, were suspended in Hank's balanced salt solution without 
Ca 
2+ t+ 
and Mg. The viability of the cells was estimated to be 80-90% 
by the exclusion of the dye trypan blue. The kidney cells were finally 
resuspended in L15 Leibovitz medium with glutamine containing tryptose- 
phosphate broth (10% w/v) and foetal calf serum (10% w/v) for metabolic 
studies. 
Protein content of the kidney cell suspension was estimated 
as described for hepatocytes. 
2.2.4.4 Methods Used in the Study of the Metabolism by Isolated 
Cell Preparations 
Radiochemical compounds (5-10 
i 
(XC i, 100, M) were incubated 
with the cell suspension (5 ml) in a conical flask (50 ml) in a shaking 
water bath at 37°C. In the case of the rat hepatocytes and the kidney 
cells, aliquots (100 ,, 
a) of the incubate were taken at timed intervals 
and added to ice-cold acetone (201) to stop the reaction, while in the 
case of intestinal mucosa cells, the incubations were stopped by the 
addition of ice-cold acetone (1 ml) to the total incubate (5 ml). Ice-cold 
acetone used at the concentration described caused as immediate uptake of 
the dye trypan blue by the cells, indicating cell damage. 
The incubation were centrifuged and the supernatents 
(20-30, tA1) were chromatographed on silica gel 60 F254 pre-coated thin 
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layer plates (Merck). Qualitative and quantitative estimation of 
metabolites were by radiochromatogram autoradiography, liquid scintillation 
counting and reverse isotope dilution. The methods used were as described 
previously for the identification of urinary metabolites. 
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CHAPTER 3 
BENZOIC ACID 
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3.1 INTRODUCTION 
Benzoic acid (C7 H602) is a colourless, odourless, light 
feathery crystalline material of M. W. 122.1 and m. p. 122°C. It has 
a pKa of 4.17 and is readily soluble in several organic solvents including 
ethanol, ether and chloroform. It is only sparingly soluble in cold 
water, however, it is soluble in hot water from which it may be 
recrystallized. It also sublimes at 100 
°C. 
It occurs naturally both in the free and combined form. 
It is found generally as esters in plants, as essential oils, gums and 
resins. For example, most berries contain approximately 0.05% benzoic 
acid and in gum benzoin, from which benzoic acid was first isolated, there 
may be as much as 20%. 
It has anti-microbial properties and at concentrations of 
0.1% it acts as an effective preservative for pharmaceutical preparations. 
It is also employed as a preservative in the food industry where the 
permitted level is not more than 1 part in 1000. The antibacterial and 
antifungal properties of benzoic acid are due to the undissociated acid 
and its preservative effect is exhibited in slightly acid media. Anti- 
microbial properties are apparently not exhibited at pH above 5, although 
some undissociated material must still be present. 
Medically benzoic acid has been used as a urinary antiseptic 
and it is used in the treatment of fungal infection of the skin, e. g. as 
Compound Benzoic Acid Ointment which contains 6% benzoic acid and 3% 
salicylic acid. Also, benzoic acid has been used as the basis of a 
liver function test. 
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Benzoic acid shows little toxicity in man, although mild 
irritation of the skin and mucous membrane may be experienced on exposure 
to large doses. The LD50 of benzoic acid in the rat has been shown to 
be 4. lg kg-1 while the lethal dose in dogs is 2g kg-1. 
3.2 METABOLISM OF BENZOIC ACID 
Since the discovery more than 120 years ago (Keller 1842) 
that benzoic acid is conjugated with glycine in the mammalian body, the 
fate of benzoic acid in the animal body has received much attention. 
The metabolites of benzoic acid in most species are 
hippuric acid (benzoylglycine) and benzoylglucuronide, although some 
species may also produce ornithuric acid (N2 N5 dibenzoylornithine). 
There is apparently no evidence to show that benzoic acid 
forms sulphate conjugates (Bray et al 1946), furthermore, it is not 
decarboxylated neither by mammalian tissues nor by gastrointestinal 
organisms. The administration of carboxyl-14C benzoic acid to rats 
does not give rise to 
14co2 
in the expired air (Bernhard et al 1955) and 
in vitro incubation of rat caecal contents with ring-U-14C benzoic 
acid for 4 days gives 99% recovery of benzoic acid by reverse isotope 
dilution (Brewster 1976). 
However, benzoic acid has been reported to be hydroxylated 
in the rat and the guinea pig and trace amounts of 2-, 3- and 4- 
hydroxybenzoic acids have been detected in the hydrolysed urine of these 
14 
animals dosed-with carboxyl- C benzoic acid 
(Acheson and Gibbard 1962). 
Also, it appears that these hydroxylated benzoic acids may be present as 
sulphate conjugates, since 
it has been observed that incubating benzoic 
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acid with rat liver slices in the presence of 
35S 
sulphate, followed 
by chromatogram autoradiography showed a faint, but clear radioactive 
spot corresponding to 4-sulphato-oxybenzoic acid (Sato et al 1956). 
The conjugation of benzoic acid with glycine and glucuronic 
acid to form hippuric acid and benzoylglucuronide respectively is subject 
to species variation and is dose dependent, while the conjugation with 
ornithine to form ornithuric acid appears to be restricted to birds and 
reptiles. 
In a study of the fate of benzoic acid in various species 
(Bridges et al 1970) it was found that when given orally at 50mg kg-1, 
benzoic acid is excreted almost entirely (90-100%) as hippuric acid in 
most of the herbivorous and omnivorous animals investigated. The animals 
studied included man and several species of monkeys, such as rhesus 
monkey, squirrel monkey and capuchin monkey, and several species of 
rodents including the rat, mouse, guinea pig, lemming, hamster and 
gerbil. The pig and the rabbit were also included in the study. In 
these species benzoylglucuronide was excreted as a metabolite, but only 
in trace amounts. 
On the other hand, appreciable amounts of benzoylglucuronide 
were excreted by the carnivorous species, the dog and the ferret (- 20%), 
but not by the cat, which is not unexpected since the cat has a defective 
glucuronic acid conjugation mechanism (Robinson and Williams 1958). 
The differences in the amount of benzoylglucuronide and 
hippuric acid excreted by various species following benzoic acid 
administration may be explained 
in terms of the rate of mobilization of 
glycine for conjugation and 
by the dose level of benzoic acid. For 
example, the ferret excreted some 
22% of the 24 hour excretion as 
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benzoylglucuronide when benzoic acid was administered at 50 mg kg-1, 
but when the dose was increased to 198 mg kg-1 glycine and glucuronic 
acid conjugation was about equal and at 400 mg kg-1 glucuronic acid 
conjugation predominated with 49% benzoylglucuronide and 30% hippuric 
acid being excreted. The ferret also excreted appreciable amounts of 
free benzoic acid but it is suggested that this may well have arisen 
from breakdown of benzoylglucuronide, which is relatively labile. 
(Bridges et al 1970). 
The rabbit, on the other hand, shows no such changes in 
the amount of hippuric acid and benzoylglucuronide excreted. Thus at 
50 mg kg-1 the rabbit excreted benzoic acid entirely as hippuric acid. 
When the dose level was increased to 200 mg kg-1 glycine conjugation of 
benzoic acid was still nearly complete (97-100%) and only trace amounts 
of benzoylglucuronide were detectable in the urine (Bridges et al 1970). 
It is suggested that the rate of glycine mobilization is 
an important factor in the synthesis of hippuric acid from benzoic acid 
and may account for the differences in the ratio of benzoylglucuronide 
to hippuric acid excreted by various species. For example, the ratio of 
glucuronide to hippuric acid is about 
when the dose was 450 mg kg-1 (Willia; 
that the rate of glycine mobilization 
while in the rabbit it is about 24 mg 
2: 1 in the dog and 1: 4 in the rabbit 
ms 1959) and it has been calculated 
in the dog is about 3.5 mg kg-1 hr-1 
kg-1 hr-1 (Quick 1931). Furthermore, 
it has been shown that if the availability of glycine is increased by 
feeding exogenous glycine, hippuric acid excretion is increased and 
glucuronide formation depressed 
(Hainline and Lewis 1953). Indeed when 
no glycine was fed, the rate of glycine mobilization 
in the rabbit was 
-1 -1 but when glycine was fed with the calculated to be about 21 mg 
kg hr -1 
benzoate, the rate of glycine mobilization was calculated to be about 
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51 mg kg-1 hr-1 (Hainline and Lewis 1953). 
It has been shown that only free glycine may be utilized 
in hippuric acid synthesis and any precursors must first be converted to 
glycine before utilization. However, some free glycine is present in 
mammalian tissues which is imediately available for conjugation with 
small doses of benzoic acid. For example, in the rat this amounts to 
10 mg 100 g-1 and is referred to as the "first glycine pool" (Arnstein 
and Neuberger 1951). This "first glycine pool" is in a relatively slow 
equilibrium with a larger "pool" of glycine and glycine precursors and 
the larger "pool" only participates in hippuric acid synthesis when 
larger doses of benzoic acid are administered. Indeed it has been stated 
that the rate of hippuric acid synthesis is independent of the dose 
except for doses of benzoic acid of 25 mg kg-1 or less, whereas that of 
glucuronide synthesis is dependent upon the dose (Bray et al 1951). Thus 
it can be seen that both the dose level of benzoic acid and the rate of 
glycine mobilization play important parts in species variation in benzoic 
acid metabolism. At small doses all species tend to excrete benzoic 
acid as hippuric acid, but with larger doses, species with relatively high 
rates of glycine mebolization will excrete predominantly hippuric acid 
(e. g. rat), whereas in species where glycine mobilization is relatively 
slow, saturation of the glycine pathway may occur resulting in an increase 
in glucuronic acid conjugation. 
In the 20 or so species investigated by Bridges et al 
(1970), the cat and the Indian fruit bat are of particular interest in 
that they are apparently deficient in glucuronic acid and glycine 
conjugation mechanisms respectively. Thus the cat excretes benzoic acid 
entirely as hippuric acid while the Indian 
fruit bat excretes benzoic acid 
predominantly as benzoylglucuronide. 
The deficiency of glucuronic acid 
conjugation mechanism in the cat 
is well known. Indeed, it appears that 
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the cat like animals such as the lion, civet and genet show a similar 
pattern of conjugation mechanism as the domestic cat (French, et al 1974). 
Conjugation with glycine or some other amino acid (e. g. 
ornithine) is almost universal among animals ranging from insects to man. 
The absence of such conjugation is unusual, but it has been reported that 
the carrion crow and grey African parrot did not excrete hippuric or 
ornithuric acid when dosed with benzoic acid (Baldwin, et al 1960). The 
absence of hippuric acid synthesis by the Indian fruit bat has been 
confirmed both in vivo and in vitro experiments (Bababunmi, et al 1973), 
but deficiency in glycine conjugation is apparently substrate dependent 
since the Indian fruit bat excretes the glycine conjugate phenaceturic acid 
as the major metabolite of phenylacetic acid (Ette, et al 1974). The 
metabolites of benzoic acid and phenylacetic acid are also different in 
man, they are hippuric acid and phenylglutamine respectively (Williams, 
1959 ), however, both acids are conjugated with glycine in the rat. 
The excretion of ornithuric acid (N2 NS dibenzoylornithine) 
as a metabolite of benzoic acid was discovered by Jaffe, (1877) in hens 
and it has been shown that in several species of birds studied, ornithuric 
acid is the major metabolite of benzoic acid. However, not all birds 
form ornithine conjugates. For example, chicken, turkey, goose and duck 
excrete ornithuric acid after benzoic acid administration whereas pigeon 
and dove appear to form only hippuric acid (Baldwin et al 1960, Bridges, 
et al 1970). All species of birds examined also 
form benzoylglucuronide. 
Ornithuric acid is also excreted as a major metabolite 
of benzoic acid by several species of reptiles 
including lizard, snake, 
tortoise and crocodile (Smith, 1957) and the gecko 
(Bridges, et al, 
1970). 
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The excretion of ornithuric acid does not preclude the 
excretion of hippuric acid from benzoic acid since species such as the 
hen excrete some 5-20% of the dose of benzoic acid as hippuric acid 
(Bridges et a1f1970). Indeed glycine conjugation occurs in the hen to a minor 
extent as reported by Suga, (1919) and Chang and Johnson, (1956). Also the 
formation of hippuric acid from ingested aromatic acids has been 
reported (Komori et al 1926) and hippuric acid is a normal urinary metabolite 
of turtles (Schiff 1859, Khalil, 1947). It appears that in all species 
studied so far ornithine conjugates are always accompanied by small 
amounts of glycine conjugates (Smith 1957). 
The tissue distribution in the ability to metabolise 
benzoic acid has been investigated using tissue slices and homogenates 
and it has been shown that benzoic acid is metabolised not only by the 
liver, but also by the kidneys and the small intestine. Indeed, in the 
dog glycine conjugation of benzoic acid has been shown to occur only in the 
kidneys (Friedmann and Tachan, 1911, Quick, 1932, Snapper, et al 1923, 
Borsook and Dubnoff, 1940). Metabolism of benzoic acid by other tissues 
has not been demonstrated. 
The ability of the kidneys to conjugate benzoic acid 
with glycine has been demonstrated by several workers (Schmiedeberg and 
Burge, 1877, Quick, 1932) and in a pharmacokinetic investigation in the 
rabbit it was shown that the enzyme system involved may be different from 
that of the liver but there was considerable individual variation (Wan and 
Rigelman, 1972). 
The involvement of the kidney in the in vivo metabolism 
of benzoic acid has been considered and 
in an attempt to investigate the 
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fractional metabolism of benzoic acid by specific organs, namely the 
kidneys and the liver (Wan and Rigelman, 1972), it was found that there 
was considerable variation and that fractional metabolism of benzoic acid 
in the kidneys ranged from 21-88%. Clearly the kidneys make an appreciable 
contribution to the in vivo metabolism of benzoic acid in the rabbit, but 
unfortunately it was not possible to determine the relative contribution 
of the liver and the kidney in the in vivo metabolism of benzoic acid and 
it is likely that dose level and availability of glycine are important 
factors for consideration. 
Using liver and kidney slices and homogenates Irjala, (1972) 
was able to demonstrate hippuric acid synthesis in these tissues in 
several species including the rat, guinea pig, dog and cat. Similar 
rates of hippuric acid synthesis were observed in liver slices and 
kidney slices in all species investigated except the dog and the cat, 
where the rate of synthesis of hippuric acid in kidney slices was 
greater than that found in liver slices. On the other hand, liver 
homogenates showed considerably more glycine conjugating activity than 
kidney homogenates in all species studied except the dog and the cat, where 
activity in the kidney homogenates predominated. It was suggested that 
differences between the observations from the tissue slices and homogenates 
may have been due to factors such as the penetration of substrate into 
tissue slices and the greater exposure of the potential enzyme mechanism 
for glycine conjugation in homogenates. Kidney slices have been shown to 
actively accumulate aryl substrates whereas liver slices do not (Cross 
and Taggart, 1950, Scharchter, et al, 1955), and this may be significant 
in the in vivo metabolism of benzoic acid. Such observations illustrate 
the difficulties involved in investigations using relatively crude 
biological preparations. 
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The ability of the intestine of the rat to conjugate 
benzoic acid with glycine has also been demonstrated (Strahl and Barr 
1971), and the synthesis of hippuric acid in everted gut sacs was found 
to be low (. I--=l%). There was apparently no hydrolysis of hippuric acid 
by the gastrointestinal mucosa or by intestinal microorganisms, but there 
was some accumulation of benzoic acid and hippuric acid in the intestinal 
tissues. Interestingly an extramitochondrial thermolabile factor was 
found to be present in the intestinal mucosa which apparently inhibited 
the in vitro glycine conjugation of benzoic acid in both the liver and 
the kidneys and it is possible that this inhibitory factor may be involved 
in the low level of synthesis of hippuric acid in the intestine. The 
nature of the inhibition was not known and it is suggested that since 
glycine conjugation occurs in the mitochondria, extramitochondrial 
inhibition may not occur in vivo (Irjala, 1972). 
The tissue distribution of glycine conjugation of benzoic 
acid has also been investigated in various species and in most species 
studied the major site of glyciný-- conjugation was the liver. However, 
glycine conjugation of benzoic acid in the dog occurring only in the 
kidneys has already been described, but recently, using a sensitive 
radiochemical technique, hippuric acid synthesis has been demonstrated 
in dog liver slices and homogenates, although this was insignificant 
compared with the synthetic activity of the dog kidneys (Irjala, 1972) . 
It was also shown that synthesis of hippuric acid by 
cat kidney homogenates was greater than cat liver 
homogenates (Irjala, 
1972). In man hippuric acid synthesis is markedly affected by liver 
damage and indeed formation of hippuric acid from ingested sodium 
benzoate 
has been used in liver function tests. This suggests that glycine 
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conjugation of benzoic acid in man occurs predominantly in the liver. 
Interestingly the rhesus monkey was found to metabolise benzoic acid 
only in the liver (Wan and Rigelman, 1972). 
The synthesis of ornithuric acid in species which excrete 
this compound as a metabolite of benzoic acid also shows some tissue 
distribution. For example, ornithine conjugation of benzoic acid in 
the chicken was found to occur in the kidneys, the liver apparently shows 
no such activity (McGilvery and Cohen 1950). It is probable that the 
mechanism of synthesis of ornithuric acid and hippuric acid is similar. 
3.3 IN VIVO INVESTIGATION OF BENZOIC ACID METABOLISM 
[jflg_u_14cJ_Benzojc 
acid (50 mg kg-1) was administered 
to the animals as described in Chapter 2. Urine and faeces were collected 
and assayed as described. 
The Rf values and methods of detection of benzoic acid 
and its metabolites are given in Table 3.1. 
The results of orally administered 
14C-benzoic 
acid in 
the sheep, the pig and the rat are summarized in Tables 3.2 and 3.3. 
It is significant that a major proportion of the administered 
dose was excreted by these animals relatively rapidly after oral 
administration. Thus in the case of the pig 
77% of the administered 
dose was excreted within 5 hours after oral administration of 
14C-benzoic 
acid while in the sheep 57% was excreted within 
4 hours after administration. 
24 hours after oral administration the radioactivity excreted 
in the urine 
was 91,82 and 92% of the administered 
dose in the sheep, the pig and the 
rat respectively. 
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Negligible amounts of radioactivity (< 1%) were excreted in the 
faeces, indicating that the major pathway for the elimination of orally 
administered benzoic acid was by urinary excretion. 
The major metabolite in all these species was hippuric 
acid. Benzoylglucuronide and benzoic acid were also detected in the urine. 
In the rat they were 4.8% and 2.8% of the dose respectively, but in the 
sheep and the pig only traces of these metabolites were present (less than 
1%). Free benzoic acid found in the urine may arise from the bacterial 
decomposition of benzoylglucuronide which is relatively labile (Bridges 
et al 1970). 
It has been shown that the amount of benzoylglucuronide 
and hippuric acid excreted following oral administration of benzoic acid 
depends upon the dose and that in some species such as the ferret, increase 
in the dose of benzoic acid results in an increase in benzoylglucuronide 
excretion with a concomitant decrease in hippuric acid excretion, while in 
other species, e. g. rabbit, only hippuric acid was excreted irrespective 
of the dose of benzoic acid although traces of benzoylglucuronide may 
be detected at higher doses of benzoic acid (Bridges, et al, 1970). Thus, 
following on from these reports, 
14C 
benzoic acid at various dose levels 
(10-400 mg kg-1) was administered orally to a group of rats. The excreta 
were collected and analysed as described and the results are summarized 
in Table 3.4. 
The results showed that at all dose levels studied some 
80% of the dose was excreted in the urine within 24 hours. Negligible 
amounts of radioactivity were detected in the faeces implying that 
urinary excretion is the major route of elimination of orally administered 
14C-benzoic 
acid in the rat. 
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A study of the metabolic profile showed that at all dose 
levels studied, hippuric acid was the major urinary metabolite. A small 
amount of free benzoic acid was also detected, but this may have arisen 
from bacterial hydrolysis of benzoylglucuronide. Benzoylglucuronide was 
found to be present in all urine samples. Also there appears to be a 
trend in that there was a slight increase in the proportion of benzoyl- 
glucuronide and a slight decrease in hippuric acid when the dose level 
of benzoic acid was increased. 
3.4 METABOLISM OF BENZOIC ACID IN URETER CANNULATED RATS 
The ureters of anaesthetised male rats (250 g) were 
cannulated as described, they were dosed with 
[ring_u_14c] 
benzoic acid 
at 50 mg kg-1 and 100 mg kg-1 by intraduodenal injection as described. 
After intraduodenal injection urine was collected at 
intervals of 10 minutes for a period of 2 hours and urine samples were 
assayed for radioactivity as described. Metabolic profiles of the 10 
minute samples were determined by thin layer chromatography of aliquots 
(20-40 , l) of urine on silica gel 60 pre-coated plates (Merck) in solvent 
system G followed by radiochromatogram autoradiography. The areas of 
the chromatograms corresponding to benzoic acid (Rf 0.95), hippuric acid 
(Rf 0.71) and benzoylglucuronide (Rf 0.37) were located and compared with 
the corresponding dark spots on the autoradiograms. These areas were 
marked on the chromatograms, cut out and placed into scintillation vials 
and counted as described. The radioactivity associated with each of the 
areas was expressed as a percentage of the radioactivity recovered from 
the radiochromatogram. 
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The rate of urinary elimination of radioactivity after 
intraduodenal administration is summarized in Figure 3.1. Metabolic 
profiles of the 10 minute samples are illustrated in Figure 3.2 and the 
rate of excretion of hippuric acid and benzoylglucuronide are shown in 
Figures 3.3,3.4 and 3.5. 
The results obtained from anaesthetised animals (Figure 3.1) 
showed that at the dose levels studied some 2% of the dose was recovered 
in the urine within 10 minutes after administration and that at 50 mg kg-1 
about 80% of the dose was excreted within 2 hours while at 100 mg kg-1 
about 70% of the dose was recovered in the urine in 2 hours. 
The rate of elimination of radioactivity, which may be 
calculated from the linear portion of the curve showed that at 50 mg kg-1 
the rate was in the order of 8.5% of the dose per 10 minutes while at 
100 mg kg-1 it was in the order of 7.7% of the dose per 10 minutes. The 
linear portion of the graph represents the maximal rate of elimination 
of metabolites of benzoic acid at the particular dose studied. 
At both dose levels the major metabolite was hippuric acid 
and it can be calculated that the rate of elimination of hippuric acid 
was 1.47psno1e min-1 (0.26 mg min-1) and 0.85, vmo1e min-1 (0.15 mg min-1) 
when 205,1ýmoles (100 mg kg-1) and 102.51ý&moles (50 mg kg-1) of benzoic 
acid was administered to the rats (250 g) respectively. The rate of 
elimination of benzoylglucuronide was calculated to be 0.2 t&mole min-1 
(59.6 g min -1 ) when the animals were dosed with 2O5&moles of benzoic 
acid and 0.14 , mole min-1 (41.71ug min-1) when 
dosed with 102.5/mole 
of benzoic acid (Figures 3.4 and 3.5). 
These figures showed that the metabolism of benzoic acid 
followed the kinetics of a first order reaction. The rate of elimination 
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FIGURE 3.2 
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FIGURE 3.3 
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FIGURE 3.4 
THE RATE OF URINARY ELIMINATION OF 
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of both metabolites is dependent upon the dose and increases with 
increasing doses of benzoic acid. Saturation of the systems involved 
in the metabolism of benzoic acid was not observed at the dose levels 
used and it is likely that a maximum rate of elimination would be reached 
when saturating levels of benzoic acid were administered. 
The ratio of hippuric acid to benzoylglucuronide at 2 
hours after intraduodenal administration of benzoic acid was calculated 
to be 6.6: 1 at 50 mg kg-1 and 8: 1 at 100 mg kg-1. This suggests that 
relatively more benzoylglucuronide was being excreted at a dose of 
50 mg kg-1 that at 100 mg kg-1, although it can be demonstrated that there 
is a trend towards a slight increase in the relative amounts of 
benzoylglucuronide with increasing doses of benzoic acid. However, it 
should be noted that at 2 hours after administration benzoylglucuronide 
found in the urine has reached a maximum and plateaued when the dose 
was 50 mg kg-1, but at 100 mg kg-1 this has yet to be achieved (Figure 
3.3). 
When the ratio of hippuric acid to benzoylglucuronide 
found in the urine at different times after intraduodenal administration 
of benzoic acid was plotted against time (Figure 3.6), it can be seen 
that more hippuric acid than benzoylglucuronide was excreted throughout 
the 2 hour period, but the relative amounts of hippuric acid to 
benzoylglucuronide found in the urine appears to change with time. 
Initially the ratio of hippuric acid to benzoylglucuronide in the urine 
was high, but it drops rapidly to a constant level and then gradually 
rises again as the administered benzoic acid is metabolised and excreted. 
Figure 3.2 shows the percentage of the dose excreted at 
each time interval as hippuric acid and 
benzoylglucuronide and it can be 
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FIGURE 3.6 
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seen that maximum excretion occurs between 50-60 minutes and 40-50 
minutes for doses of 50 mg kg-1 and 100 mg kg-1 respectively. 
3.5 METABOLISM OF BENZOIC ACID IN ISOLATED CELL PREPARATIONS 
Isolated cell preparations were prepared as described 
in Chapter 2 and 
[rjng_u_l4c1eflzojc 
acid (lOO QMM 
Smr-i/lOJ i) was 
incubated with the cell suspension (5 ml) as described. 
Samples of the incubates obtained at 5 minute intervals 
from rat kidney cells and liver cells (100 mal), and from intestinal 
mucosal cells (5 ml) at 15 minute intervals were assayed by thin layer 
chromatography after centrifugation to remove denatured protein. Aliquots 
of the supernatents (20-40 )1) were chromatographed on silica gel 60 plates 
(Merck) in solvent system G. The areas corresponding to benzoic acid 
(R 
f 0.93), hippuric acid 
(R 
f 0.71) and 
benzoylglucuronide (R f 0.37) were 
located and compared with the corresponding dark spots on the auto- 
radiograms. These areas were marked on the radiochromatogram and were 
cut out and placed into scintillation vials and counted as described. 
The radioactivity associated with each area was expressed as a percentage 
of the radioactivity recovered from the radiochromatograms. 
Autoradiograms from isolated rat intestinal mucosal 
cells, kidney cells and hepatocytes are shown in Figures 3.7; 3.8; 3.9; 
and it can be seen that essentially no metabolism of benzoic acid 
by isolated intestinal mucosal cells was detected during the period of 
1 hour. On the other hand, isolated rat liver and kidney cells show 
progressive metabolism of benzoic acid to hippuric acid and benzoyl- 
glucuronide. 
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FIGURE 3.7 
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Quantitative results for benzoic acid metabolism by rat 
kidney cells and hepatocytes are given in figures 3.10 and 3.11 and they 
show an increase of hippuric acid and benzoylglucuronide with time 
accompanied by a concomitant decrease in benzoic acid. 
The rate of synthesis of hippuric acid by rat hepatocytes 
was calculated to be 0.69 Amole 106 cells-1 min-1 while the rate of 
metabolism of benzoic acid was calculated to be 0.75iLmole 106 cells-1 
min-1. At the end of the incubation, the ratio of hippuric acid to 
benzoylglucuronide to benzoic acid was found to be 18: 1: 1. 
The rate of synthesis of hippuric acid by isolated kidney 
cells was calculated to be 0.25 i)mole mg protein-1 min-l, while the rate 
of benzoic acid metabolism was calculated to be 0.26ýAmole mg protein-1 
min-1. Some synthesis of benzoylglucuronide was also observed and at 
the end of a one hour incubation only about 1% (5 nmole) of benzoic acid 
was converted to benzoylglucuronide. Interestingly, the autoradiogram 
from kidney cells also showed the presence of two extra radioactive spots 
which were not seen in the autoradiogram from liver cells. The nature of 
these spots has not been investigated, but their chromatographic behaviour 
compared to benzoic acid and benzoylglucuronide suggest that they may be 
hydroxy-benzoic acids and their conjugates and at the end of the incubation 
they accounted for about 2-3% (10-15 Alnoles) of the benzoic acid substrate. 
The presence of nephrcns and tubules in the isolated 
kidney cell preparations presented a problem in the counting of cells 
as described. Consequently, quantitative results 
in metabolism studies 
using kidney cells are expressed 
in terms of the protein content of the 
kidney cells in the cell suspension. 
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In comparing the rate of metabolism of benzoic acid and 
hippuric acid synthesis by liver and kidney cells it can be calculated 
that the rates of hippuric acid synthesis were 0.46 and 0.25t1mo1e mg 
protein-1 min-1 for liver cells and kidney cells respectively while the 
rate of metabolism of benzoic acid was O. 5 r mole mg protein-1 min-1 for 
liver cells and 0.26omole mg protein-1 min-1 for kidney cells. 
The results show that under the conditions of the isolation 
and metabolism studies as described, both liver cells and kidney cells 
are capable of metabolising benzoic acid by glycine conjugation and to 
a lesser extent by glucuronic acid conjugation, liver cells being twice 
as active as kidney cells. Also it is speculated that kidney cells may 
be capable of hydroxylating benzoic acid to form hydroxybenzoic acid. 
Intestinal mucosal cells do not appear to metabolise benzoic acid under 
the conditions of the experiment. 
3.6 DISCUSSION 
The results of the investigations involving benzoic acid 
were summarized in the previous sections and in the in vivo studies a 
significant result was that 80-90% of the 
14C 
administered to the animals 
was excreted in the urine within 24 hours of 
dosing. Indeed a majority 
-1 
of the dose of benzoic acid (50 mg kg 
) was excreted within about 8-9 
hours by both the sheep (79% in 9 hours) and the pig (80% in 8 hours). 
However, previous reports have shown that the pig excreted only about 
50% of the dose in 24 hours after oral administration of 
50 mg kg-1 of 
benzoic acid (Bridges et alp1970). 
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This rapid excretion of metabolites of benzoic acid 
appears to be common in most animal species and some 50-100% of the 
dose was recovered in the urine within 24 hours and in most laboratory 
animals, including the rat, this 24 hour urinary excretion is in the 
order of 80-100% (Bridges(et a1,1970). Unfortunately, little is known 
about the rates of excretion and 50-100% excretion in 24 hours represents 
a wide variation. It is likely that the rate of excretion of metabolites 
may show considerable species variation and may reflect the importance 
of different metabolic pathways in different species. 
Little or no metabolites of benzoic acid were excreted in 
the faeces of these animals indicating that urinary excretion is the major 
pathway for the elimination of benzoic acid. Furthermore, it suggests 
that there is little or no biliary excretion of benzoic acid and its 
metabolites. Indeed it has been shown that biliary excretion of 
metabolites of benzoic acid is in the order of about 2% in several 
laboratory animals after intraperitoneal and intravenous injection 
(Abou-el-Makarem, et al 1967a). 
Like the majority of mammalian species, the major metabolite 
of benzoic acid in the sheep and the pig was hippuric acid and traces 
of some benzoylglucuronide were also detected. This confirms previous 
observations that in the sheep (Martin1966) and the pig (Bridges, et al 
1970) benzoic acid is converted mainly to hippuric acid and some 
benzoylglucuronide. However, the present investigation shows only traces 
of benzoylglucuronide synthesis and little or no 
free benzoic acid was 
detected in the urine, although previous investigations have shown the 
presence of considerable amounts of 
free benzoic acid (:: n- lO%) in the 
urine of the sheep and the pig, and 
benzoylglucuronide (2-15%) in the 
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urine of sheep, but only traces in the pig. 
In the investigation of benzoic acid metabolism by the 
sheep (Martin 1966) several grams of benzoic acid together with glycine 
were administered to the sheep by infusion into the rumen or abomasum 
via permanent cannulae. A range of dose levels was used ranging from 
0.2 g kg-1 to 1g kg-1, and it was found that the amount of benzoyl- 
glucuronide increased with increasing dose of benzoic acid. Also it was 
believed that free benzoic acid found in the urine may have arisen from 
hydrolysis of benzoylglucuronide and hippuric acid since free glucuronic 
acid and glycine were also found in the urine of the sheep. 
Bacterial decomposition of benzoylglucuronide, which is 
relatively labile was also assumed to be the major source of free benzoic 
acid in the urine of pig and several other species studied (Bridges', et 
al, 1970). Furthermore, it is possible that hydrolysis of hippuric acid 
may also give rise to free benzoic acid in the urine since the enzyme 
hippuricase which hydrolyses glycine conjugates is found to be present 
in kidneys of several species including the rabbit, pig, cow and chicken 
(Schachter, et al, 1955). Faecal microorganisms capable of hydrolysing 
hippurates have also been reported (Norman and Grupp 1955). 
In the investigation of metabolism of benzoic acid in 
the sheep, a ruminant, it should be noted that benzoic acid is a normal 
constituent of sheep urine. It is the principle aromatic compound excreted 
in the urine of sheep (Martin, 1975). It's origin is unknown, 
but is 
believed to be dietary in nature. 
The amount of benzoic acid excreted varies with the 
1 
variety of food intake and 
has been determined to be 2.7-13.3 g kg- 
of food and it has been suggested 
that the urinary benzoic acid excreted 
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by ruminants may be derived from rumen microbial metabolism of 3-hydroxy 
derivatives of 3-phenyl-propionic or cinnamic acid. The latter being 
widely distributed in plants (Martin, 1975). Indeed, because of the 
ability of intestinal bacteria and mammalian tissues to synthesise benzoic 
acid from dietary precursors, hippuric acid is often found as a normal 
constituent of urine in many species. 
It has been pointed out previously that in some species, 
increase in the dose of benzoic acid was accompanied by an increase in 
the relative amounts of benzoylglucuronide excreted (Williams, 1959c, 
Bridges et al 1970). The rat appears to follow the same trend when 
dose levels ranged from 10 mg kg-1 to 400 mg kg-1, but the change in the 
relative amounts of hippuric acid and benzoylglucuronide was not very 
significant. However, it is possible that more marked changes would be 
observed if higher dose levels were used in the investigation. This 
phenomenon is believed to be due to a combination of factors including 
the rate of glycine mobilization (Bray, et a1,1951) and availability of 
free glycine (Arnstein and Neuberger, 1951). 
The dose level used in the present in vivo investigation 
was 50 mg kg-l. This is well below the toxic level of benzoic acid in 
these species. In the rat, LD50 of benzoic acid was 4.1 g kg-1 and in 
the sheep the lethal dose was 1.1-1.8 g kg-1 (Martin, 1966). Toxic 
symptoms in the sheep included severe muscular weakness accompanied by 
muscular tremors and anorexia. The lethal dose of benzoic acid in the 
pig is not known, however, no undue symptoms of stress were observed in 
-1 
the pig dosed with 50 mg kg of benzoic acid and it was assumed that 
this was well below the toxic level. 
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The metabolism of benzoic acid was also studied in ureter 
cannulated rats in an attempt to investigate the kinetics of in vivo 
metabolism and the changes in the urinary metabolic profile with time. 
The kinetics of benzoic acid metabolism have been studied 
previously in the rabbit (Bray, et al, 1951). The dose of benzoic acid 
administered was in the order of 1-2 g kg-1 and it was found that hippuric 
acid formation took place at a constant rate and that the acid was 
excreted immediately up to a limiting rate which appears to vary 
considerably between rabbits, but the average rate of formation and 
excretion of hippuric acid was calculated to be 147 mg hr-1. It was 
also found that the rate of hippuric acid synthesis may be increased 
when glycine was administered together with benzoic acid. On the other 
hand, synthesis of benzoylglucuronide was a first order process and the 
percentage of the dose of benzoic acid excreted as benzoylglucuronide 
is dependent not only upon the dose, but also upon whether or not glycine 
was administered. Indeed it has been suggested that the rate of hippuric 
acid formation is independent of the amount of benzoic acid in the body 
probably for amounts down to 25 mg kg-l, whereas, conjugation with glucuronic 
acid is dependent on the dose of benzoic acid. 
For comparison with in vivo studies, the dose levels used 
in the present investigation were 50 mg kg-1 and 100 mg kg-1 and it was 
found that in the rat, the metabolism of benzoic acid approximates to 
a first order process. The synthesis and elimination of 
both hippuric 
acid and benzoylglucuronide were 
dose dependent and they were eliminated 
in the urine at a constant rate after an apparent 
initial lag phase. 
At the dose levels studied constant elimination of metabolites occurred 
for a period of about 1 hour and as 
the amount of metabolites eliminated 
in the urine increased, the rate of elimination 
decreased so that elimination 
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plateaued when the majority of the dose had been excreted. The constant 
rate of elimination of hippuric acid and benzoylglucuronide by the rat 
at 50 mg kg-1 was calculated to be 150 , tLg min-1 and 41.7 8 min-1 
respectively; at 100 mg kg-1 the rates were 260 ýg min-1 and 59.6 ý. g min-1 
respectively. 
Benzoic acid has a pKa of 4.17. It is a weak electrolyte 
and is equally well absorbed from the stomach or the intestine of rats 
(Schanker, et a1,1957,1958). Thus it is interesting to note that within 
10 minutes after the administration of benzoic acid into the duodenum, 
conjugated metabolites in the order of 2% of the dose were detected in 
the urine and after 2 hours some 70-80% of the dose was excreted in the 
urine. 
This suggests that at the dose levels studied, absorption 
from the intestine, distribution, metabolism and excretion of benzoic acid 
were very rapid and not rate limiting. Indeed a limiting rate of excretion 
of metabolites of benzoic acid was not observed and it is likely that 
this would occur only when saturating levels of benzoic acid were 
administered. The limiting factor in the synthesis of hippuric acid 
is apparently the availability of free glycine (Arnstein and Neuberger. 
1951, Hainline and Lewis, 1953). It has also been shown that the rate 
of hippuric acid synthesis is increased if glycine was added exogenously 
(Hainline and Lewis, 1953, Arnstein and Neuberger, 1951, Bray, et al 
1953) 
and this was accompanied by a simultaneous 
decrease in glucuronide 
excretion. 
The species difference in the degree of conjugation of 
benzoic 
acid with glucuronic acid 
has also been explained in terms of the 
availability of free glycine 
and the rate of glycine mobilization (Bray 
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et al 1951, Hainline and Lewis 1953). Thus if glycine mobilization is 
relatively fast, large doses of benzoic acid will tend to be predominately 
excreted as hippuric acid, but if glycine mobilization is relatively slow, 
then glucuronide formation becomes an important aspect in the metabolism 
of benzoic acid. 
In the present investigation the results suggest that the 
rate of glycine mobilization in the rat, sheep and pig may be relatively 
rapid, but unfortunately, the dose levels used may not be high enough to 
demonstrate benzoylglucuronide formation. At a dose of 500 mg kg-1 it 
has been reported that 31% of the dose of benzoic acid is excreted as 
benzoylglucuronide by the pig (C2onka. 1924). The sheep also excretes 
significant amounts of benzoylglucuronide when high doses of benzoic 
acid are administered (Martin, 1966). 
An interesting observation in the ureter cannulated rat 
experiments was that the ratio of hippuric acid to benzoylglucuronide 
found in the urine at different times after intraduodenal administration 
varies with time. Initially, considerably more hippuric acid was excreted 
than benzoylglucuronide, but as metabolism and excretion proceeds, the 
ratio of hippuric acid to benzoylglucuronide reaches a constant which is 
maintained for some time, and as the amount of benzoic acid in the body 
is reduced due to metabolism and elimination, the relative amount of 
hippuric acid to benzoylglucuronide excreted increases indicating that 
hippuric acid synthesis is very significant in the metabolism of benzoic 
acid and that benzoylglucuronide synthesis 
depends on the level of benzoic 
acid in the body. 
The ratio of hippuric acid to benzoylglucuronide is always 
in favour of hippuric acid, that is hippuric acid excretion 
in the rat 
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predominates. However, this variation in the ratio may reflect the 
importance of various pathways of metabolism of benzoic acid in vivo. 
Interestingly, the period of time that the ratio of hippuric acid to 
benzoylglucuronide was constant also corresponded with the maximal 
excretion of metabolites of benzoic acid at the dose levels studied. 
Studies on the kinetics of urinary elimination and the 
urinary metabolic profile of benzoic acid gives little information on 
the ability of various tissues to metabolise benzoic acid and the 
contribution of various tissues towards its overall metabolism. 
In an attempt to investigate the tissue distribution in 
the ability to metabolise benzoic acid, isolated cell preparations from 
the rat were used. It was found that both the liver and the kidneys 
but not the intestine were capable of metabolising benzoic acid. Hippuric 
acid was the major metabolite in both cases and on the basis of protein 
content of the cell preparations, it can be demonstrated that rat liver 
cells are about twice as active as rat kidney cells in conjugating 
benzoic acid with glycine. The rate of hippuric acid synthesis in liver 
cells was calculated to be 0.46 tlmole mg-1 min-1 and for kidney cells 
0.25 (mole mg-1 min-l. Interestingly both liver cells and kidney cells 
from the rat show some ability to synthesise benzoylglucuronide. 
Previously, several workers, using crude tissue preparations 
were able to demonstrate that besides the liver, 
both the kidneys and 
the intestine were capable of metabolising benzoic acid to hippuric acid 
(see Section 3.2), but unfortunately no information was available on the 
ability of extrahepatic 
tissues to form benzoylglucuronide. 
The ability of the intestine of the rat to conjugate 
benzoic acid with glycine was 
demonstrated using everted gut sacs 
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(Strahl and Barr 1971) and intestinal slices and homogenates (Irjala, 
1972). The synthesis of hippuric acid by the intestine was extremely 
low and is negligible compared with the liver and the kidneys. In the 
present investigation using isolated cells from the intestinal mucosa, 
no metabolism of benzoic acid was detected and it is likely that other 
factors may be involved in the metabolism of benzoic acid by the 
intestine and further investigation on these factors may be necessary 
in order to elucidate the involvement of the intestine in benzoic acid 
metabolism. 
It is worth pointing out that an advantage of using 
isolated cell preparations rather than tissue slices and homogenate in 
the study of the metabolism of benzoic acid is that both metabolic 
pathways of glycine and glucuronic acid conjugation are demonstrated 
concurrently by the isolated cells and information on the relative 
importance of each pathway in the different tissues may be determined. 
In the rat liver and kidneys, benzoylglucuronide formation 
is detectable and it is a minor pathway in the overall metabolism of 
benzoic acid. 
The tissue distribution of glycine conjugation of benzoic 
acid found in various species studied suggest that it may 
have a 
significant role in the species 
difference in the relative amounts of 
hippuric acid and benzoylglucuronide excreted 
in the urine. 
The dog, and ferret excrete a considerable amount of 
benzoylglucuronide following a single 
dose of benzoic acid compared with 
other mammalian species studied which 
excrete only a small amount of 
benzoylglucuronide. Indeed, the 
ferret shows an increase in benzoylglucuronide 
excretion with increase 
in dose of benzoic acid (Bridges, et a1,1970). 
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The cat and the dog have also been shown to exhibit 
greater hippuric acid synthetic activity in the kidneys than in the 
liver (Irjala'1972). Although information on tissue distribution of 
glycine conjugation in the ferret is not available, our preliminary 
investigations on benzoic acid metabolism by isolated cells from the 
ferret have indicated that glycine conjugation in ferret liver is very 
low, but there was a significant level of benzoylglucuronide synthesis, 
and it is likely that ferret kidneys may show considerable glycine 
conjugation of benzoic acid. 
These observations suggest that a supplementary explanation 
for species differences in the amount of hippuric acid and benzoyl- 
glucuronide excreted in the urine may be proposed. 
After a single dose of benzoic acid, the liver is the 
major organ of metabolism first encountered and species with active 
hepatic glycine conjugating mechanisms will tend to metabolise benzoic 
acid to hippuric acid, while benzoylglucuronide may be the major hepatic 
metabolite of benzoic acid in species such as the dog, the cat and 
perhaps the ferret where glycine conjugation of benzoic acid in the 
liver is absent or low. Benzoic acid is a relatively polar material, 
therefore, it is likely that unmetabolised benzoic acid may be cleared 
from the liver and passed to the kidneys where further metabolism by 
glycine conjugation may take place prior to elimination from the body. 
Indeed fractional metabolism of benzoic acid by the liver and the kidneys 
has been demonstrated in the rabbit (Wan and Rigelman, 1972). Glycine 
conjugation of benzoic acid in tissues other than the 
liver and the 
kidneys has not been demonstrated except in the intestine where hippuric 
acid synthesis was very 
low (Strahl and Barr, 1971, Irjala, 1972) so that 
fractional metabolism of benzoic acid by the liver and the kidneys 
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together with the availability of glycine and the rates of glycine 
mobilization may be involved in the species difference in the metabolism 
of benzoic acid. 
Interestingly, the fruit bat which excretes only benzoyl- 
glucuronide shows an apparent absence of hippuric acid synthesis in both 
its liver and kidneys (Bababunmi et al 1973). 
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ADDENDUM 
Subsequent to the completion of Chapter 3, some preliminary 
investigations on the metabolism of benzoic acid by isolated cells from 
the dog and the ferret were performed. The methodology was essentially 
as described in Section 3.5 and quantitative results for the metabolism 
of benzoic acid by ferret and dog kidney cells and hepatocytes are 
summarized in Figure 3.12 and 3.13 respectively. 
In the kidney cells from the dog the rate of formation 
of hippuric acid was calculated to be 0.56 ºlmole mg protein-1 min-1 
while in the ferret kidney cells this was calculated to be 0.29 rnmole 
mg protein-1 min-1. The protein concentration of the kidney cell 
suspensions from the dog and the ferret were 5.7 mg ml-1 and 11.5 mg ml-1 
respectively. Synthesis of benzoylglucuronide from kidney cells was found 
to be negligible and after 1 hour of incubation benzoylglucuronide 
accounted for <2% ( 1,10 n mole) and <1% ( <5 n mole) of the benzoic acid 
substrate from the dog and the ferret respectively. Interestingly the 
kidney cells from both species gave three minor metabolites (= 2%) of 
benzoic acid which have yet to be identified, but their chromatographic 
behaviour compared to hippuric acid and benzoylglucuronide suggests that 
they may be hydroxybenzoic acid conjugates. 
Compared to the kidney cells, metabolism of benzoic 
acid by liver cells is very low. In the dog liver cells only about 5% 
(25 1)mo1e) of the benzoic acid substrate was metabolised after 1 hour 
of incubation, and the metabolites were benzoylglucuronide and hippuric 
acid and they were found to be in the ratio of about 4: 1. The rate of 
benzoylglucuronide synthesis by dog liver cells was calculated to be 
I. Oý_, nmole mg protein-1 hr-l. In the ferret liver cells about 10% 
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(5O n mole) of the benzoic acid substrate was converted to benzoylglucuronide 
in 1 hour while hippuric acid formation was negligible, accounting for 
(0.5% (-(2.5 rmo1e). The rate of benzoylglucuronide synthesis in 
ferret liver cells was calculated to be G. 53_I\mole mg protein-1 hr -l. 
The hepatic cellular protein concentration in the dog liver cell suspension 
was 3.9 mg ml-1 while that of the ferret liver cell suspension was 10.7 
mg ml-1, 
These results showed that in both species the kidneys are 
the major organ involved in the metabolism of benzoic acid by glycine 
conjugation and these observations may be presented as additional 
support for the hypothesis that a contributory factor in the species 
variation of metabolism of benzoic acid is in the tissue distribution 
of glycine conjugation of benzoic acid in different species as discussed 
in Section 3.6. 
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CHAPTER 4 
PHENOL 
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4.1 INTRODUCTION 
Phenol (C6H60) is a colourless, volatile, crystalline 
material, or sometimes a white crystalline mass, with a characteristic 
odour. It tends to redden on exposure to air and light, particularly 
in an alkaline atmosphere. It has a M. W. of 94.11 and melts at 35-400C 
depending on the purity. Commercial preparations of phenol generally 
contain water and some traces of cresols. 
It has a flash point at 790C and is easily liquified in 
the presence of water (about 8%). It's pKa at 250C is 10.0 and it is 
soluble in water. The pH of an aqueous solution of phenol is about 6.0. 
It is soluble in several organic solvents including alcohol, chloroform, 
ether, benzene and carbon disulphide, but is almost insoluble in 
petroleum ether. 
It occurs naturally and is found as a normal constituent 
of animal urine, e. g. in man about 10 mg day-1 is excreted in conjugated 
forms (Parke 1968). The diet is the main source of phenols in animal 
urine and results from microbial decomposition of food residues in the 
digestive tract, e. g. microbial decomposition of tyrosine gives rise to 
phenol. 
Phenol has many uses and in industry it is often the 
starting material for the manufacture of a great many products such as 
dyes, plastics, resins, antiseptics and therapeutic agents. 
It has been used as a general disinfectant either as a 
solution or mixed with sha. led lime. Medically phenol has been used as 
a topical anaesthetic and antiseptic. In vetinary medicine it has been 
prescribed as an intestinal antiseptic. 
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Phenol has an oral LD50 of 530 mg kg-1 in rats. In man, 
phenol is extremely toxic and ingestion of phenol even in small amounts 
causes intense burning of the mouth and throat, followed by marked 
abdominal pains and distress. Other symptoms may include nausea, vomiting, 
circulatory collapse, paralysis, convulsion and coma. Death from phenol 
ingestion is generally due to respiratory failure and sometimes cardiac 
arrest. 
Poisoning by absorption through the skin is also possible 
and if exposure is sufficiently severe, local contact with skin or 
mucous membrane may induce gangrene or corrosion. Chronic poisoning 
with renal and hepatic damage may occur from industrial contact. The 
fatal oral doses of phenol for adults have ranged from 1g- 10 g, for 
infants from 50 mg - 500 mg. 
It has been stated that phenol is extremely toxic and 
Oehme (1969) conducted toxicity studies in mice with phenylsulphate, 
phenylglucuronide and phenol. It was found that the toxicity of phenyl- 
glucuronide is about one-fifth that of phenol while phenylsulphate is 
approximately one-eighth as toxic as phenol. It is apparent from this 
work that conjugation greatly reduced the toxicity of phenol and is an 
example of conjugation as a true detoxication mechanism. 
4.2 METABOLISM OF PHENOL 
The metabolic fate of phenol has been studied for over a 
century and the biological reactions involved in the urinary excretion of 
phenol were initially reported by Baumann, (1876a, 1876b, 1876c). In 
this series of papers it was reported that phenol was excreted as a 
sulphuric acid conjugate in both man and dog. Oxidation of phenol to 
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catechol and quinol was also reported a few years later (Baumann and 
Preusse 1879a and 1879b). Indeed they suggested that the dark colour of 
urine excreted by dogs following phenol administration may be a result of 
further oxidation of catechol and quinol. Kulz (1890) reported the 
presence of phenylglucuronide in rabbit urine following the injection of 
phenol. 
The metabolites of phenol in most species are now known 
to be phenylglucuronide, phenylsulphate, some conjugated quinol and trace 
amounts of conjugated catechol. 
The synthesis of phenylglucuronide and phenylsulphate is 
influenced by a number of factors including the dose, the diet and the 
route of administration. 
For example, in the rabbit it appears that glucuronic and 
conjugation of phenol is considerably higher than sulphate conjugation when 
the dose of phenol is relatively large, so that for doses of about 125 mg - 
250 mg kg-1 the percentage of phenol excreted as sulphate is about 20% 
of the dose while glucuronic acid conjugation accounts for about 70% in a 
24 hour urine. However, at doses lower than 100 mg kg-1 the amount of 
sulphate conjugate rises with falling dose level (Williams, 1938). Indeed 
it appears that at 50-60 mg kg-1 the amount of glucuronide and sulphate 
conjugates of phenol excreted by the rabbit is about equal (Parke and 
Williams, 1953), whereas at 25 mg kg-1 sulphate conjugation exceeds that 
of glucuronic acid conjugation (Capel, et al 1972). This dose dependency 
in the elimination of phenol conjugates has also been domonstrated in 
the sheep. In a Kinetic study of metabolism of phenol by the sheep 
(Maylin, 1971) it was shown that phenol was metabolised and eliminated in 
the urine as phenylglucuronide and phenylsulphate and it was observed that 
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the relative amounts of these conjugates was dose dependent. Thus at 
low doses phenylsulphate was the major urinary metabolite, whereas at 
higher doses phenylglucuronide became the major metabolite. Free 
phenol, in the order of about 5%, was also found in the urine. 
The nature of the diet can play a major role in the 
metabolism of foreign compounds. In the case of phenol it has been 
shown that glucuronic acid conjugation is a first order process and is 
proportional to the body level of phenol, whereas sulphate conjugation 
is independent of the body level of phenol, but dependent upon the 
availability of sulphate (Bray, et al, 1952). Thus if sulphate precursors 
such as L-cysteine and sodium sulphate are added simultaneously to the 
diet of animals dosed with phenol, sulphate conjugation will be increased 
while glucuronic acid conjugation is correspondingly decreased. For 
example, at a dose of 250 mg kg-1 phenylsulphate excreted by rabbit in the 
24 hour urine, following administration of phenol in the absence and the 
presence of sulphate precursors in the diet is 15% and 30% of the dose 
respectively (Bray et al, 1952 b) . 
It is well known that the route of administration of a 
compound may play an important part in the metabolic profile of that 
compound. Indeed Palkan and Wipple, (1922) have pointed out that the 
metabolism of phenol after oral administration is different from that 
after intravenous administration. They found both free and conjugated 
phenol following intravenous doses, but only conjugated phenol was detected 
in blood following the equivalent dose administered orally. Relatively 
large oral doses were required to produce significant concentrations of 
free phenol. Further investigations concerning this aspect of phenol 
metabolism have not been reported. However, studies describing the 
influence of the route of administration on metabolism have been reported 
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for other compounds. 
Interestingly, when Garton and : )illiams, (1949) investigated 
the metabolic fate of phenylsulphate and phenylglucuronide, they found 
that phenylsuiphate was excreted rapidly following oral and intravenous 
administration. Approximately 90% of the dose was recovered in the urine 
within 24 hours. However, rabbit when injected with phenylglucuronide 
excreted the dose quantitatively within 24 hours, but following oral 
administration only 50% of the dose was recovered. A considerable increase 
in etheral sulphate output occurred concurrently with the decreased 
excretion of phenylglucuronide. Garton and Williams (1949) postulated that 
the phenylglucuronide is poorly absorbed in the intestine and consequently 
hydrolysis of the glucuronide by gut microorganisms gives rise to phenol 
which is then absorbed and metabolised by conjugation with both glucuronic 
acid and sulphate. 
In a study of the fate of phenol in various species (Capel, 
et a11 1972), it was found that when given orally at 25 mg kg-1, the 
majority of species studied excreted four metabolites, namely, the sulphates 
and glucuronides of phenol and quinol. Species which excreted four 
metabolites included man and several rodent species such as the rat, 
mouse, hamster, guinea pig, lemming, jerboa and gerbil. In all cases 
phenylsulphate and phenylglucuronide were the major metabolites while 
conjugates of quinol occurred only in small amounts. 
In man, the total quinol excreted in 24 hours after 
administration is about 1% of the phenol metabolites in the urine. In 
the rat and guinea pig, the amount of quinol excreted was in the order 
of 3-5% while in other rodent species, the ability to oxidise phenol 
to quinol appears to be quite significant and is in the order of 20-30%. 
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In some species, only three metabolites were observed, 
for example, in the squirrel monkey and Capuchin monkey, quinol sulphate 
is apparently absent while quinol glucuronide appears to be absent from 
the ferret, dog, hedgehog and rabbit. However, it is likely that these 
metabolites were present, but the levels were too low for detection by 
the methods used. 
No quinol conjugates were detected in the rhesus monkey, 
fruit bat and chicken and it is likely that these species do not oxidize 
phenol to quinol. 
Capel, et al, (1972) were able to demonstrate the species 
variation in the amount of sulphate and glucuronide conjugates of phenol 
excreted. Thus at 25 mg kg- 
l, 
it appears that sulphate conjugation is 
more effective than glucuronic acid conjugation in the rat, mouse, jerboa, 
gerbil, chicken, hedgehog, dog, rhesus monkey and man (0.01 mg kg-1), 
while the reverse appears to be the case with the guinea pig, lemming, 
hamster, fruit bat, capuchin monkey and squirrel monkey. The two 
conjugation mechanisms appear to be equally effective in the ferret and 
the rabbit. 
The cat and the pig are of special interest in that the 
cat appears to excrete only sulphate conjugates while the pig appears 
to form only phenylglucuronide. Thus it appears that they have defective 
conjugation mechanisms with respect to orally administered phenol. The 
cat being defective in glucuronic acid conjugation while the pig is 
defective in sulphate conjugation. However, activities of these 
conjugation mechanisms are not entirely absent since trace amounts of 
glucuronide and sulphate conjugates of phenol are detectable in cat and 
pig urine respectively. 
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The metabolism of phenol was also investigated in cat-like 
animals by French, et al, (1974) and it was shown that the lion, civet and 
ganet excreted orally administered phenol at 25 mg kg-1 amost entirely 
as phenylsulphate indicating that they may have a defective glucuronic 
acid conjugation mechanism similar to that of the domestic cat. Interestingly 
a phosphate conjugate has been reported as a urinary metabolite in cats 
dosed with phenol (Capel, et al, 1974b) . 
The tissue distribution in the ability to metabolise phenol 
has been investigated and earlier work suggested that sulphate conjugation 
of phenol occurs both in the liver and in the intestine (Williams 1959). 
That the liver is the major organ in the metabolism of 
foreign compounds is well known, but the ability of the intestine to 
conjugate phenols has been demonstrated. For example, intestinal 
sulphate conjugation of isoprenaline has been shown to be the major route 
of sulphate conjugation of orally administered isoprenaline (George et al 
1974). Indeed this represents an example of differences in metabolism 
due to route of administration. When given intravenously isoprenaline is 
excreted mainly as free isoprenaline, whereas after oral dosing excretion 
is largely as an etheral sulphate conjugate (Conolly, et al, 1972). 
Glucuronic acid conjugation of 1-naphthol by the intestine has also been 
demonstrated recently by means of an in situ intestinal loop technique 
where blood draining from the venous supply of the perfused loop is 
collected and assayed for 1-naphth, +ylglucuronide (Bock, and Winne, 1974). 
By means of exteriorized cannulae, phenol and phenol conjugates in 
the blood plasma from the portal vein and the hepatic vein together 
with the bile may be monitored and Maylin, (1971) was able to demonstrate 
that in the sheep, both the liver and the intestine were involved 
in the metabolism of phenol. Thus phenylglucuronide, phenylsulphate 
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and some free phenol were detected in the hepatic venous plasma following 
infusion of phenol into the cannulated mesenteric vein, while free phenol 
and phenol conjugates were detected in the portal vein as well as the 
hepatic vein following administration of phenol via intestinal cannulae. 
No biliary excretion was observed, so that enterohepatic circulation is 
not significant in the metabolism of phenol by the sheep. Interestingly, 
it was noted that after administration of phenol, the relative proportions 
of phenol, phenylglucuronide and phenylsulphate found in the plasma of 
both hepatic and portal venous blood changes with time. 
The ability of the intestine to conjugate phenols may be 
of considerable importance in the detoxication of phenols. Indeed, 
recently it has been proposed that the gastrointestinal tract plays an 
important part in the detoxication of phenol, so much so that the liver 
is not essential in the detoxication of phenol (Powell et al 1974). 
Evidence for this proposition included the observation that whole body 
autoradiograms of animals which had received 
14C 
phenol orally or 
intraperitoneally showed that the level of isotope in the liver did not 
at any time exceed that of the blood suggesting that the liver has no 
ability to concentrate either phenol or its metabolites and this was due 
either to the limiting uptake of phenol by the liver or a rapid turnover 
of phenol in the liver. Furthermore, it was demonstrated that in vitro 
metabolism of phenol by isolated gut preparations resulted in the 
synthesis of phenylsulphate (5%) and phenylglucuronide (95%). No unchanged 
phenol was detected. In situ intestinal loop experiments on wholly 
anaesthetised rats showed that only conjugates of phenol were detected 
in the portal blood after administration of phenol in the intestinal 
loop by a continuous perfusion technique. Phenol conjugates were also 
detected in the intestinal perfusate and after 2 hours, no unchanged 
phenol was detected and phenylsulphate (72%) and phenylglucuronide (28%) 
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were the metabolites present. Thus it was suggested that free phenol in 
the intestine is transported as conjugates so that the role of the liver 
is minimal in the detoxication of orally ingested phenol. However, 
when the gastrointestinal tract was by-passed as in intravenous 
administration of phenol, detoxication of phenol by the liver assumes 
its major importance. 
Some information is also available on the ability of 
tissues other than the liver and the intestine to metabolise phenols. 
For example, phenol sulphotransferase activity towards p-nitrophenol 
and 4-methylumbelliferone in rabbit lung soluble fraction has been 
demonstrated (Hook and Bend, 1976) and sulphate conjugation of a pulmonary 
metabolite of benzpyrene has also been identified recently (Cohen/et al 1976). 
It is likely that where sulphate and glucuronic acid conjugation mechanisms 
are present, conjugation of phenol may take place. 
4.3 IN VIVO INVESTIGATIONS OF PHENOL METABOLISM 
[U-14C]-phenol, 
25 mg kg-1 was administered to the animal 
as described in Chapter 2. Urine and faeces were collected and assayed 
as described. 
The Rf values and methods of detection of phenol and some 
of its metabolites are given in Table 4.1 and the results of orally 
administered 
14C-phenol 
metabolism in the sheep, the pig and the rat are 
summarized in Tables 4.2,4.3,4.4. 
The tables show that after oral administration of 
14C-phenol 
a significant proportion of the dose was excreted by these animals 
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Table 4.2 
Urinary excretion of 
14C-Phenol 
by Sheep and Pig 
S ecies 
Dose Time Volume of % of Administered p 
mg Kg µCi (hr. ) Urine (ml) Dose Excreted 
Sheep 1 25 111.0 0- 3 178 46.8 
3- 5 228 33.5 
5- 8 235 . 5.0 
8-24 1060 2.4 
Sheep 2 25 127.3 0- 2 90 0.0 
2- 4 36 0.0 
4- 6 215 79.7 
6- 8 105 4.5 
8-24 300 1.5 
Pig 1 25 52.3 0- 3 0 0.0 
3- 5 222 64.4 
5- 8 170 18.7 
8-24 315 3.0 
Pig 2 25 112.1 0- 2 90 72.9 
2- 4 60 6.3 
4- 8 120 5.0 
8-19 410 0.6 
19-21 60 0.2 
21-24 112 0.2 
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relatively rapidly. At 8 hours after administration some 85% of the 
dose was recovered from sheep urine, 84% from pig urine and 90% from 
rat urine, and at 24 hours the elimination of radioactivity was 87%, 
86% and 97% for the sheep, pig and rat respectively. Negligible amounts 
of radioactivity (less than 0.5% of the administered dose) were excreted 
in the faeces suggesting that urinary elimination is the major route 
for the excretion of orally administered phenol. 
Identification of conjugates of phase I metabolites of 
phenol was based on differential enzymic hydrolysis and solvent extraction, 
while identification of phase I metabolites was by thin layer chromatography 
and reverse isotope dilution analysis. The methods used were as described 
in Chapter 2. 
Chromatography, followed by radiochromatogram scanning 
and "strip counting" of urine samples from the species studied showed 
the presence of two major peaks (I and II) for the sheep and the rat, 
which corresponded to phenylglucuronide-and phenylsulphate respectively. 
In the pig essentially only one peak (I) was observed which corresponded 
to phenylglucuronide (see Figures 4.1,4.2). Colour reactions with spray 
reagent (a) showed that I gave a positive naphthoresorcinol reaction 
indicating the presence of glucuronides. Spray reagent (d), a coupling 
reagent for phenols and (e) a typical spray reagent for reducing centres 
such as free aromatic hydroxyl groups, gave positive reactions at the 
areas of the chromatograms associated with I and II, indicating that 
components of I and II may also consist of hydroxy-metabolites of phenol 
such as quinol and/or catechol conjugates. Indeed when pig urine was 
chromatographed in solvent system Ga radioactive area on the thin layer 
chromatogram which had an Rf value of 0.34-0.38 (Ia) gave a positive 
reaction with spray reagents (a), (d) and (e)_ When sheep urine was 
I 
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similarly chromatographed an additional radioactive area with Rf o. 66- 
0.68 (IIa) was observed and gave faint but positive reactions with spray 
reagents (d) and (e). Ia and IIa were subsequently determined to be 
quinolglucuronide and quinolsulphate respectively. 
Following enzymic hydrolysis, thin layer chromatography 
of urine samples and the hydrolysates, together with radiochromatogram 
autoradiography revealed that the dark spots on the autoradiogram 
corresponding to peak I were lost after hydrolysis with , )-glucuronidase, 
while the dark spots corresponding to peak II were hydrolysed by 
arylsulphatase (Figures 4.3,4.4 and 4.5). It should be noted that 
after enzymic hydrolysis, phenol which is extremely volatile is the 
major radioactive component in the hydrolysate. Consequently detection 
of phenol by' chromatography and autoradiography as described, gives 
poor results. Indeed F'igures 4.3,4.4 and 4.5 which are autoradiograms 
of thin layer chromatograms developed in solvent system G of urine 
which has been hydrolysed by f-glucuronidase and arylsulphatase showed 
little or no phenol (Rf 0.96-1.0) at the solvent front, radiolabelled 
phenol being lost from the thin layer plate during the drying of the 
developed chromatogram and during the autoradiography procedure. Also, 
it should be noted that in some cases (see Figures 4.4 and 4.5), complete 
hydrolysis of glucuronic acid conjugates of metabolites of phenol with 
ketodase was not observed. This was believed to be due to the presence of 
an inhibitor in the urine samples, however, if additional enzyme was 
added to the hydrolysate and reincubated as described, complete hydrolysis 
of the glucuronides may be achieved. 
Quantitative estimation of radioactivity in etheral extracts 
showed that after ý, -glucuronidase hydrolysis of 8 hour urine samples 
some 50%, 90% and 46% of the radioactivity of the hydrolysates from 
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FIGURE 4-4 
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FIGURE 4.5 
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sheep, pig and rat urine respectively was extracted into the ether 
phase, while the amount extracted after arylsulphatase hydrolysis was 
38%, 2% and 56% from the sheep, pig and rat respectively. When the 8 
hour urine samples were incubated with acid phosphatase at pH 4.5 
and the hydrolysates were solvent extracted as described, the amount of 
radioactivity extracted into the ether phase was found to be 12% from 
the sheep urine, while extraction from the pig and rat urine hydrolysates 
gave essentially control levels of radioactivity. Control values 
ranged from 0-4% for all enzymic hydrolysis experiments and were taken 
into-account when results from hydrolysis experiments were calculated. 
Negligible amounts of radioactivity (< lam) were extracted 
into the ether phase when untreated urine from the animals was solvent 
extracted, indicating that essentially no unconjugated metabolites were 
present in the urine. 
From the enzyme hydrolysis experiments it can be deduced 
that orally administered phenol at 2.5 mg kg-1 is excreted as glucuronides 
and sulphates. In the rat 46% of the 8 hour urinary metabolites was 
found to be glucuronides and 56% to be sulphates, while in the sheep, 
the corresponding figures are 50% and 38%. Very low levels of sulphate 
conjugates of phenol metabolites were observed in the pig and at 25 mg kg-1 
only 2% of the urinary metabolites was identified as sulphate conjugates, 
while glucuronic acid conjugates accounted for 90% of the urinary 
metabolites. Interestingly some 12% of the urinary metabolites from the 
sheep dosed with phenol was apparently excreted conjugated with phosphate. 
Phosphate conjugates of phenol metabolites were not detected in the urine 
of the pig and the rat. 
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In sheep urine it was also observed that there were 
changes in the pattern of metabolites found in the urine at various 
times after dosing and it was found that glucuronides were the major 
urinary metabolites at 3 hours after oral dosing, but subsequently 
sulphates were the major metabolites. However, at 8 hours the major 
urinary metabolites were conjugated with glucuronic acid (figure 4.6). 
Studies on the ether extracts as described in Chapter 2 
showed that the major radiolabelled component was phenol. Quinol was 
also present and was found to be about 8% in the sheep and the pig, but 
in the rat it was only 3%. Catechol was not found to be present by 
reverse isotope dilution analysis and the possible presence of resorcinol 
was not determined. 
The 8 hour urinary metabolites of orally administered 
phenol which have been identified by the methods described are summarized 
in table 4.4. Identification of phosphate conjugates is incomplete, but 
for discussion see Section 4.6. 
4.4 METABOLISM OF PHENOL IN URETER CANNULATED RATS 
The ureters of anaesthetised rats (250 g) were cannulated 
and the animals dosed with 
[U-14C1-phenol 
at 12.5 mg kg-1 and 25 mg kg-1 
by intraduodenal injection as described. 
Urine samples were collected at 10 minute intervals for a 
period of 2 hours and the samples were assayed for radioactivity as 
described. The metabolic profile of the 10 minute samples was determined 
by thin layer chromatography of aliquots (20-40U) of urine on silica 
gel 60 pre-coated plates (Merck) in solvent system G followed by 
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radiochromatogram autoradiography. The areas of the chromatograms 
corresponding to glucuronides (Rf 0.34-0.49) and sulphates (Rf 0.66-0.72) 
were located and compared with the corresponding dark spots on the 
autoradiogram. These areas were marked on the radiochromatogram cut out 
and placed into scintillation vials and counted as described. The 
radioactivity associated with each of these areas was expressed as a 
percentage of the radioactivity recovered from the radiochromatogram. 
No unconjugated metabolites were detected since ether extraction of the 
urine recovered little or no radioactivity in the ether fraction. 
The rate of urinary elimination of radioactivity after 
intraduodenal administration and the percentage of the dose excreted at 
each time interval are summarized in Figures 4.7 and 4.8 respectively. 
Metabolic profiles of 10 minute urine samples are illustrated in Figure 
4.9 and the rates of excretion of the sulphate and glucuronide conjugates 
of metabolites of phenol are shown in Figures 4.10,4.11 and 4.12_ 
The results . 
in Figure. 4.7 show that at the dose levels 
studied 2-3% of the dose was recovered in the urine within 10 minutes 
after administration and that at 12.5 mg kg-1 about 75% of the dose was 
recovered in 2 hours, while at 25 mg kg-1 about 70% of the dose was 
recovered in 2 hours. Furthermore, it can be calculated from the linear 
portion of the curve that the rate of elimination of radioactivity is in 
the order of 11.7% of the dose per 10 minutes when the dose of phenol 
was 12.5 mg kg-1 while at 25 mg kg-1 the rate was 9.5% of the dose per 
10 minutes. This would indicate that the relative rate of elimination of 
phenol after intraduodenal administration is dose dependent and decreases 
with increasing dose of phenol. In Figure 4.8, which shows the percentage 
of the dose excreted at each time interval, it can be seen that at 12.5 
mg kg-1 maximum excretion occurs between 20-30 minutes while at 25 mg kg-1 
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FIGURE 4.8 
0/ 14 EXCRETED AT TIMED INTERVALS AFTER 
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FIGURE 4.9 
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FIGURE 4-10 
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FIGURE 4.11 
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FIGURE 4.12 
THE RATE OF URI NARY ELIMI NATION OF 
PHENYLSULPHATE 
0 PHENOL at 12.5 mgkg-1 (33.2, umo(e animal- 
1) 
0 PHENOL at 25 mgkg -1 (66.4 umo(e animal 
T) 
24 
20 
16 
W 
t-- 
J 
J 12 
z 
z 
Q 
tV 8 ö 
E 
4 
mins 
RESULTS ARE PLOTTED AS THE MEAN FROM 2 ANIMALS 
20 40 60 80 100 120 
147 
maximum excretion occurs between 30-40 minutes. 
At both dose levels the major metabolites were phenyl- 
glucuronide and phenylsulphate. Quinol glucuronide and quinolsulphate 
were also detected, but only as very minor metabolites. The rate of 
elimination of glucuronide and sulphate metabolites of phenol were 
calculated to be 0.23 , (/, mole min-1 and O. 18 frrnole min 
1 
respectively 
when the rats (250 g) were administered 33.2, vrnole (12.5 mg kg-1) of 
phenol. At a dose of 66.4 mole (25 mg kg-1) the rate of glucuronide 
elimination was 0.35/Anmole min-1 and the rate of sulphate elimination 
was O. 3pmole min-1 (Figures 4.11 and 4.12). 
These figures show that the metabolism of phenol follows 
the kinetics of a first order process. The rates of elimination of 
both glucuronide and sulphate were dose dependent and increased with 
increasing dose of phenol. Saturation of the system involved in the 
metabolism of phenol was not observed at the dose levels used and it is 
likely that at saturating levels a maximum rate of elimination would be 
observed and at such levels toxic symptoms may be exhibited. 
In Figure 4.9 where the percentage of the dose excreted 
as sulphate and glucuronide conjugates at different time intervals 
is plotted against time, it can be seen that the relative percentage of 
conjugate excreted at both dose levels rises rapidly to a maximum and 
then falls as phenol is being metabolised and excreted. At 12.5 mg kg-1 
maximum elimination of conjugate occurs between 20-30 minutes, while at 
25 mg kg-1 it occurs between 30-40 minutes after administration. Although 
both glucuronide and sulphate conjugates show a similar pattern of 
elimination, the relative amount of glucuronide eliminated at the earlier 
time intervals is greater than that of sulphate, but at later time 
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FIGURE 4.13 
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intervals more sulphate was eliminated. Indeed, when the ratio of 
sulphate to glucuronide in the urine at different times after administration 
of phenol, is determined (Figure 4.13) it can be seen that this ratio 
changes with time. At 12.5 mg kg-1 sulphate elimination initially 
predominates, but the relative amount of glucuronide elimination increases 
with time until more glucuronide was eliminated than sulphate. However, 
as metabolism and elimination occur the relative amount of glucuronide 
excreted decreases again resulting in a rise in the ratio of sulphate 
to glucuronide with time. Similar changes in the sulphate to glucuronide 
ratio were observed at the higher dose level of phenol, but the changes 
were less pronounced. 
Interestingly, the ratio of sulphate to glucuronide at 
2 hours after intraduodenal administration of 
14C-phenol 
was calculated 
to be 1.1 to 1 and 0.9 to 1 at doses of 12.5 mg kg-1 and 25 mg kg-1 
respectively, indicating that at 2 hours the relative amount of sulphate 
conjugates eliminated was higher at the lower dose level. Figure 4.10 
shows that at both dose levels the initial rate of elimination of 
glucuronide conjugate was greater than that of sulphate and that at the 
lower dose level glucuronide conjugate elimination plateaued by 2 hours, 
but sulphate conjugate elimination was still increasing. 
4.5 METABOLISM OF PHENOL IN ISOLATED CELL PREPARATIONS 
Isolated cell preparations were prepared as described in 
Chapter 2 and 
[U_14C]phenol 
(100 
, Lt-M, 
5LLCi) was incubated with cell 
suspensions (5 ml) as described. 
Samples of incubate obtained at 5 minute intervals from 
rat hepatocytes (1OO, l) and from intestinal mucosal cells (5 ml) at 
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15 minute intervals were assayed by thin layer chromatography after 
centrifugation to remove denatured protein. Aliquots of the supernatents 
(20-4o pl) were chromatographed on silica gel 60 plates (Merck) in solvent 
system G, and autoradiograms of the resultant radiochromatograms were 
prepared. The areas corresponding to phenol (Rf 0.98), phenylgiucuronide 
(Rf 0.47), phenylsulphate (Rf 0.70), quinolglucuronide (Rf 0.36) and 
quinolsulphate (Rf 0.67) were located and compared with the corresponding 
dark spot on the autoradiogram. These areas were marked out on the 
radiochromatogram and were cut out and placed into scintillation vials 
and counted as described. 
Because of the volatile nature of phenol, thin layer 
chromatographic estimation of small amounts of radiolabelled phenol as 
described was unsatisfactory, therefore the radioactivity associated with 
areas on the chromatogram corresponding to be non-volatile conjugates 
were expressed as a ratio of quinolglucuronide to phenylglucuronide to 
phenylsulphate. Quinol sulphate was not detected. 
Aliquots of the supernatents (20 J. l from liver cells and 
100 
J /Al 
from intestinal mucosal cells) were suitably diluted to 500 /Al 
and extracted with ether (2 ml). Ether extraction quantitatively 
removes unmetabolised phenol and little or no conjugates are extracted. 
The radioactivity in the ether and aqueous fractions was determined by 
liquid scintillation counting as described and from the ratio of the non- 
volatile conjugates and the level of radioactivity associated with the 
ether and aqueous fractions, the relative proportions of phenol and 
phenol metabolites at different times during the incubation may be 
calculated. 
Autoradiograms from TLC of samples from isolated rat 
intestinal mucosal cells and hepatocytes are shown in Figures 4.14 and 
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FIGURE 4.14 
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FIGURE 4.16 
METABOLITES OF 
14C-PHENOL 
FROM ISOLATED RAT INTESTINAL MUCOSAL CELLS 
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14C-Phenol (50E. ti) incubated with the cells for 1 hr. 
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14C-Phenol (100 pl7) incubated with the cells for 1 hr. 
C- Urine from the sheep dosed with 
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as standard. 
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4.15 and it can be seen that both cell preparations are capable of 
metabolising phenol. In intestinal mucosal cells, the major metabolite 
was phenylglucuronide (see Figure 4.16) while in hepatocytes phenyl- 
glucuronide, quinolglucuronide and phenylsulphate were metabolites of 
phenol (see Figure 4.14). 
Quantitative results of metabolism of phenol by hepatocytes 
are given in Figure 4.17 and Table 4.5 summarizes the results for intestinal 
mucosal cells. 
The metabolism of phenol by-intestinal mucosal cells was 
found to be very low and only 18% (0.09p. mole) of the phenol (O. 5 mole) 
was converted into non-volatile conjugates after incubation for 1 hour. 
This is equivalent to 2 Amole of phenol metabolised 106 cells-1 hr-1. 
Phenylglucuronide was the major metabolite (15%, 0. O71&mole) and some 
phenylsulphate was also formed (3% 0. O21vmole). Metabolism of phenol 
by intestinal mucosal cells also gave rise to an unidentified metabolite 
(Rf 0.58 in solvent system G, see Figure 4.16). The nature of this 
metabolite is not known and identification has yet to be carried out. 
Phenol metabolism by hepatocytes was extremely rapid and 
the rate of metabolism of phenol in two separate experiments was calculated 
to be 251-mole min-1 and 26rnmole min-1 and the number of viable cells in 
each incubation was 30 x 106 and 39.5 x 106 respectively. This indicated 
that under the conditions of the experiment metabolism of phenol was at 
a maximal rate and increases in the number of viable cells above 30 x 106 
appears to have little effect on the rate of phenol metabolism. However, 
the relative amounts of glucuronide and sulphate conjugates synthesised 
showed considerable variation. In one experiment (Figure 4.17a) synthesis 
of glucuronide and sulphate was found to be approximately equal, but in 
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Table 4.5 
Metabolism off' 
14 
C"-Phenol in Isolated Intestinal Mucosal Cells 
Time Phenol Phenylglucuronide Phenylsulphate 
(min) 
0 100.0* 0.0 0.0 
15 96.0 2.7 1.3 
30 87.0 9.8 3.2 
60 81.9 14.8 3.3 
Results are expressed as % of the radioactivity found Lin 
the incubation medium corresponding to the metabolites at different time 
'ý 100% = 0.5 pmole of 
14C-Phenol 
Total No. of viable cells 40 
±5x 106 incubation 
1 
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another experiment (Figure 4.17b) the amount of glucuronide synthesised 
was twice that of sulphate and the increase in glucuronide synthesis 
was at the expense of sulphate conjugation and was apparently due to an 
increase in the relative amount of quinolglucuronide (cf Figures 4.17c 
4.17d) 
. 
These results showed that isolated intestinal mucosal 
cells and hepatocytes are capable of metabolising phenol by conjugation. 
The hepatocytes were also able to hydroxylate phenol to give quinol. 
Furthermore, the ability of the liver cells to metabolise phenol was 
considerably greater than that of intestinal mucosal cells. 
4.6 DISCUSSION 
The results of the investigations involving phenol were 
summarized in the previous section, and like benzoic acid (Chapter 3) 
a significant observation in the in vivo investigations was that some 
90% of the dose of 25 mg kg-1 of phenol was excreted in the urine in the 
animals studied within 24 hours after oral administration. Indeed, the 
majority of the dose (84-90%) was excreted within 8 hours in these 
animals. Similar excretion of metabolites of phenol in the rat has been 
reported previously, but the pig was shown to excrete only about 51% of 
the dose of 21 mg kg-1 of phenol in 24 hours (Capel et al, 1972). Also 
there appears to be considerable species variation in the percentage 
of the dose of phenol recovered in the urine in 24 hours and at 25 mg kg-1 
this percentage ranged from 95% in the rat to 31% in the squirrel monkey 
(Capel, et al , 
1972) . 
Feacal excretion of metabolites of phenol was negligible 
in the sheep, the pig and the rat indicating that urinary excretion is 
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the major pathway of orally administered phenol. Moreover, it suggests 
little or no biliary excretion of phenol and phenol metabolites. Indeed 
Maylin (1971) was unable to demonstrate enterohepatic circulation of phenol 
or its metabolites in the biliary cannulated sheep. Biliary excretion of 
phenol and its metabolites in the rat was found to be in the order of 5%, 
the major biliary metabolite being phenylglucuronide (Abou-et-Makarem , 
et al 1967b) . 
The major urinary metabolites of phenol found in these 
animals were the conjugates of phenol itself, although some quinol 
conjugates were also detected. 
The results from the rat confirms previous observations 
that both sulphate and glucuronic acid conjugates are excreted (Capel, 
et a111972) and at 25 mg kg-1 the amount of phenylsulphate and phenyl- 
glucuronide found in the 8 hour urine was approximately equal (42% and 
55% respectively), whereas the level of quinolglucuronide (2%) was twice 
that of quinolsulphate (1%). 
In the pig, essentially only glucuronic acid conjugates 
of phenol and quinol were detected (83% and 8% respectively). This confirms 
previous reports that glucuronic acid conjugation is the major route of 
metabolism of phenol in the pig (Capel et all972). However, only 
phenylglucuronide was reported as the metabolite of phenol, but in the 
present investigation appreciable amounts of hydroxylated metabolites were 
found in the pig urine. As pointed out previously the pig is not completely 
devoid of the ability to conjugate phenols with sulphate and it has been 
suggested that there may be several phenylsulph otransferase isoenzymes 
(McEvoy and Carroll, 1971) and that the pig is deficient in some of these 
isoenzymes since it is capable of conjugating 1-naphthol with sulphate 
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to an appreciable extent (n. -3o%) (Capel. et al, 1974a). Sulphate conjugation 
of phenol in the pig is extremely low compared with glucuronic acid 
conjugation, at the dose level studied, sulphate conjugation has little 
opportunity of occurring and in the present investigation sulphate 
conjugation was found to be in the order of 4%. 
In the sheep, phenylglucuronide was the major metabolite 
(49%) found in the urine. Phenylsulphate, quinolglucuronide and 
quinolsulphate were also detected and accounted for 33%, 2% and 4% 
respectively, of the urinary metabolites of phenol. Some 12% of the 
sheep urinary metabolites of phenol was tentatively identified to be 
phosphate conjugates. 
Identification of phosphate conjugates was based on 
hydrolysis of urine samples by acid phosphatase, followed by extraction 
with organic solvent as described in Chapter 2. Reverse isotope dilution 
analysis of the resultant etheral fraction showed that phenol was essentially 
the only radiolabelled component, so that phenylphosphate was believed to 
be the phosphate conjugated metabolite, although a small amount of 
radiolabelled quinol was also found to be present. 
Further attempts in the identification of phenylphosphate 
as a urinary metabolite of phenol in the sheep included the reverse isotope 
dilution analysis of sheep urine using authentic disodium phenylphosphate 
(B. D. H. ). Authentic phenylphosphate was added to the urine and ether 
extracted at acidic pH(pH^ 1). Under such conditions phenylphosphate 
(pKa2 = 5.73) is extracted into the etheral phase and subsequent 
isolation 
and purification of phenylphosphate 
by conversion into the bis- 
cyclohexylammonium salt (m. p. 
211°C) was by the addition of excess 
cyclohexylamine to the etheral extract 
(Miyano 1955). The white 
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precipitate formed was filtered, washed and recrystal_ized from hot 
water. Recovery was extremely low and some radioactivity was found to 
be associated with the bis-cyclohexylammonium derivative of phenyl- 
phosphate, but unfortunately subsequent recrystallization to constant 
specific radioactivity and constant melting point proved to be difficult 
because of the hydrolysis of the salt during recrystallization so that 
accurate measurements cannot be made. It should be pointed out that 
during the ether extraction, phenylglucuronide (pKa 3.42) present in the 
urine may also be extracted into the organic solvent and at acidic 
conditions it is expected that radiolabelled phenylsulphate found in 
sheep urine will be hydrolysed (Garton et al 1949), so that free 
14C-phenol 
will also be extracted into the ether fraction, but phenylglucuronide 
and phenol did not form cyclohexylammonium salts. 
Attempts to identify phenylphosphate chromatographically 
included thin layer chromatography of the ether extract of acidified 
sheep urine followed by radiochromatogram scanning. This showed that 
free phenol and phenylglucuronide were the major radioactive components- 
of the ether extract, but, a small radioactive peak corresponding to co- 
chromatographed phenylphosphate (Rf 0.38-0.42 in solvent system G) was 
also observed. Indeed in a preliminary experiment studying the metabolism 
of phenol in isolated sheep hepatocytes, thin layer chromatography 
followed by radiochromatogram autoradiography showed the presence of a 
dark area on the autoradiogram corresponding to phenylphosphate. 
Unfortunately quinolglucuronide also has similar Rf values so that 
separation of quinolglucuronide and phenylphosphate in solvent system G 
is incomplete. Chromatography in other solvent systems described in 
Chapter 2 was also attempted, but proved to be unsatisfactory. 
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The use of radiolabelled inorganic phosphate in the 
investigation of phenol metabolism by the sheep in vivo and in isolated 
sheep hepatocytes was also considered, but unfortunately such experiments 
have yet to be carried out. However, collectively the results obtained 
strongly suggest that phenylphosphate is a urinary metabolic of phenol 
in the sheep. Interestingly, monophenylphosphate has been reported as 
a metabolite of phenol in the cat (Capel, et alI1974b). The characterization 
of the metabolite included paper chromatography, hydrolysis with alkaline 
phosphalase, incorporation of radiolabelled inorganic phosphate and mass 
spectrometry of the isolated metabolite. 
The finding that phosphate conjugation of phenol occurs in 
the sheep may have important implications in the species variation in the 
metabolism of phenol, whereas phenylphosphate synthesis in the cat occurs 
in the absence of glucuronic acid conjugation of phenol. The presence 
of phosphate conjugates in sheep urine is not due to impaired glucuronic 
acid or sulphate conjugation mechanisms. The sheep appears to form 
glucuronide and sulphate to a similar extent with respect to phenol 
metabolism at 25 mg kg- Furthermore, with caution, it may be suggested 
that it is possible that the sheep, being a ruminant, may show unusual 
pathways of metabolism and metabolites of orally administered compounds. 
The formation of phosphate conjugates of foreign organic 
compounds is a reaction which has been rarely observed in the past. Very 
little investigation into the possible role of phosphate synthesis in the 
metabolism of foreign compounds has been conducted, although the involvement 
of phosphate esters in biochemical reactions are numerous. -For example, 
phosphate esters are important intermediates in the absorption and 
metabolism of glucose by glycolysis and gluconeogensis which are 
universal biochemical pathways. Indeed, the interaction of phosphorylases 
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and phosphatases are important reactions in the biochemical regulation 
of carbohydrate metabolism. 
Since inorganic phosphate is more abundant than sulphate 
in animal tissues, it is surprising that phosphate esters are not more 
common as conjugates of foreign compounds. Bis-(2-amino-l-naphthyl) 
hydrogen phosphate has been shown to be a metabolite of 2-naphthylamine 
in urine of dogs (Troll et al 1959, Boyland, et al, 1961) and in man 
(Troll et al 1963). Troll and Bellman (1967) also reported that 
bis-(2-hydroxylamino-l-naphthyl) hydrogen phosphate was another metabolite 
of 2-naphthylamine. 1-Naphthyldihydrogen phosphate has been found in 
the bodies and excreta of houseflies, blowflies and New Zealand grass 
grubs (Binninget al, 1967). Houseflies and blowflies have also been 
found to form glucoside-6-phosphates of p-nitrophenol and 1-naphthol 
(Heenan and Smith 1967), but in these conjugates the phosphate group is 
not attached directly to the phenol. Interestingly, when rats were 
given large doses of ethanol intraperitoneally Tomaszewski and Buckowicz 
(1972) were able to isolate morfethylphosphate from the liver of these 
animals. 
The dose level used in the present in vivo investigation 
was 25 mg kg-l. This is well below the toxic level of phenol in these 
species. In the rat the oral LD50 of phenol was 530 mg kg-l. Information 
on the lethal doses of phenol in the sheep and the pig was not available, 
but it was observed that when the sheep was dosed with phenol at 100 mg kg 
1 
by administration via an intestinal cannula, severe toxicity occurred 
(Nlaylin, 1971) and the symptoms included muscle tremors and weakness, 
rapid breathing, haemolysis of erythrocytes and anuria. Such symptoms 
of stress were not observed in the sheep or the pig dosed with 25 mg kg-1 
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of phenol and it was assumed that the dose used was below the toxic 
level in these species. 
The metabolism of phenol was also investigated in ureter 
cannulated rats in an attempt to investigate the kinetics of in vivo 
metabolism and the possible changes in the urinary metabolic profile 
with time. 
The kinetics of phenol metabolism have been studied 
previously in the rabbit (Bray et a1,1952) and in the sheep (Maylin 1971). 
Dosage in the rabbit experiments ranged from 0.1 g kg-1 to 1g kg-1 while 
dosage used in the sheep experiments ranged from 10 mg kg-1 to 100 mg kg-1. 
It was found that both the synthesis of phenylglucuronide 
and phenylsulphate during the metabolism of phenol approximated to a first 
order process. In addition, sulphate conjugation appears to be limited 
by the availability of sulphate so that in fasting animals, the rate of 
formation of sulphate conjugates is independent of the amount of phenol 
present in the body above a certain level, but if sulphate precursors 
such as cysteine are administered simultaneously with phenol, first 
order kinetics are once again observed. 
The dose levels used in the ureter cannulated rat 
experiments were 12.5 mg kg-1 and 25 mg kg 
-1. Unfortunately, attempts 
to use higher doses of phenol resulted in severe signs of toxicity in 
the rats. Intraduodeneal administration phenol to anaesthetised rats 
as described in Chapter 2 at doses of 30 mg kg-1,40 mg kg-1 and 50 mg kg-1 
resulted in immediate toxic responses which were observed as whole body 
convulsions. At the dose levels used 
first order kinetics were observed. 
The synthesis of both glucuronides and sulphates were 
dose dependent and 
these conjugates were eliminated in the urine at constant rates 
for a 
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period of about 1 hour after intraduodenal administration, and as the 
level of 
14C-phenol 
in the body is reduced due to metabolism and 
elimination, the rate of elimination decreased and elimination plateaued. 
At 12.5 mg kg- -1 gg the constant rate of elimination of phenylglucuronide 
and phenylsulphate was calculated to be 62 pg min-1 and 34 %%g min-1 
respectively, while at 25 mg kg-1 the corresponding values were 94.5 pg min 
and 56.7 i, g min-1 respectively. 
Phenol with a pKa of 10 is well absorbed from the small 
intestine (Schanker et al, 1958). Indeed, our preliminary investigations 
in the rat using an in situ isolated intestinal loop technique showed 
that when 
14C-phenol 
(2.5 1Ci, 1.5 mg in 0.5 ml saline) was administered 
to a closed intestinal loop and the blood from the corresponding branch 
of the mesentric vein was collected at 30 second intervals from a 
mensentric vein cannula, it was possible to demonstrate that radioactivity 
was detected in the venous blood within 30 second of administration of 
phenol and some 40% of the administered radioactivity was recovered in 
the blood in 5 minutes. Thus it is interesting to note that within 10 
minutes after intraduodenal administration of 
14C 
phenol conjugated 
metabolites in the order of 2% were detected in the urine and after 2 hours 
some 70% of the dose was excreted. This suggests that at the dose level 
studied, absorption from the intestine, distribution, metabolism and 
excretion of phenol are not rate limiting. Limiting rates are likely to 
occur only at high dose levels when enzyme mechanisms involved in the 
metabolism are saturated and such levels are likely to be toxic. 
The relative amounts of glucuronide and sulphates 
eliminated were found to be dose-dependent so that at 2 hours after 
administration it was observed that sulphate conjugation predominates at 
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the lower dose level while at the higher dose level glucuronide conjugates 
predominate. This dose dependency of conjugates eliminated was also 
observed by other workers. Thus in the rabbit (Williams, 1938, Parke 
and Williams, 1953, Capel,, et al 1972), the rat and the sheep (Maylin 1971) 
increase in the dose of phenol resulted in a concomitant increase in the 
relative amounts of glucuronides and a decrease in the amount of sulphates 
excreted in the urine in 24 hours. 
However, in the present investigation, it was also noticed 
that the relative amounts of glucuronides and sulphates excreted changes 
not only with the dose but also with time. At both dose levels, glucuronic 
acid conjugates were present in the urine in a greater proportion during 
the early phase of elimination, but as elimination proceeds the relative 
proportion of glucuronides decreased and sulphate increased and this is 
reflected in the changes in the ratio of sulphate to glucuronide found 
in the urine with time. Similar observations have been reported and by 
monitoring the hepatic venous blood plasma levels of phenol and phenol 
conjugates after intestinal administration of phenol in the sheep, Maylin, 
(1971) was able to observe changes in the relative proportion of phenol, 
phenylglucuronide and phenylsulphate in blood plasma with time. Thus 
at low dose level (10 mg kg-1) glucuronide conjugates were initially 
present in the greatest proportion, but this decreased with time and 
there was an increase in sulphate conjugates accompanied by a decrease 
in free phenol. At a higher dose level (100 mg kg-1), the proportion 
of sulphate conjugates remains constant, while the proportion of 
glucuronide conjugates increases as the proportion of free phenol 
decreases. Indeed, in our investigation of the in vivo metabolism of 
phenol by the sheep such relative changes in the proportion of glucuronides 
and sulphates excreted was observed 
(see Figure 4.6). 
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Thus, if it can be suggested that the relative proportion 
of metabolites excreted in the urine at different times reflected the 
relative proportion of those metabolites found in hepatic venous blood 
plasma, then it is possible that further investigations of this phenomenon 
of changes of relative proportion of conjugates eliminated with time may 
provide an insight into the relative roles of glucuronic acid conjugation 
and sulphate conjugation in the metabolism, excretion and elimination of 
phenol. 
It has been suggested that conjugation of phenol may occur 
both in the liver and in the intestine (see Williams, 1959) and using 
isolated cell preparations from the rat it was demonstrated that both 
hepatocytes and isolated intestinal mucosal cells were capable of 
metabolising phenol. Both glucurdhide! Eý and sulphates' were detected as 
metabolites, but in the intestinal mucosal cells phenylglucuronide was 
the major metabolite. Other tissues are also capable of metabolising 
phenol and our preliminary investigation of the metabolism of phenol by 
pulmonary tissue preparations and isolated kidney cells suggest that 
phenylglucuronide and phenylsulphate are metabolites in these tissues. 
Compared to the hepatocytes, intestinal mucosal cells 
show a limited ability to metabolise phenol so that the role of the 
intestine as a major site of detoxication of orally ingested phenol as 
proposed by Powell et al, (1974) may be questionable. Only 18% of the 
phenol (O. 5, tmole) was conjugated by 45 x 106 intestinal mucosal cells 
in a1 hour incubation, whereas under similar conditions complete 
conversion of phenol to its conjugates was carried out by 
30 x 106 
hepatocytes in about 20 minutes. It is likely that under the in vivo 
situation very small amounts of a 
dose of ingested phenol may be 
metabolised by the intestinal 
tract and as described earlier, our 
IU/ 
preliminary investigations have shown that absorption of 
14C-phenol from 
the intestine is extremely rapid and, furthermore, freeze drying of 
blood samples collected from the corresponding branch of the mesentric 
vein resulted in the complete loss of radioactivity. Phenol being volatile 
is likely to be lost during the freeze drying process so that it is 
suggested that free phenol was the major radioactive component found in the 
mesentric blood. Conjugates of phenol are nonvolatile, and unlikely to 
be lost during freeze drying. The rapid absorption of phenol by the 
intestine will limit the amount of metabolism of phenol carried out by 
the intestine. 
Clearly further investigation is necessary before constructive 
discussion on the role of the intestine in the metabolism of ingested 
phenol can be considered. However, it is important to point out that a 
criterion used by Powell et al (1974) and Maylin, (1971) in determining 
intestinal metabolism of phenol was that conjugated metabolites of phenol 
were detected in the portal blood plasma after administration of phenol 
into the intestine, but portal blood samples were monitored only some 
time after the administration of phenol so that recirculation of hepatic 
metabolites into the portal blood via systemic circulation is a real 
possibility. Thus, phenylglucuronide and phenylsulphate detected in 
the portal blood 5 minutes (Maylin, 1971) and 30 minutes (Powell et al 
1974) after perfusion of phenol into an in situ intestinal loop may be 
of hepatic origin. 
It was demonstrated that conjugation of phenol resulted 
in the detoxication of phenol, so that the toxicity of phenylglucuronide 
and phenylsulphate is about one-fifth and one-eighth respectively of that 
of phenol (Oehme. 1969) and it will 
be recalled that when doses of phenol 
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ranging from 30 mg kg-1 to 50 mg kg-1 were administered intraduodeneally 
to rats immediate toxic responses were observed. If the intestine was 
capable of detoxicating ingested phenol then such immediate toxic responses 
would not be observed. It is therefore suggested that the toxic responses 
resulted from the rapid absorption of free phenol into the general 
circulation. Fortunately the considerable ability of the liver to 
conjugate phenol is able to limit the potential hazard of ingested phenol 
with respect to the health of the whole organism. However, it is 
important to point out that these observations do not preclude the 
ability of the intestine to detoxicate phenol since, in these experiments 
the animals used were anaesthesized and the dose level used may be such 
that the intestinal conjugation mechanism was overwhelmed. Indeed, it 
is possible that the intestine may play a role in the detoxication of the 
small amounts of phenolic material ingested daily in a normal diet. 
The considerable ability of the liver to metabolise phenol 
was demonstrated by isolated hepatocytes. Thus it was observed that under 
the conditions of the experiment phenol was metabolised at a maximal 
rate by the liver cells and this was calculated to be in the order of 
25 \mole min-1 at a cell density of 30 x 106 cells or higher. However, 
the metabolic profile of hepatocyte metabolism of phenol appears to 
show considerable variation in the relative proportion of glucuronide 
and sulphate conjugates synthesised. This may reflect the analogous 
situation in vivo where the proportion of phenylglucuronide and 
phenylsulphate excreted in the urine is dose dependent. In the hepatocyte 
experiments the "dose" of phenol was the same, 
i. e. 0.5 nmole, but the 
cell density was different in the two experiments. Where glucuronide 
and sulphate synthesis was approximately equal 
(see Figure 4.17a), the 
6 
cell density was 30 x 10 cells, whereas when 
twice as much glucuronide 
than sulphates was produced the cell 
density was 39.5 x 106 cells (see 
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Figure 4.17b). It is interesting to note that increase in the glucuronide 
conjugation observed in Figure 4.17b was apparently due to increased 
quinolglucuronide synthesis (Figure 4.17d) when compared with the 
observation of Figure 4.17c.. 
Clearly other factors may be involved in the variation in 
the metabolic profile. Indeed it may represent individual variation of 
the animals used since hepatocytes for the experiments were obtained 
from individual rats. The state of the animal prior to excision of its 
liver may also be involved so that in fasted animal availability of 
sulphates within the cell may be a limiting factor although the Leibovitz 
medium used in the metabolic studies is well supplied with inorganic 
sulphate. 
The apparent increase in the level of quinolglucuronide 
may be due to the fact that whereas under the in vivo situation where 
the turnover of phenol and phenol metabolites in the liver may be extremely 
rapid, no such rapid turnover is possible with isolated hepatocyte 
incubations. Phenol and phenol metabolites are in continuous contact 
with hepatocytes during the incubation, so that increase in aromatic 
hydroxylation is a real possibility. 
Thus it can be seen that although isolated rat hepatocytes 
can be demonstrated to metabolise phenol, further investigation of the 
control of conjugation and aromatic hydroxylation is necessary before 
understanding of the metabolism of phenol and other xenobiotics by 
hepatocytes is achieved. 
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CHAPTER 5 
ANILINE 
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5.1 INTRODUCTION 
Aniline (C6H7 N) is an oily liquid at room temperature. 
It is colourless when freshly distilled, but darkens on exposure to air 
and light. It has a M. W. of 93.12 and m. p. of -60C. It's flash point 
is 70-760C and it's pKa is 4.6 and pKb is 9.3 
It is poisonous, has a characteristic odour, is volatile 
with steam and is combustible. It is soluble in several organic solvents 
including alcohol, benzene and chloroform. It is also soluble in water 
to some extent and forms salts with acids. The pH of an aqueous 
solution of aniline is about 8. 
Aniline was first obtained by the dkstructive distillation 
of indigo and later it was isolated from coal tar. It has many 
industrial uses, particularly in the synthesis of dyes, e. g. it is the 
active ingredient in shoe dyes, insoluble inks and many other of the 
"aniline" dyes. It is also used in the manufacture of pharmaceutical . 
products, e. g. many of the analgesics are aniline based. 
Aniline is toxic, it has an oral LD50 of 460 mg kg-1 
in rats and the lethal doses in other animals are: - guinea pig 
2.5 g kg-1; rabbit 1.0 g kg-1, dog 0.5 g kg-1, and cat 0.2 g kg-1. 
Toxicity in man may occur from inhalation, ingestion or cutaneous 
absorption of aniline. Symptoms of toxicity include cyanosis, 
methaemoglobinemia, anemia, vertigo, headache, nausea and mental 
confusion. 
172 
5.2 METABOLISM OF ANILINE 
Early work on the metabolic fate of aniline appears to 
be very scanty. Schmiedeberg, (1878) fed dogs with aniline acetate and 
identified p-aminophenol in the urine after acid hydrolysis and Muller, 
(1887) studied a human case of poisoning by 25 g of aniline and found 
that the urine reduced Fehlings solution and contained conjugated 
p-aminophenol. Elson et al (1946) found that at a dose of 72.5 mg kg-1 
aniline is excreted exclusively as etheral sulphate, whereas the 
equivalent dose 'of p-aminophenol (90". 0 mg kg-1) is excreted entirely as 
glucuronide. They suggest that this may preclude the view that aniline 
is converted in the body to p-aminophenol, which is then conjugated 
with glucuronic acid and sulphate and that it is possible for etheral 
sulphate formation to take place directly in the aromatic nucleus 
without preliminary formation of the free phenolic compound. 
In a study on the fate of aniline in the rabbit (Smith 
-1 
and Williams, 1949), it was shown that at dose levels of about 500 mg kg 
the metabolites of aniline included glucuronides and sulphates of 
o- and p-aminophenol and possibly 4-aminoresorcinol. These accounted 
for some 40-45% of the administered dose. Some N-acetylated derivatives 
were also identified, but the major metabolite was a labile glucuronide 
which accounted for over 50% of the administered dose. 
The nature of the labile glucuronide was not known and 
a dihydroxyaniline glucuronide type structure was proposed as the possible 
labile metabolite. Later the labile conjugate was believed to be the 
N-glucuronide of aniline. Indeed this labile N-glucuronide was also 
thought to be the principle metabolite of aniline by Ishidate, et al, (1958). 
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N-4lucuronide synthesis is interesting because in 
physiological conditions it can proceed enzymically or non-enzymically. 
Bridges and Williams (1962) using free glucuronic acid and several arylamines 
including aniline as substrates were able to demonstrate that N-glucuronide 
formation was non-enzymic both in vitro and in vivo. Enzymic synthesis 
of N-glucuronides of arylamines including aniline has been demonstrated 
by Axelrod et al (1957,1958). They showed that in the presence of 
UDPGA and UDPGA transferase from guinea pig liver microsomes, 
N-glucuronides are formed from several arylamines. This observation 
has also been confirmed by Arias (1961) and Isselbarcher et al (1962). 
Arias (1961) was able to show that Gunn rats, which have defective 
glucuronyl transferase activities were able to synthesise the 
N-glucuronide of aniline both in vitro and in-vivo. This therefore 
suggests that the enzymes responsible for the synthesis of etheral and 
ester glucuronides may be different from those involved in the synthesis 
of N-glucuronides. Indeed Isselbacher et al (1962) reported the 
solubilization of glucuron. ýL. transferases from rabbit liver microsomes, 
by treatment with snake venom, which we unable to catalyse the formation 
of aniline N-glucuronide but readily catalysed the formation of ester and 
ether: -' glucuronides. On the other hand, Leventer et al (1965) have 
solubilized N-glucuronyl transferase for aniline from guinea pig liver 
microsomes by sonic oscillation. 
In an investigation of the metabolism and disposition 
of aniline in the isolated, blood perfused liver of the rat (Boobis 
and Powis. 1975) it was found tvu-the major metabolite produced by the 
perfused liver was an acid labile conjugate which represented about 1/3 
of the perfused aniline. This acid labile conjugate was also believed 
to be the N-glucuronide of aniline. However, Parke (1960) using 
14C 
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aniline showed that at an oral dose of 160-500 mg kg-1 the amount of 
N-glucuronide excreted in the urine was about 3-10% and that the major 
pathway of metabolism of aniline appears to be aromatic hydroxylation 
followed by conjugation with glucuronic acid and sulphate. 
Other aniline conjugates have also been observed. For 
example, phenylsulphamic acid (N-sulphate of aniline) was detected in 
the urine of rabbits dosed with aniline, but it was not found in the 
rat (Boyland et al 1957). It is also acetylated to a small extent to 
give acetanilide, but it is not methylated (Williams 1959) and 
interestingly a novel metabolite, 3' -glutamyl-anilide has been identified 
recently as the major metabolite of aniline in the cattle tick - 
Boophilus microplus (Willox et al 1976). 
It has been stated that the major pathway of aniline 
metabolism is hydroxylation of the aromatic nucleus, but hydroxylation 
of the amino group can also occur to a small extent to give phenylhydroxy- 
lamine. Indeed Kiese (1959) has identified phenylhydroxylamine as the 
metabolite of aniline responsible for the production of methaemoglobin 
following injection of aniline to the dog and it is suggested that the 
toxic effects of aniline are due to the metabolite, phenylhydroxylamine 
(Lipschitz 1920, Von Isselentz 1939, Schlirine 1943 and Jenkin et al 
1972). N-Hydroxylation of aniline has been demonstrated in the isolated 
perfused liver and lung of the cat (Kiese and Uehleke 1961) and in 
washed rat liver microsomes in the presence of NADPH and oxygen (Uehleke 
1961), but evidence for phenylhydroxylamine as a urinary metabolite of 
aniline has not been shown (Von Jagow et al 1966, Parke 1960), although 
it may be detected in the blood (Kiese 1959). However, hydroxylamines 
of p-substituted derivatives of aniline are apparently excreted in 
the urine (Kiese 1966). 
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Phenylhydroxylamine readily rearranges to p-aminophenol 
in the presence of acid. Indeed a chemical synthesis of p-aminophenol 
utilises this property of phenylhydroxylamine giving yields of about 
90% of 2 (Vogel 1956, Fieser and Fieser 1961). 
Chemically, phenylhydroxylamine may be obtained by the reduction of 
nitrobenzene with zinc or iron powder and dilute acid or electrolytically 
and interestingly, methaemoglobin formation due to nitrobenzene results 
from the enzymic reduction of nitrobenzene to nitrosobenzene and 
phenylhydroxylamine (Parke 1968). Thus it is possible that the urinary 
p-aminophenol may be derived from the acid catalysed chemical rearrangement 
of the N-hydroxylated metabolite of aniline. Indeed conversion to 
p-aminophenol has been shown to be the major metabolic change of 
phenylhydroxylamine and at an oral or subcutaneous dose of 40 mg kg-1 
about 45% of the dose of phenylhydroxylamine was recovered in 2 days 
as doubly conjugated p-aminophenol, probably the glucuronide and sulphate 
of N-acetyl 2-aminophenol (Williams 1959). The mechanism of reaction was 
unknown, but was believed to involve the reduction of phenylhydroxylamine 
to aniline and subsequent oxidation to p-aminophenol and conjugation. 
Phenyihydroxylamine might also rearrange to o-aminophenol 
since it has been pointed out that arylamines are converted to o-aminophenols 
via enzymic N-hydroxylation and enzymic or acid catalysed rearrangement of 
the N-hydroxy derivatives (Miller, et al, 1960, Boyland and Booth, 1962, Booth 
and Boyland, 1964). However, enzymic rearrangement of phenyihydroxylamine 
to o-aminophenol has not been demonstrated, although N-hydroxyacetanilide 
has been shown to rearrange to N-acetyl-o-aminophenol (Booth and Boyland, 
1964). Arylhydroxylamine substrates, which have been shown to rearrange 
to o-aminophenols through the action of an enzyme of the soluble fraction 
of the liver, tended to be p-substituted aniline and acetanilide derivatives 
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and the rearrangement is believed to proceed via the corresponding 
quinolimines and quinolimides. (Miller et al 1960, Boyland and Booth 
1962). 
Aniline, besides forming sulphate and glucuronide 
conjugates may also form cysteine conjugates. Traces of o- and 
p-aminophenyl and N-acetyl-p-aminophenyl-mercapturic acids have been 
detected in the urine of rats and rabbits dosed with aniline (Boyland 
et al 1963), and it is suggested that the synthesis of the mercapturic 
acid may arise from reaction of phenylhydroxylamine, with some sulphydryl 
compounds such as glutathione, cysteine and acetylcysteine, in vivo 
through the intermediate formation of quinolimine (Boyland and Booth, 
1962). Quinolimines are also oxidative products of aminophenols. Indeed 
neutral or alkali solutions of aminophenols readily darken with the 
formation of quinolimines. Quinolimines are extremely sensitive and 
are transient in aqueous solution undergoing hydrolysis to the quinones. 
Probably one of the most studied foreign compound 
metabolism reactions is aromatic hydroxylation to give phenols. It has 
been shown to occur in all species examined, such as insects, fish, birds, 
reptiles and mammals including man (Smith, 1968, Parke, 1968, Williams, 1967). 
Although this reaction occurs in most species, the orientation of the 
phenolic metabolite formed by the hydroxylation reaction in mammals 
shows considerable species variation. The relative amounts of the o- and 
p-aminophenol excreted and the ratio of the total p-aminophenol to 
total o-aminophenol found in the urine after complete hydrolysis with 
acid have been determined in several animal species receiving aniline 
orally. It was shown to vary from 15 in the gerbil, to 0.4 in the cat 
(Parke 1960) and it appears that carnivores have a p-/o- ratio of 1 or 
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less while the P-/9- ratio in rodents is much higher (Williams 1967) 
(See Table 5.6). 
The species variation in o- and p-hydroxylation of aniline 
also shows an apparent correlation with the toxicity of aniline. Thus 
cats, dogs and other carnivores, to which aniline is very toxic produce 
mostly o-aminophenol, whereas rabbit and other herbivores to which 
aniline is less toxic produce mostly p-aminophenol (Parke 1960). Therefore 
it would appear that the toxicity of aniline may be due to o-aminophenol, 
this metabolite being more toxic than the p-isomer. It has been suggested 
that two aniline hydroxylases are present and species variation is due 
to the variation of the activities of these enzymes from species to 
species (Williams 1967). 
Aniline is a so-called type II substrate (Schenkman et al. 
1967), that is, it produces a type II difference spectrum by interacting 
with the haem, - 
iron of cytochrome P450' However, a type I difference 
spectrum for aniline has also been demonstrated (vainio and Henninen, 
1972). It is also one of a few type II substrates which can be demonstrated 
to be hydroxylated in vitro by microsomes, but this may be due to its 
type I component, since it can be shown that in the absence of acetone, 
aniline gives a type I difference spectrum under conditions in which the 
type II sites on the microsomes are saturated with imidazole. Thus 
spectral observations and microsomal metabolism may be difficult to 
interpret. Nevertheless, aniline-4 hydroxylase is an enzyme system widely 
measured in vitro and indeed it is often used to evaluate the properties 
of the microsomal mixed function mono-oxygenase system of enzymes. 
In general aniline hydroxylase activity is monitored 
by incubating microsomes with a NADPH regenerating system and aniline. 
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Aniline and its metabolite p-aminophenol are extracted from the incubation 
mixture into ether and subsequently separated from each other by additional 
extraction with alkali containing phenol which reacts with p-aminophenol 
in alkali to form a blue phenol-indophenol complex. This blue complex 
is quantitatively determined spectrophotometrically (\ max 630-670 Am). 
The activity of microsomal aniline hydroxylase determined 
as described is influenced by a number of factors. It is induced 
by pretreatment with the classical inducers of microsomal enzymes such 
as phenobarbital and 3-methylcholanthrene, (Kato et al 1970, Lu, et al 
1972) and it has also been demonstrated to be stimulated in vitro by 
several compounds including ethylisocyanide (Imai and Sato, 1966), acetone 
(Anders, 1968, Uainio, and Hanninen, 1972) , 2,2' -bipyridij. 
t, (Anders, 1969) , 
paraoxon (Stevens, et al, 1972), metyrapone (Kahl, et "al, 1973) and 
haemoglobin (Jonen, et al/1976). Interestingly, acetone (Anders, 1968) 
2,2'-bipyridi t.. (Anders, 1969) , metyrapone (Leibman, 1969) and some 
pyridyl ketones (Leibman änd Ortiz, 1973) also enhance microsomal 
hydroxylation of acetanilide. 
It appears that these compounds only stimulate the 
in vitro hydroxylation of the so-called type II (and reverse type I) 
substrates and either have no effect or inhibit the other in vitro 
activities of the microsomal mixed function mono-oxygenase system. Thus 
acetone and haemoglobin apparently have no effect on the N-demethylation 
of ethylmorphine, aminopyrine and D.; N'dimethylaniline (Anders, 1968, Jonen, 
et al 1976) while in vitro metabolism of type I compounds such as 
hexabarhitaland aminopyrine are invariably inhibited by metyrapone 
(Leibman, 1969, Netter, et al 1969). On the other hand 2Z' hipyridine, 
besides stimulating aniline hydroxylase in vitro was also shown to 
stimulate N-dealkylation of N-methyl-, and IN'dimethyl, ºaniline, but 
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inhibited 1,1-de-ethylation of ethylmorphine and aminopyrine (Anders, 1969). 
Interestingly, ethylisocyanide was shown to exhibit both stimulatory 
and inhibitory effects on microsomal hydroxylase (Imai and Sato, 1966) 
and the inhibitory effect was found to be due to a competition between 
ethylisocyanide and oxygen gor the microsomal enzyme. 
The mechanism of in vitro stimulation of aniline 
hydroxylase by these compounds remains to be elucidated, but it has been 
proposed that since type II substrates such as aniline produce an 
inhibition of cytochrorne P450 reduction by NADPH cytochrome P450 
reductase (NADPH cytochrome c reductase), whereas type I compounds 
stimulate this reduction (Gigon, et al 1969), it is possible that the 
mechanism of in vitro stimulation of aniline hydroxylase may be related 
to the rate of reduction of cytochrome P450. That is, the presence of 
compounds such as acetone in vitro removes the inhibition of cytochrome 
p450 reductase by type II substrates (Anders 1969, Vainio and Hanninen 
1972). A number of possible explanations for the enhancement of aniline 
hydroxylase by haemoglobin were discussed by Jonen et al (1976). - 
By using reconstitutated microsomal enzyme systems, it 
has been demonstrated that besides NADPH and molecular oxygen, three 
microsomal components are essential for aniline hydroxylase activity; 
namely: cytochrome 'P450'' NADPH cytochrome P450 reductase and a lipid 
fraction (Lu et al 1972). However, it has been shown that numerous 
r- - 
haemoproteins and a flavin could replace the native enzyme systems and 
achieve considerable rates of aniline hydroxylation and also of nitro- 
reductase activity (Symms and Juchau, 1974). These findings were 
initiated by the realization that aniline hydroxylation in the rat and 
human placenta was due to the catalytic activity of contaminating 
haemoglobin with NADPH as the electron donor (Juchau and Symms, 1972). 
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This illustrated that it is unsuitable to study mono-oxygenase activities 
in homogenates of many extrahapatic tissues from which blood has not 
been efficiently perfused. The haemoproteins which are capable of 
catalysing aniline hydroxylation included cytochrome b5, methaemoglobin, 
metmyoglobin, cytochrome c, peroxidase and catal ase and in the presence 
of flavins such as FMN, FAD or riboflavin, the reaction rates are 
markedly increased. 
From the works of Symms and Juchau, it can be shown that 
the constituents of an aniline hydroxylating system are: an electron 
donor such as NADH or NADPH, a suitable haemoprotein and molecular 
oxygen together with the substrate, indicating that hydroxylation of 
aniline may be carried out by an "artificial" system, and the fact that 
the elements of these "artificial". systems comprised only of biological 
compounds, e. g. haemoproteins which are analogous to the components 
proposed to be functional in the hepatic microsomal mixed function 
oxidase system suggested that common catalytic mechanisms may be involved. 
Indeed numerous "artificial" model systems capable of effecting the 
hydroxylation of organic compounds have been proposed and investigated 
in attempting to gain some insight into the mechanism of oxygenation 
of substrate in microsomal mixed function oxidation reactions. Such 
systems have been reviewed recently by Ullrich and Standinger, (1971) 
and Hamilton, (1974). Moreover, it is particularly interesting to note 
that microsomal haemoproteins such as cytochrome b5 are also capable of 
catalysing p-hydroxylation of aniline (Symms and Juchau, 1974). Clearly 
it can be seen that the mechanism of microsomal aniline hydroxylation to 
give p-aminophenol is complex, possibly involving more than one pathway 
of reaction and may even give rise to in vitro artifacts. 
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The ability of various tissues to metabolise aniline 
has been considered and by determining aniline hydroxylase activity in 
microsomal preparations it has been demonstrated that besides the liver, 
other tissues such as the intestine, the lungs, the kidneys and the 
brain are able to metabolise aniline by converting it to p-aminophenol. 
(Feuer et al, 1971, Hook, et al, 1972, Bend et al 1972, Litterst, et a1,1975, 
Hook and Bend, 1976). However, in view of the preceding discussion 
regarding microsomal aniline hydroxylase activity, the validity of these 
observations may be questionable and further investigations are necessary 
in order to establish the ability of extrahepatic tissues to metabolise 
aniline. 
The rate of in vitro metabolism of aniline in the rat 
-has been investigated recently (Wisniewska-Knypl and Joblonska, 1975) by 
determining the unmetabolised aniline remaining in the animal tissue 
at several timed intervals after administration of a dose of aniline 
at 50 mg kg-1. Unmetabolised aniline was determined colourimetrically 
following steam distillation of aliquots of homogenates of the whole 
animal (i. e. blood and carcass, minus the skin and tail), and it was 
found that at 50 mg kg-l the biological half life of aniline was about 
67 minutes. Also it was found that metabolism of a single dose of 
aniline was considerably accelerated if the animals were pretreated with 
either phenobarbital or 3.4 benzpyrene, but was inhibited after 
ad, -ninistration of SIý'525A. The biological half lives of aniline in 
these situations were calculated to be 42,37 and 86 minutes respectively- 
Indeed using indirect methods such as hexabarbital sleeping time (Convey, 
and Burns, 1963) and antipyretic activity of phenacetin (Conney, et al 
1966) for the assessment of in vivo rates of metabolism and assay of 
microsomal aniline hydroxylase activity, it was observed that repeated 
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exposure of rats to aniline at a daily dose of 50 mg kg-1 for 1 month 
results in a stimulation of drug metabolism as manifested by an increase 
in the aniline hydroxylase activity, shortening of hexabarbital sleeping 
time and a reduction of the antipyretic effects of phenacetin. Thus 
suggesting that prolonged exposure to aniline stimulates its own metabolism 
(WisniewskaKnypl, et al, 1975). Rabbits exposed to low doses of aniline 
for 18-26 days showed an increase rate of excretion of p-aminophenol in 
the urine. (Minkina et al 1970). 
5.3 IN VIVO INVESTIGATION OF ANILINE METABOLISM 
[-14cI-aniiine, 
50 mg kg-1 was administered to the 
animals as described. Urine and faeces were collected and assayed as 
described in Chapter 2. 
The Rf values and methods of detection of aniline and some 
of its metabolites are given in Table 5.1 and the results of orally 
administered 
14C-aniline 
metabolism in the sheep, the pig and the rat 
are summarized in Tables 5.2,5.3 and 5.4. 
The tables showed that after oral administration of 
14C 
- 
aniline a significant proportion of the dose was excreted by these 
animals in 24 hours. In the rat some 96% of the administered dose was 
recovered in the urine within 24 hours while, in the sheep the recovery 
was in the order of 80%. However, at 24 hours the radioactivity found 
in pig urine corresponded to about 56% of the administered dose of 
aniline and furthermore, where urinary excretion from the pig was 
monitored to 31 hours, the recovery of radioactivity between 24 and 31 
hours after administration was only in the order of 2%. Faecal excretion 
of radioactivity during the first 24 hours was found to be in the order 
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Table 5.. 2 
Urinary Excretion of 
14C 
Aniline by Sheep and Pig 
Species Dose Time Volume of ä of Administered 
Mg Kg 4Ici. (hr) Urine (ml) Dose Excreted 
Sheep 1 50 94.1 0- 3 18 0 
3- 5 176 31.5 
5- 7 564 20.7 
7-24 2800 29.5 
Sheep 2 50 135.3 04- 2 100 0 
2- 4 165 26.8 
4- 6 110 22.3 
6- 8 80 19.4 
8-24 250 10.6 
Pig 1 50 98.4 0- 3 68 * 7.8 
3- 5 65 25.0 
5- 7 54 10.7 
7-24 150 16.5 
24-31 2200 1.9 
Pig 2 50 80.9 0- 3 152 20.1 
3- 6 150 20.8 
6- 9 94 4.2 
9-21 560 6.6 
21-24 56 0.9 
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of 1% in the sheep and 2% in the pig. Faecal excretion in the rat was 
not determined, but was believed to be negligible. 
Identification of metabolites of aniline was based on 
chromatography, differential enzymic hydrolysis, solvent extraction 
and reverse isotope dilution analysis as described in Chapter 2. 
Thin layer chromatography followed by radiochromatogram 
scanning of urine samples from the species studied showed the presence 
of several peaks (Figure 5.1). Radiochromatograms of urine from the 
sheep showed the presence of peaks I, II and IV, while peaks I, II, V, 
VI and VII were obtained in the radiochromatograms from pig urine and from 
rat urine peaks I, II and III were produced. The Rf values of these 
peaks and their colour reactions with several spray reagents are given 
in Table 5.3. 
Colour reaction with spray reagent (a) showed that 
positive naphthoresorcinol reactions were given by II, IV and V indicating 
the presence of glucuronides. The use of spray reagents (h) and (i) 
which are typical reagents for detecting free aromatic amino groups showed 
that III, IV and V contained components with free aromatic amino groups 
and when chromatograms were first sprayed with reagent (j) i. e. 0.5M HC1 
and heated at 1000C for a few minutes, subsequent colour reactions with 
(h) and (i) showed that positive reactions were also given by I, II 
VI and VII, indicating that aromatic amino groups are exposed as 
the result of acid hydrolysis in the area of the radiochromatogram 
corresponding to these peaks. Using spray reagent (g) positive colour 
reactions were observed in the area corresponding to VI indicating 
the presence of divalent sulphur and suggesting the possible presence 
of a radiolabelled mercapturic acid. 
IV -' 
FIGURE 5.1 
THIN LAYER RADIOCHROMATOGRAM SCAN OF URINE 
FROH ANIMALS DOSED WITH 14C-ANILINE 
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Following enzymic hydrolysis, thin layer chromatography 
of urine samples and their hydrolysates, together with radiochromatogram 
autoradiography revealed that the dark areas on the autoradiogram 
corresponding to peaks II, IV and V disappeared after hydrolysis with 
p -glucuronidase and there was a concomitant appearance of a dark area 
corresponding to peak VII. On the other hand, hydrolysis with arylsulphatase 
resulted in the disappearance of dark areas corresponding to peaks I and 
III, and with a concomitant appearance of a dark area corresponding 
to VII (Figures 5.2,5.3 and 5.4). Thus II, IV and V are glucuronic 
acid conjugates, while I and III are sulphate conjugates and the aglycones 
being components of VII which can be extracted into organic solvent. 
Interestingly peak VI, which was observed only from radiochromatogram 
of pig urine was not hydrolysed by either 13-glucuronidase or arylsulphatase 
(Figure 5.3). 
Quantitative estimations of ethereal extracts for 
radioactivity showed that after p -glucuronidase hydrolysis of 24 hour 
urine samples some 70% of the radioactivity of the hydrolysate from the 
sheep and the pig was extracted into the ethereal phase, whereas from 
the rat only 16% was extracted. On the other hand, the amount of 
radioactivity extracted after arylsulphatase hydrolysis was in the 
order of 21%, 15% and 77% from the urine hydrolysates of the sheep, the 
pig and the rat respectively. When the 24 hour urine samples were 
incubated with acid phosphatase at pH 4.5 and the hydrolysates were 
solvent extracted as described, the amount of radioactivity extracted 
into the ether phase was found to be essentially. the same as control level. 
Control levels which are taken into account when results from enzymic 
hydrolysis experiment are calculated, ranged from about 4% in the sheep, 
7% in the rat and 10% in the pig_ These values corresponded to the 
!J1 
FIGURE 5.2 
ENZYMIC HYDROLYSIS OF URINE FROM THE SHEEP DOSED WITH 
14C-ANILINE 
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FIGURE 5.3 
ENZYMIC HYDROLYSIS OF URINE FROM THE PIG DOSED WITH 
14C-ANILINE 
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VII - "Deconjugated" Metabolites 
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level of radioactivity found in the ether fraction when untreated urine 
from these animals was solvent extracted. This indicated the presence 
of metabolite of aniline which are not conjugated with glucuronic acid 
or sulphate, and are organic solvent extractable. 
Thus from the enzymic hydrolysis experiments it can be 
deduced that orally administered aniline at 50 mg kg-1 is excreted in the 
24 hour urine essentially as glucuronides and sulphates and no phosphate 
conjugates were detected. In the rat 16% of the 24 hour urinary metabolites 
was found to be glucuronide and 77% to be sulphates. In the sheep the 
corresponding figures are 70% and 21% while in the pig they are 70% 
and 15% respectively. 
Qualitative and quantitative investigation of etheral 
extracts of hydrolysates from the enzymic hydrolysis of urine samples 
by thin layer chromatography, radiochromatogram scanning and reverse 
isotope dilution analysis revealed that the major radiolabelled component 
of all ether extracts was N-acetyl-p-aminophenol, although o- and 
p-aminophenol were also present, but they accounted for only a small 
proportion of the radioactivity of the ether extract (Figure 5.5). 
On the other hand, investigation of etheral extract from untreated urine 
samples showed that both N-acetyl-p-aminophenol and acetanilide were 
radiolabelled components from the sheep and the pig while in the rat 
N-acetyl-p-aminophenol was found to be the major radiolabelled 
component. 
From these observations it was deduced that VII is 
essentially N-acetyl-p-aminophenol while I being the major radiolabelled 
component in rat 24 hour urine is N-acetyl-p-aminophenylsulphate and II 
being the major radiolabelled component of pig urine is N-acetyl-p- 
aminophenylglucuronide. Other peaks are identified as p-aminophenylsulphate, 
FIGURE 5.5 
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III; p-aminophenylglucuronide, IV; o-aminophenylglucuronide, V; and 
mercapturic acids, VI_ A peak corresponding to o-aminophenylsulphate 
was not identified, but compared with the chromatographic behaviour of 
other metabolites in the solvent system used, o-aminophenylsulphate is 
likely to have a Rf value greater than I but less than VII. (See 
Addendum to Chapter 5). m-Aminophenol was not found to be a phase I 
metabolite of aniline by reverse isotope dilution analysis and 
N-glucuronides, and N-sulphates of aniline were not detected. The 
possible presence of free aniline in the urine of the animals studied 
was not determined, although free aniline may be derived from the 
hydrolysis of N-conjugates of aniline which are relatively labile. 
However, from the results obtained it is likely that little or no free 
aniline would be found in the urine of these animals. 
The 24 hour urinary metabolites of orally administered 
aniline which have been identified by the methods described are 
summarized in Table 5.4, and mercapturic acids as possible metabolites of 
aniline are discussed in Section 5.6. 
Interestingly it was also observed that in both sheep 
and pig urine there were changes in the pattern of metabolites found in 
the urine at various times after dosing (Figures 5.6). Thus in the sheep 
the relative proportion of glucuronides in the urine increased with 
time together with a concomitant decrease in the proportion of metabolites 
not conjugated with glucuronic acid or sulphate. Sulphate conjugated 
metabolites apparently remain constant with time. In the pig on the 
other hand, there is an apparent decrease in the relative proportion 
of glucuronic acid conjugates with time together with a concomitant 
increase in the proportion of metabolites not conjugated with glucuronic 
acid or sulphate . Again, sulphate conjugates appear to remain constant 
with time. 
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5.4 METABOLISM OF ANILINE IN URETER CANNULATED RATS 
The ureters of anaesthetised rats (250 g) were cannulated 
and dosed with 
[U-14C]-aniline 
at 25 mg kg-1 and 50 mg kg-1 by 
intraduodenal injection as described. 
Urine samples were collected at 15 minute intervals 
for a period of 3-4 hours and the samples were assayed for radioactivity 
as described. The metabolic profiles of 15 minute samples were 
determined by thin layer chromatography of aliquots (20-40 ß, tl) of urine 
on silica gel 60 precoated plates (Merck) in solvent system B followed 
by radiochromatogram autoradiography. The areas corresponding to 
N-acetyl-p-aminophenylsulphate (I, Rf 0.64), N-acetyl-p-aminophenyl- 
glucuronide (II, Rý 0.3), p-aminophenylsulphate (III, Rf 0.52), 
p-aminophenylglucuronide (IV, Rf 0.13) and N-acetyl-p-aminophenol 
(VII, Rf 0.93) were located and compared with the corresponding dark 
spots on the autoradiogram. These areas were marked on the radio- 
chromatogram, cut out and placed into scintillation vials and counted 
as described. The radioactivity associated with each of these areas 
was expressed as a percentage of the radioactivity recovered from the 
radiochromatogram. Other possible metabolites of aniline were not 
detected by the methods used. 
The rate of urinary elimination of radioactivity after 
intraduodenal administration is summarized in Figure 5.7. Metabolic 
profiles of 15 minute urine samples are illustrated in Figures 5.8 and 
5.9, and the rates of excretion of various metabolites of aniline are 
shown in Figure 5.10 and 5.11. 
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URI NARY EXCRETION OF RADIOACTIVITY AFTER 
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FIGURE 5"9 
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FIGURE 5 . 10 
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FIGURE 5.11 
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investigation did not saturate the systems involved in the metabolism of 
aniline. In Figures 5.8 and 5.9 where the percentage of the dose 
excreted as different metabolites at different time intervals are plotted, 
it is interesting to note that maximum elimination of p-aminophenylsulphate 
(III) occurred at about 1 hour after administration whereas maximum 
elimination of N-acetyl-p-aminophenylsulphate occurred at about 11i to 
2 hours after administration. When the ratio of N-acetyl-p-aminophenyl- 
sulphate to p-aminophenylsulphate in the urine at different times after 
administration was determined (Figure 5.12), it can be seen that the ratio 
changed with time. At either dose level, elimination of both sulphate 
conjugates was in the same order initially, but as metabolism and 
elimination occurred, the relative amount of N-acetyl-p-aminophenylsulphate 
found in the urine increased so that this ratio increased with time. 
Indeed, this increase is best illustrated at the lower dose level. -At 
the higher dose level this change in the ratio in less pronounced but 
in Figures 5.10 and 5.11 it can be seen that elimination of p-aminophenyl- 
sulphate has plateaued by 3 hours after administration at the lower dose 
level, whereas at the higher dose level elimination of p-aminophenylsulphate 
is just beginning to plateau. At both dose levels, the amount of 
N-acetyl-p-aminophenyl conjugates found in the urine was still increasing 
3 hours after intraduodenal injection of 
14C-aniline. 
5.5 METABOLISM OF ANILINE IN ISOLATED CELL PREPARATIONS 
Isolated cell preparations were prepared as described 
in Chapter 2 and 
[u-14j- 
aniline (100 ý,, M, 5 ýi&Ci) was incubated with 
cell suspension (5 ml) as described. 
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Samples of incubates obtained at 5 minute intervals from 
rat hepatocytes (1001 1) and from gut cells (5 ml) at 15 minute intervals 
were assayed by thin layer chromatography after centrifugation to remove 
denatured protein. Aliquots of the supernatent (20-40/,, l) were 
chromatographed on silica gel 60 plates (Merck) in solvent system 
B and autoradiograms of the resultant radiochromatograms were prepared. 
The areas corresponding to N-acetyl-p-aminophenylsulphate (I, Rf 0.64); 
N-acetyl-p-aminophenylglucuronide (II, Rf 0.3); p-aminophenylsulphate (III, 
Rf 0.52); p-aminophenylglucuronide (IV, Rf 0.13) and N-acetyl-p- 
aminophenol (VII, Rf 0.93) were located and compared with the corresponding 
dark areas found on the autoradiograms. The autoradiograms of radio- 
chromatograms from samples from isolated rat intestinal mucosal cells 
and hepatocytes thus obtained are shown in Figures 5.13 and 5.14 respectively. 
It can be seen that rat hepatocytes are capable of 
metabolising aniline progressively, and after 1 hour, 5 dark aras on 
the autoradiogram (Figure 5.14) corresponding to the 5 metabolites 
of aniline which have been previously identified were observed. Intestinal 
mucosal cells on the other hand, showed only one dark area on the 
autoradiogram (Figure 5.13) which corresponded to VII. A dark area on 
the autoradiograms corresponding to the origin was also seen, but the 
nature of this radioactive band was not known and it is believed to be 
due to the association of radiolabelled materials with components of 
cell debris which are not chromatographed in solvent system B. 
Interestingly the dark areas on Figure 5.14 corresponding 
to VII showed changes with time. Initially, it can be seen as a 
diffused dark area which gradually appears more discreet and at 1 hour 
a distinct dark area was observed corresponding to VII. This indicated 
that in hepatocytes, the areas on the chromatograms corresponding to VII 
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may contain more than one component and that the relative proportions 
of these components are subject to changes with time. Similar 
observations were also obtained from the autoradiogram from the 
intestinal 
mucosal cell samples (Figure 5.13). However, it may be recalled that 
aniline and acetanilide have the same Rf value as N-acetyl-p-aminophenol 
in solvent system B (see Table 5.1) and furthermore, aniline appears as a 
diffused area when developed in this solvent system- Thus it is likely 
that the dark areas in Figure 5.13 and 5.14 which corresponded to VII 
may consist of components which are mixtures of aniline, acetanilide 
and N-acetyl-p-aminophenol. Indeed, when aliquots (20-40 jvl) of 
supernatent from the hepatocytes were chromatographed on silica gel G 
plates (Schleicher and Schull) in solvent system L and autoradiograms were 
prepared as described (Figure 5.15), three dark areas corresponding to 
aniline (X, Rf 0.69), acetanilide (Y, Rf 0.64) and N-acetyl-p-aminophenol 
(Z, Rf 0.43) were observed and the relative proportions of these three 
metabolites apparently changed with time so that the dark areas 
corresponding to aniline decreased with time and at 1 hour essentially 
only acetanilide and N-acetyl-p-aminophenol were observed. This indicated 
that the dark area corresponding to VII in solvent system B may be 
resolved into aniline, acetanilide and N-acetyl-p-aminophenol in solvent 
system L. The dark areas on the autoradiogram (Figure 5.15) which 
corresponded to Rf values ranging from 0 to 0.1 are 0-conjugated 
metabolites of aniline and they are not chromatographed in solvent 
system L. On the other hand, when aliquots (20-40`1) of supernatent 
from intestinal mucosal cells were chromatographed in solvent system L, 
aniline and acetanilide were observed to be the components in the 
supernatents which are radiolabelled indicating that acetanilide was 
the intestinal metabolite of aniline. Indeed when aliquots (1 ml) of 
the supernatents from intestinal mucosal cell samples were solvent 
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extracted with ether (2 x5 ml), quantitative extraction of radioactivity 
(95% - 102%) into the ethereal Fraction was observed and subsequent 
reverse isotope dilution analysis of the ethereal fraction with authentic 
acetanilide and N-acetyl-p-aminophenol revealed that acetanilide was 
the intestinal mucosal cellular metabolite of aniline (Table 5.5a). 
Negligible amounts of N-acetyl-p-aminophenol were detected ((0.1%) 
and unmetabolised aniline was assumed to be the major radiolabelled 
component in the ethereal fraction. When on the other hand, an aliquot 
(1 ml) of the supernatent from the isolated rat hepatocytes which had 
been incubated with aniline for 1 hour was similarly extracted with 
ether, it was found that only 25% or so of the radioactivity was extracted 
into the ether fraction and subsequent reverse isotope dilution analysis 
with acetanilide and N-acetyl-p-aminophenol showed that both compounds 
are ether extractable metabolites of aniline of rat hepatocytes. These 
metabolites accounted for: 52% and--48% of the radioactivity in the ether 
extract respectively (Table 5.5b) and the remaining radioactivity was 
believed to be due to free aniline. 
Free aminophenols were not detected as metabolites of 
aniline in either isolated rat hepatocytes or intestinal mucosal cells and 
the possible synthesis of aniline N-glucuronide either as a metabolite of 
cellular metabolism or chemical reaction was not observed. However, it 
should be pointed out that aniline N-glucuronide is very labile under 
acid conditions and chromatography in the acidic solvent system B will 
effectively hydrolyse any N-glucuronide which may be present giving 
rise to free aniline, whereas chromatography in the 
basic solvent system L 
will conserve any N-glucuronide which may be present, 
but aniline-N- 
glucuronide is likely to remain at the origin when chromatographed on 
silica gel, thin layer plate in solvent system 
L. 
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Table 5.5 
Ether Extractable Metabolites of 
14C-Aniline 
from Isolated Cells 
a) Isolated Intestinal Mucosal Cells from Rat 
Time (min) N-Acetyl-p-aminophenol Acetanilide 
f pmole % pmole 
0 0.0 0.0 0.0 0.0 
15 <0.1 - 3.5 0.02 
30 <0.1 - 6.5 0.03 
60 0.1 - 7.9 0.04 
b) Isolated Hepatocytes from Rat 
60 12.0 0.36 13.0 0.07 
100% = 0.5 µmole of 
14C-Aniline 
Ether extraction of radioactivity fron a 100% 
(95-105%) 
b 25 ö 
Total No. of viable cells incubation a) 40 
+ 5x 106 
b) 35 - 5x 10 
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Quantitative analysis of the metabolism of aniline 
by isolated hepatocytes was performed by thin layer chromatography of 
aliquots of samples of supernatents, followed by the determination 
of the 
14C 
content of areas on the resultant radiochromatogram 
corresponding to the various metabolites of aniline which have been 
identified. The methods used were as described previously and the 
radioactivity associated with each of these areas was expressed as a 
percentage of the radioactivity recovered from the radiochromatogram. 
The preliminary results are summarized in Figure 5.16 
and it should be pointed out that these results must be viewed with some 
caution since possible loss of 
14C-aniline 
from the chromatograms during 
chromatography and autoradiography was not taken into account so that 
the relative proportion of the metabolites of aniline reported for the 
early stages of the incubation may be artificially high when compared 
with unmetabolised aniline. Unfortunately detailed investigations 
by organic solvent extraction and reverse isotope dilution analysis 
of the ether extractable metabolites from samples of incubates at 
various times have yet to be carried out. However, after incubation for 
1 hour, the relative proportion of metabolites of aniline from isolated 
rat hepatocytes was found to be: N-acetyl-p-aminophenylsulphate (25%); 
N-acetyl-p-aminophenylglucuronide (14%); p-aminophenylsulphate (14%); 
p-aminophenylglucuronide (12%); N-acetyl-p-aminophenol (12%) and 
acetanilide (13%). The radioactivity at the origin of the radiochromatograms 
developed in solvent system B was found to be in the order of 5-10% 
of the 
14C 
recovered from the radiochromatogram. 
Figure 5.16 illustrates the time course of metabolism of aniline 
by rat hepatocytes. With the exception of acetanilide, all metabolites 
of aniline are found to increase with time of incubation until a plateau 
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is reached and after incubation for about 1 hour, maximum synthesis 
of these metabolites was observed- Maximum synthesis of acetanilide, 
on the other hand, appears to occur in about 25 minutes, but interestingly 
subsequent incubation resulted in a fall in the level of acetanilide. 
This indicated that acetanilide is further metabolised by isolated 
hepatocytes probably to N-acetyl-D-aminophenol conjugates. Throughout the 
time course of the metabolism, synthesis of N-acetyl-p-aminophenylglucuronide 
and p-aminophenylglucuronide was approximately equal whereas synthesis 
of the sulphate conjugates of N-acetyl-p-aminophenol and p-aminophenol 
was in the ratio of about 1.7 to 1. 
These results showed that isolated rat intestinal 
mucosal cells and hepatocytes are capable of metabolising aniline. In 
the intestinal cells, this was found to be low and the metabolic pathway 
was N-acetylation. In the hq. patocytes, metabolism of aniline involved 
N-acetylation, aromatic hydroxylation, and 0- conjugation with glucuronic 
acid and sulphate. N-Conjugation with glucuronic acid and sulphate was 
apparently not observed. 
5.6 DISCUSSION 
The results of the investigation involving aniline are 
summarized in the previous sections and in the following discussion, 
these results will be considered in terms of the metabolic profile of 
orally administered aniline at 50 mg kg-l, the pathways involved in 
the metabolism of aniline and its relationship to toxicity with reference 
to methaemoglobin formation. A brief discussion on the kinetics of in 
vivo metabolism of aniline and the ability of various tissues to metabolise 
aniline will also be considered. 
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In the sheep some 80% of the dose of 50 mg kg-1 of 
aniline was excreted in the urine within 24 hours after administration, 
but in the pig only 56% of the administered dose was excreted in the 
urine durng the first 24 hours. When urinary excretion in the pig was 
monitored during the second day, only about 2% of the dose was excreted 
between 24-31 hours (see Table 5.2), suggesting that excretion of the 
remaining dose of aniline in the pig may be very slow. Indeed, compared 
to benzoic acid and phenol urinary elimination of aniline in both species 
appears to be slow. In the rat, 96% of the dose was excreted within 24 
hours of administration. Faecal excretion was in the order of 1-2% in 
the sheep and the pig during the first day. Unfortunately, subsequent 
faecal excretion was not monitored, but is is believed that since biliary 
excretion of metabolites of aniline is generally small, then faecal 
excretion of aniline metabolites may be negligible compared to urinary 
excretion. Biliary excretion of aniline and its metabolites in the rat 
is reported to be in the order of about 6%, the major biliary metabolite 
being p-aminophenylglucuronide (Abou-el-Makaremet al 1967). 
The major urinary metabolites of aniline found in these 
animals were glucuronic acid and sulphate conjugates of N-acetyl-p- 
aminophenol leading to the unusual appearance of double conjugates in 
the urine. In the sheep and the pig, N-acetyl-p-aminophenylglucuronide 
was the major urinary metabolite (60% and 69% respectively), while in 
the rat the sulphate conjugate was the major metabolite accounting for 
some 56% of the total urinary metabolites. Urinary N-acetyl-p-aminophenyl- 
sulphate in the sheep and the pig was about 15% and 9% respectively, 
while urinary N-acetyl-p-aminophenylglucuronide in the rat was roughly 
13%. Thus, it can be seen that N-acetylation appears to be the major 
-1 
conjugation mechanism for the metabolism of aniline at 50 mg kg in 
L1ö 
these three species. Indeed acetanilide and free N-acetyl-p-aminophenol 
were also detected as minor urinary metabolites of aniline together with 
the glucuronides and sulphates of o-, and p-aminophenol in each species. 
Urinary metabolites of aniline which are N-acetylated accounted for 
82%, 85% and 76% in the sheep, pig and rat respectively, and conjugates 
of aniline, i. e. the labile N-glucuronide and phenylsulphamic acid were 
not detected as urinary metabolites in the present investigation. 
Interestingly, N-acetyl-p-aminophenol is the pharmacologically active 
compound, paracetamol (Acetaminophen) and the synthesis of this compound 
during the metabolism of aniline give rise to an example of in vivo 
drug activation. Furthermore, the finding that N-acetylation is an 
important pathway in the metabolism of aniline may rationalise the 
observation of Elson et al (1946) who showed that equivalent amounts of 
aniline and p-aminophenol are excreted-exclusively as. 0-sulphates and 
0-glucuronides respectively. 
The results obtained from the present in vivo investigations 
fail to confirm previous observations, where it was shown that the major 
urinary metabolite of aniline was either the glucuronic acid and sulphate 
conjugates of aminophenols (Parke 1960) or the acid labile N-glucuronide 
(Smith and Williams 1949, Ishidate et al 1958). It should be noted that 
acetylation of aniline has been shown to occur in vitro and an 
acetyltransferase from pigeon liver which is capable of carrying out 
this reaction has been isolated and purified (Jacobson 1961). Interestingly, 
acetyl-CoA or acetanilide derivatives were shown to be capable of acting 
as the acetyl-donor. 
A common feature in the previous investigations was the 
use of relatively strong acids in the hydrolysis of glucuronic acid 
and sulphate conjugated metabolites to obtain the phase I metabolites 
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for identification. However, such strong hydrolytic procedures will also 
deacetylate any N-acetylated metabolites and may account for the previous 
observations of low levels of N-acetylated derivatives of aniline as 
urinary metabolites. In the present investigation conjugate hydrolysis 
was by specific enzymes under much milder hydrolytic pH conditions than 
those previously used and the chemical environment of the enzymic 
experiments were such that in the absence of enzymes no significant 
chemical hydrolysis of even relatively labile conjugates appeared to 
occur. Furthermore, the differences between the reported metabolic 
profiles of aniline and the present results may also be partially due 
to the dose levels used. In earlier experiments using the rabbit and 
the rat, the dose levels used ranged from 200-500 mg kg-1 (Smith and 
Williams, 1949, Parke, 196O, Boyland, et al 1963) that is, considerably 
higher than the 50 mg kg-1 dose used in the present investigation. At 
the high dose levels used, the animals showed symptoms of toxicity and 
indeed some animals died in about 3 days after dosing with 500 mg kg-1 
of aniline (Parke, 1960). Toxic symptoms were not observed in the present 
in vivo investigations and it was assumed that 50 mg kg-l was well below 
the toxic level of aniline in these species. 
The identification of acetylated metabolites, i. e. 
N-acetyl-p-aminophenol and acetanilide was based on co-chromatography and 
reverse isotope dilution analysis with authentic metabolites of the 
ether extracts obtained from enzyme hydrolysed urine. Enzymic hydrolysis 
with (3 -glucuronidase and arylsulphatase which was carried out 
in an 
acetate buffer resulted in the deconjugation of glucuronides and 
sulphates respectively leaving the aglycone which was organic solvent 
extractable. The use of ketodase as the commercial preparation of 
1g-glucuronidase, which was supplied as a solution of the enzyme in an 
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acetate buffer necessitated the use of 0.1 M acetate buffer pH 5.0 and 
this raises the possibility that the N-acetyl derivatives may be artifacts 
formed during the enzymic incubations as the result of interaction with 
the acetate ions. However, studies using a different source of 
ß -glucuronidase We. from Helix pomatia, Sigma type I) and in the 
presence of a citrate buffer showed that N-acetyl derivatives are found 
to be the major urinary metabolites of aniline. Indeed since chemical 
synthesis of N-acetyl derivatives of aromatic amines generally required 
drastic conditions such as refluxing with acetic anhydride, spontaneous 
acetylation of aniline and its metabolites is unlikely to occur under the 
mild conditions of enzymic hydrolysis so that N-acetylation is fundamental 
in the pathway of metabolism and urinary elimination of administered 
aniline, and may play an important role in the metabolism and detoxication 
of aniline. 
The excretion of mercapturic acid conjugates as minor 
metabolites of aniline has been previously suggested (Boyland, et al 
1963). In the present investigation, an unidentified sulphur containing 
metabolite from the pig was observed. This metabolite was not hydrolysed 
by f3 -glucuronidase or arylsulphatase, but gave a positive reaction 
with potassium dichromate - silver nitrate spray reagent (Knight and 
Young 1958) which indicated the presence of divalent sulphur atoms. It 
is therefore suggested that this unknown metabolite may be a mercapturic 
acid. Indeed, since N-acetyl-p-aminophenol, the pharmacologically 
active compound paracetamol was identified as the major metabolite in 
the present investigation and since Mitchell et al 
(1975) have shown that 
paracetamol induced liver necrosis was a result of the 
depletion of 
glutathione by paracetamol in forming a readily excreted mercapturic 
acid, this unknown metabolite may be a mercaoturic acid 
derived from 
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N-acetyl-p-aminophenol conjugation with glutathione. Unfortunately 
complete identification of this metabolite has yet to be completed. 
Another interesting observation in the pig compared with the other 
two species studied was that whereas urinary excretion of the administered 
aniline in the sheep and the rat was in the order of 80-90% of the dose 
in 24 hours, only about 56% of the dose was eliminated in the urine of 
the pig in 24 hours, suggesting that elimination of aniline in the 
pig is much slower than the other two species. Furthermore, if mercapturic 
acid of N-acetyl-p-aminophenol was indeed a metabolite of aniline in 
the pig, this may reflect important differences in the pathways of metabolism 
of aniline in these species and. possible consequences in terms of 
detoxication. Indeed the fact that the pig shows deficiencies in sulphate 
conjugation may be of significance in alternative pathways of metabolism 
in the. pig which will merit further investigation. 
Since N-acetyl-p-aminophenol was previously identified 
only as a minor metabolite of aniline (Smith and Williams 1949, Parke 
1960), the importance of acetylation in the metabolism of aniline has 
not been considered, but it was proposed (Smith and Williams 1949) 
that acetylation occurred after aniline has been oxidised to p-aminophenol 
which was followed by 0-conjugation and there may be no direct acetylation 
of aniline. However, the present investigation has shown that N-acetylation 
was important in the metabolism of aniline and that O-conjugates of 
N-acetyl-p-aminophenol were the major metabolites of aniline indicating 
some similarities between the metabolism of aniline and acetanilide. 
Indeed, at one time a generally accepted belief was that aniline and 
acetanilide are interconvertible in vivo by N-acetylation and N 
deacetylation, 
but based on their observation that aniline is metabolised mainly to an 
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acid labile glucuronide, Smith and Williams (1949) suggested that 
acetanilide and aniline are not metabolically equivalent. Acetanilide 
is metabolised and excreted in the urine as glucuronic acid and sulphate 
conjugates of N-acetyl-p-aminophenol_ (Smith and Williams 1948). 
From the present observation it may be possible to 
propose that in the species studied, orally administered aniline at 
50 mg kg-1 may be primarily N-acetylated and subsequently metabolised 
as acetanilide by aromatic hydroxylation and O-conjugation, and that 
0-conjugates of aminophenols may arise from either direct aromatic 
hydroxylation of aniline followed by O-conjugation or via N-deacetylation 
of the acetyl derivatives. Indeed it has been suggested that acetylation 
of arylamine and deacetylation of N-acetylarylamine derivatives may be 
catalysed by closely related enzyme systems (Bray et al 1950) and the 
rate of acetylation and deacetylation may be a function of the electronic 
configuration of the aniline and acetanilide derivatives (Perault and 
Pullman 1963). However, aromatic hydroxylation of aniline to aminophenols 
followed by N-acetylation as suggested by Smith and Williams (1949) still 
remains an alternative route of metabolism of aniline, and indeed in a 
study of the metabolism of aminophenols (Bray et al 1952a) it was shown 
that 17% and 45% of a dose of about 400 mg kg-1 of o- and p-aminophenol 
respectively was excreted as N-acetyl-p-aminophenol in free and 
n-rnný1inatPc3 forms. 
NH2 C H3CO"NH C H3CO"NH 
OH 
CH3C0"NH 
0-R 
Jr 
NH 2 
0-R 
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Attempts to rationalize these two pathways of formation 
of N-acetyl-p-aminophenol from the observations of the present 
investigation-were unsuccessful but interestingly acetanilide was 
identified as a metabolite of aniline in isolated rat hepatocytes and 
intestinal mucosal cells. Indeed it was the only metabolite detected 
in isolated intestinal mucosal cells. Observations from these hepatocytes 
(see Figure 5.16) suggest that acetanilide formed is further metabolised, 
probably to 0-conjugates of N-acetyl-p-aminophenol. Clearly further 
investigation of the interrelationship between acetylation and deacetylation 
pathways must be considered before understanding of the involvement of 
acetylation in the in vivo metabolism of aniline can be achieved. 
It has already been suggested that the dose level of 
aniline administered may influence the metabolite pattern. Thus at the 
high dose levels used in previous investigations, it is possible that 
either the acetylation pathway is saturated (although acetylases are 
not known to be readily saturatable enzymes) or enzymic deacetylation 
of the products of the acetylase enzyme is extensive due to 
"activation" 
of deacetylase by high levels of acetyl derivatives. High levels of 
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acetyl derivatives may arise as the result of the failure of the kidneys 
to eliminate the acetyl derivatives rapidly. Thus on the basis of the 
percentage of the dose, metabolites excreted as acetyl derivatives will 
be low. Unfortunately few systematic studies have been carried out on 
the interrelationship of the roles of N-acetylation and N-deacetylation 
pathways in the metabolism of foreign compounds. However, some preliminary 
investigations on the deacetylation of acetyl derivatives of sulphanilamide 
have been conducted with reference to the metabolism of sulphanilamide 
(Bridges and Williams 1963) and recently the in vivo metabolism of a 
number of acetyl -14C1-acetanilides in the rat has been studied (Smith 
and Griffiths 1976). Using the criteria that excretion of 
14CO2 
in 
expired air is a measure of N-deacetylation of N-14C-acetyl-derivatives, 
Smith and Griffiths (1976)were able to demonstrate that acetyl -14C- 
acetanilides are metabolised to a considerable extept-by N-deacetylation 
although the products may subsequently undergo re-acetylation. In the 
present investigation very little 0-conjugates of aminophenols were 
detected in the urine whereas O-conjugates of N-acetyl-p-aminophenol 
were the major urinary metabolites. This suggests that the in vivo 
acetylation of aniline in the species studied is high whilst the 
deacetylation of acetylated metabolites of aniline is low. 
Urinary N-acetyl-p-aminophenol conjugates may also 
arise from another metabolic pathway, i. e. N-hydroxylation of aniline 
to give phenylhydroxylamine. Phenylhydroxylamine or its N-hydroxy 
conjugates have not been identified as a urinary metabolite of aniline, 
but it is metabolised to glucuronic acid and sulphate conjugates of 
N-acetyl-p-aminophenol (Williams, 1959). The mechanism of reaction is 
believed to involve reduction of the hydroxylamine to the parent amine 
which is subsequently metabolised by N-acetylation and aromatic hydroxylation. 
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The reduction of phenylhydroxylamine to aniline was believed to be a 
non-enzymic reaction, but recently it has been shown that this reduction 
is catalysed by a microsomal enzyme (Kadlubar. et al 1973) and indeed 
an NADH dependent reductase has been isolated from pig liver microsomes 
which is capable of converting arylhydroxylamine to aromatic amines 
(Kadlubar and Zieglar, 1974). Phenylhydroxylamine has been demonstrated 
to be an intermediate in aniline metabolism and is the principle 
metabolite responsible for the toxicity of aniline in causing methaemoglobin 
formation (Kiese, 1959). However, whether N-hydroxylation of aniline 
is an important pathway in the overall metabolism of aniline remains 
to be investigated. It may be possible to gain indirect information 
here by studying the metabolism of aniline in rat hepatocytes in the 
presence of erythrocytes and minotoring the metabolic profile and 
methaemoglobin formation in the erythrocytes. 
Aromatic hydroxylation has been demonstrated to be 
the major pathway in the metabolism of aniline in that both o- and 
p-aminophenol are phase I metabolites. As the relative proportion 
of these phenols is subject to considerable species variation (Parke 
1960), it was suggested that two aniline hydroxylases are responsible 
for the synthesis of the two isomeric phenols and that the relative 
activities of these enzymes vary from species to species, thus giving 
a possible explanation for the species variation in o- and p-hydroxylated 
metabolites of aniline (Parke/1960, Williams, 1967). In the present 
investigation, urinary o-hydroxylated metabolites of aniline in the 
three species studied accounted for only about 4-10% of the urinary 
metabolites, whereas the remaining urinary metabolites were essentially 
p-hydroxylated derivatives. Now, since it has been 
demonstrated that 
N-acetyl derivatives constituted the major metabolites of aniline in 
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these animals, it is therefore proposed that species variation in o- and 
P-hydroxylation may be influenced by the acetylation of aniline- If 
metabolism of aniline involved primary N-acetylation, then the acetanilide 
so formed would be preferentially hydroxylated in the p- position. This 
is because of the steric hindrance of the o- position by the acetamino 
group and the greater inactivation of the o- position due to the inductive 
effect of the acetamino substituent. Thus species which show extensive 
acetylation of aromatic amines, e. g. aniline, will give rise to higher 
levels of p-hydroxylated metabolites relative to o-hydroxylated metabolites, 
. whereas species which eliminate a relatively higher level of o-hydroxylated 
metabolites will tend to show lower activities towards acetylation of 
aromatic amines. On the other hand, if aromatic hydroxylation occurs 
prior to N-acetylation of aniline, then the relative activities of the 
proposed aniline-2-hydroxylase, and aniline-4-hydroxylase and not the 
activities of N-acetylase will have the major influence on the orientation 
of the hydroxylation. However, if one considers the N4-acetylation of 
sulphanilamide, which is an example of acetylation of an aromatic 
amino group (see Table 5.6), it can be seen that with the exception of 
the guinea pig and the cat, there is an apparent correlation between 
the acetylation of aromatic amines and the ratio of p- to o-hydroxylation 
of aniline in vivo in the species shown. Thus a high p-/o- ratio 
correlates with high acetylation of aromatic amino groups while a low 
r_/o- ratio correlates with low in vivo aromatic N-acetylating activities. 
This suggests that N-acetylation of aniline may be the important factor 
in determining the formation of o- and p-hydroxylated metabolites and 
indicates that the primary reaction in metabolism of aniline is N-acetylation. 
It should be noted, however, that this apparent correlation is necessarily 
only tentative since species variation in deacetylation reactions and 
other metabolic interconversions of aniline has not been considered. 
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Table 5.6 
Species Variation in o- & p- Hydroxylation of Aniline and N4-Acetylation 
of Sulphanilamide 
Species p-/o- Ratio of Lethal Dose N4-Acetylation of* 
Aniline Hydroxylation of Aniline Sulphanilamide to 
g Kg -1 ; Total N4+ N 
N4; 
Cat 0.4 0.2 14 (65) 
Dog 0.5 0.5 0 (82) 
Ferret 1.0 - -- 
Mouse 3.0 20 (49) 
Hen 4.0 - 25 
(47) 
Rabbit 6.0 1.0 43 (22) 
Rat 6.0 - 33 
(36) 
Hamster 10.0 - -- 
Guinea pig 11.0 2.5 14 (65) 
Gerbil 16.0 - -- 
Expressed as % of dose excreted in urine. 
High proporations of sulphanilamide were excreted as the free drug 
in these species. The values are given in parentheses. 
N. B. Species differences in deacetylation reactions are not taken 
into consideration. 
Table adapted from Parke 1960 and Bridges & Williams 1963 
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Indeed, deacetylase activities may show considerable species variation 
(Bridges and Williams, 1963, Williams, 1967) and also the extent of 
deacetylation may be substrate dependent. Thus Smith and Griffiths, 
(1976) have shown that in the rat in vivo deacetylation of acetanilide 
(25-31%) was considerably higher than the deacetylation of N-acetyl-p- 
aminophenol (6%) when equivalent amounts (1.4 mmole kg-1) of the acetyl 
derivatives were administered. 
Besides the direct hydroxylation of aniline catalysed 
by "aniline hydroxylase", the introduction of a hydroxyl group into the 
aromatic nucleus may be achieved via N-hydroxylation to give phenyl- 
hydroxylamine followed by rearrangement to either o- or p-aminophenol. 
Although this rearrangement to p-aminophenol in the presence of acid 
has been demonstrated (Fieser and Fieser 1961), such rearrangement of 
phenylhydroxylamine to o-aminophenol has not been demonstrated either 
chemically or during the metabolism of aniline. However, since it 
has been pointed out that acetanilide derivatives are converted to 
o-aminophenols via enzymic N-hydroxylation and enzymic or acid catalysed 
rearrangement of the N-hydroxy derivatives (Miller et al 1960 , Boyland 
and Booth, 1962, Booth and Boyland, 1964), then N-hydroxylation of 
N-acetylated metabolites of aniline such as acetanilide and N-acetyl-p- 
aminophenol may also be a possibility in the biotransformation and 
elimination of administered aniline. Indeed, the first unequivocal 
demonstration of N-hydroxylation in vivo was that N-acetyl-N-2- 
fluorenylhydroxylamine was the major metabolite of the acetyl derivative: 
2-acetylaminofluorene (Cramer, et al, 196O). However, Booth and Boyland, 
(1964) were unable to demonstrate theN-hydroxylation of acetanilide 
using rabbit liver microsomes, although they were able to show that 
N-acetyl-N-phenylhydroxylamine (N-hydroxyacetanilide) was isomerized 
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to N-acetyl-o-aminophenol by the soluble fraction of rabbit liver. Now 
since o-substituted acetanilides are readily deacetylated (Bray et al 1950) 
then, deacetylation of N-acetyl-o-aminophenol will give o-aminophenol 
which has been identified as a metabolite of aniline. N-}lydroxylation 
of N-acetyl-p-aminophenol to give a toxic quinolimide intermediate (see 
Figure 5.17a) which reacts preferentially with glutathione has been 
postulated as the pathway of formation of the mercapturic acid of 
N-acetyl-p-aminophenol (Mitchell et al 1975). Quinolamine intermediates 
from N-hydroxylation of aniline and aminophenol are also considered 
to be precursors in the formation of mercapturic acid metabolites from 
aniline by reacting with glutathione by Boyland and his colleagues 
(1962,1963). Clearly, additional investigations are necessary in order 
to elucidate the relationship between N-acetylation, N-hydroxylation and 
aromatic hydroxylation in the metabolism of aniline and the pathways of 
biotransformation of aniline are summarized in Figure 5.18. 
It has been proposed that since species which produce 
mostly o-aminophenol tend to be very susceptible to the toxic effects 
of aniline so that the toxicity of aniline may be due to o-aminophenol 
which is more toxic than the p-isomer (Parke 1960). Indeed the formation 
of a reactive quinolimine intermediate may be a contributing factor 
in 
the toxicity of aniline. However, the apparent correlation between 
acetylation of the aromatic amino group and o- and p-hydroxylation 
suggests that acetylation of aniline may have a role 
in the detoxication 
of aniline. 
The mechanism of methaemoglobin formation from administered 
aniline results from N-hydroxylation of aniline to give phenylhydroxylamine. 
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Phenylhydroxylamine is involved in an enzymic cycle (see Figure 5.17b) 
in which oxidation of phenylhydroxylamine to nitrosobenzene is coupled 
to the conversion of ferrohaemoglobin to ferrihaemoglobin. In the red 
cells nitrosobenzene is enzymically reduced back to phenylhydroxylamine 
and so starting a cycle of events by which one molecule of phenylhydroxyla- 
mine transforms many equivalents of ferrohaemoglobin to ferrihaemoglobin. 
This will continue until either the phenylhydroxylamine and nitrosobenzene 
are removed or further metabolised by other metabolic pathways or until 
all ferrohaemoglobin has been oxidised (Kiese, 1971 and cited references). 
Now if acetylation prevents the interconversion of phenylhydroxylamine 
and nitrosobenzene either by preventing the formation of phenylhydroxylamine 
from N-hydroxylation of aniline or by giving rise to the formation of 
N-acetyl-N-phenylhydroxylamine (N-hydroxyacetanilide), then this would 
reduce the-toxicity of aniline in methaemoglobin formation via the 
enzymic hydroxylamine/nitrosobenzene interconversion. Thus it is 
possible that species which actively acetylate aromatic amino groups may 
be less sensitive to aniline intoxication, whereas, species with slow 
aniline acetylase activities may be more sensitive to aniline induced 
methaemoglobin formation. Interestingly it has been suggested that 
deacetylation is a requisite step for the formation of methaemoglobin 
by acetanilide analogues and the rate of deacetylation may be the 
limiting factor in the expression of their haemotoxicity (Heymann, et al. 
1969, Beattie et al 1973, Mitchell; et al 1973) and since it has been shown 
that N-acetyl-p-aminophenol is not deacetylated to any great extent 
(Smith and Griffiths, 1976), then the formation of N-acetyl-p-aminophenol 
from aniline may indeed be a detoxication reaction with respect to 
methaemoglobin formation. 
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Following from the observation that the urinary 
metabolic profile of aniline in the sheep and the pig showed changes 
with time, the metabolism of aniline was also investigated in ureter 
cannulated rats in an attempt to study not only the possible changes 
in the urinary metabolic profile of aniline with time, but also the 
kinetics of in vivo metabolism. 
The kinetics of in vivo metabolism of aniline at 
50 mg kg-l in the rat have been investigated previously by Wisniewska- 
Knypl and Jablonska, (1975). By using a relatively crude methodology 
it was found that the biological half life of aniline was in the order 
of about 1 hour. However, in the present investigation using dose levels 
of 25 and 50 mg kg-1, it was found that 50% of the dose of aniline was 
eliminated in the urine in about 3 hours and that urinary metabolites 
of aniline may be detected within 15 minutes of intraduodenal administration, 
although this represented only about 0.5% of the dose. Aniline with a 
pKa of 4.6 is well absorbed from the small intestine (Schanker, et al, 
1958), but its slow rate of elimination and high lipophilicity 
suggest that distribution and metabolism may be limiting factors in the 
rate of elimination of orally administered aniline. An interesting 
observation from the ureter cannulation experiments was that at both 
dose levels studied O-conjugates of p-aminophenol were eliminated maximally 
before maximal elimination of the N-acetyl derivative (see Figure 5.8 and 
5.9) and that by about 3 hours elimination of p-aminophenylsulphate has 
plateaued whereas elimination of N-acetyl derivatives was still increasing 
(see Figures 5.10 and 5.11). Thus, the fact that the urinary metabolic 
profile of aniline in the rat showed changes with time suggests that the 
in vivo metabolism of aniline is very complex and a more detailed 
investigation of distribution and metabolism by various tissues is 
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necessary to the understanding of the roles of various pathways and 
the kinetics of the metabolism of aniline- 
In an attempt to investigate the ability of various 
tissues to metabolise aniline, some preliminary experiments were carried 
out in isolated rat hepatocytes and intestinal mucosal cells. It was 
found that whereas rat hepatocytes metabolise aniline to glucuronic 
acid and sulphate conjugates of both N-acetyl-p-aminophenol and 
p-aminophenol, such conjugates were not detected as metabolites in rat 
intestinal mucosal cells. Indeed the only metabolite of aniline detected 
in rat intestinal mucosal cell was acetanilide. Acetanilide and free 
N-acetyl-p-aminophenol were also detected as metabolites in rat 
hepatocytes. 
Up till now, the ability of various tissues to metabolise 
aniline has been demonstrated by showing the formation of p-aminophenol 
from aniline in tissue homogenates or microsomal preparations. However,. 
from the works of Symms and Juchau discussed in Section 5.2, it was shown 
that p-hydroxylation of aniline may be achieved by an "artificial" system 
and the requirements of such systems may be simply, an electron donor, 
a suitable haemoprotein and molecular oxygen together with the substrate, 
so that the presence of "aniline hydroxylase" activity in a particular 
tissue homogenate or microsomal preparation may not necessarily reflect 
the ability of that tissue to metabolise aniline in vivo. Indeed the find- 
ing that N-acetyl-p-aminophenol is the major metabolite of aniline suggests 
that N-acetylation may be a more relevant enzymic activity for 
consideration. Moreover, -in vitro studies of aniline metabolism 
using rnicrosomes and JTADPH regenerating system have a1--ays shoTm that 
p-aminophenol and not Td-acetyl-p-aminophenol was the metabolite of 
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aniline and furthermore, there are apparently no reports of o-aminophenol 
as a metabolite of microsomal metabolism of aniline. This failure to 
observe N-acetyl derivatives in microsomal metabolism stems from the 
fact that N-acetylation involves the transfer of the acetyl moiety 
from acetyl-CoA to the aromatic amino group catalysed by N-acetyl- 
transferase enzyme systems which are present in the soluble fraction of 
cells (Weber and Cohen 1967). Such systems will not be present in the 
in vitro incubation medium involving microsomes, so that microsomes may 
not be the best tissue preparation for the study of aniline metabolism. 
Indeed the mechanism of microsomal aniline hydroxylation is poorly 
understood and as discussed in Section 5.2 it is influenced by a number 
of factors such that constructive interpretation of in vitro aniline 
hydroxylase activity may prove to be difficult and give rise to erroneous 
hypotheses which have no bearing on the in vivo situation. The use of 
isolated cells in the present investigation provides an advantage over 
other in vitro investigations in that a full complement of biochemical 
reactions are present in the intact cells so that metabolism involving 
more than one metabolic pathway in different cellular compartments 
may be monitored at the same time and this may provide a closer 
relationship to the in vivo situation. 
In the present studies using isolated rat hepatocytes, 
it was observed that the relative proportion of O-conjugates of 
p-aminophenol in the incubation was apparently higher than that observed 
in the in vivo situation. At the end of 3 hours' incubation some 
25% of the aniline (O. 5 , utmole) in the rat 
hepatocyte incubates was 
detected as 0-conjugates of p-aminophenol whereas under 
in vivo 
conditions roughly 16% of the urinary metabolites of aniline 
in the 
rat were 0-conjugates of p-aminophenol. The remaining metabolites 
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in both the in vivo and in vitro experiments were N-acetylated derivatives 
of aniline. This apparent difference may be similar to the observation 
of phenol metabolism in isolated rat hepatocyte discussed in Chapter 4 
(Section 4.6) and result from the continuous contact of N-acetylated 
metabolites with the hepatocytes in the incubation mixture so that 
higher deacetylation may occur. Under in vivo conditions the clearance 
of metabolites from the liver may be such that deacetylation is very 
low. Also it was noted that during the thin layer chromatographic 
investigation of aniline metabolites from rat hepatocytes some 5-10% 
of the radioactivity remained at the origin (see Figure 5.14). The 
nature of this is not known, but the presence of N-conjugated metabolites 
and the binding of radioactive metabolites to cellular macromolecular 
components may be real possibilities and merits further investigations. 
Thus from the foregoing discussion it can be seen that 
metabolism of aniline is very complex and involves several metabolic 
pathways. Clearly, understanding of the nature and the role of the 
various metabolic pathways involved in the detoxication and elimination 
of administered aniline requires a more detailed investigation and such 
investigations must take into account the dose level of aniline in 
relation to metabolic reactions such as N-acetylation, N-deacetylation and 
N-hydroxylation together with aromatic hydroxylation and O-conjugations. 
Furthermore, a re-examination of the metabolic profile of o- and p-aminophenol, 
acetanilide, phenylhydroxylamine and N-acetyl-p-aminophenol may 
be helpful 
in providing a clearer understanding of the pathways of aniline metabolism. 
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ADDENDUM 
Subsequent to the completion of Chapter 5, some 
preliminary investigations on the metabolism of aniline by isolated 
dog hepatocytes were performed. The methodology was essentially as 
described in Section 5.5 and although quantitative determinations have 
yet to be carried out, thin layer chromatography followed by radio- 
chromatogram autoradiography revealed that aniline was metabolised by 
dog liver cells to a major metabolite which had a Rf value of 0.71-0.73 
on silica gel 60 F254 precoated plates (Merck) when developed in solvent 
system B. Enzymic hydrolysis with arylsulphatase followed by thin layer 
chromatography in solvent systems K and L showed that this metabolite 
was o-aminophenylsulphate. Small amounts of acetanilide, N-acetyl-p- 
aminophenol and p-aminophenolsulphate together with traces of free o- and 
p-aminophenol were also tentatively identified as metabolites of aniline 
in isolated dog hepatocytes. 
It has been shown that the dog metabolises aniline 
predominately by o-hydroxylation (Parke 1960). It is also highly 
susceptible to the toxic actions of aniline (see Table 5.6) and it 
shows a deficiency in acetylating aromatic amino groups (Williams 1967). 
Thus the observation that o-aminophenylsulphate was the major metabolite 
of aniline in isolated dog hepatocytes and that only small amounts of 
acetyl derivatives were produced may be presented. as additional support 
for the involvement of N acetylation in detoxication of aniline and 
the orientation of aromatic hydroxylation as 
discussed in Section 5.6. 
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CHAPTER 6 
FINAL DISCUSSION 
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In the last chapter a comparison of the metabolic 
capabilities between farm animals (sheep and pig) and laboratory 
animals (rat) will be made, The discussion will also attempt to assess 
the importance of studying kinetics of in vivo metabolism, the ability 
of different tissues to metabolise the compounds investigated and their 
possible influence on the observed urinary metabolic profile of these 
compounds. Furthermore, some suggestions for future investigation 
will be proposed. 
In this thesis, the in vivo metabolism of three "simple" 
monosubstituted benzenes has been investigated. In the sheep, the pig 
and the rat it has been demonstrated that in these species both qualitative 
and quantitative similarities in the metabolism benzoic acid, phenol 
and aniline are generally observed. However, some differences are also 
shown and these may have important significance in species variation. 
Rates of Metabolism 
Following a single oral dose of these "model" compounds 
urinary elimination in all three species is normally rapid, some 80-100% 
of the dose being recovered in the urine during the first 24 hours after 
administration of the compound. Indeed it is noticeable that even with 
the sheep and pig, a major portion of the dose is eliminated 
in the 
first voiding of urine. However, the pig when dosed with aniline at 
50 mg kg-1 is an exception in that only about 56% of the administered 
dose is recovered in the urine during the first 
24 hours. Faecal 
excretion during this time in these species was very small, 
being about 
2% of the dose for the compounds investigated. This 
therefore suggests 
that intestinal absorption is largely complete and that urinary excretion 
240 
is the major pathway for the elimination of these compounds. 
It is generally believed that large animals tend to be 
slower in metabolising foreign compounds than small animals because of 
their slower metabolic rate. Although little or no kinetic information 
in the in vivo metabolism and elimination of these compounds is available 
our data on 24 hour excretion figures would not support this contention. 
It was also observed that in all three species the elimination of orally 
administered aniline was slower than that of administered benzoic acid 
and phenol. This is due partly to the more lipophilic nature and probably 
as a consequence, the more complex pathway of metabolism of aniline 
compared to phenol and benzoic acid. 
Route of Metabolism 
A comparison of the urinary metabolic profile from all 
three species reveals the fate of a particular "model" compound is rather 
similar. Thus hippuric acid is the major metabolite of benzoic acid, 
phenylglucuronide and phenylsulphate are the major metabolites of 
phenol and the unusual double conjugates of N-acetyl-p-aminophenyl- 
glucuronide and N-acetyl-p-aminophenylsulphate are the major metabolites 
of aniline in all three species. However, some significant differences 
were also observed . The 
limited sulphate conjugating ability of the 
pig with respect to phenol does not appear to extend to the phenolic 
metabolite of aniline, thus implying that the widely reported deficiency 
of sulphate conjugation in the pig is highly substrate dependent. This 
is supported by the finding of Capel, et al (1974a) who showed that 
substantial amounts of 1-naphthylsulphate, but not 2-naphthylsulphate 
are excreted by the pig following injection of 1-naphthol and 
2-naphthol 
respectively. The unusual formation of significant amounts of phosphate 
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conjugate of phenol in the sheep has also been demonstrated. This 
apparently is not due to any deficiency in other conjugating mechanism 
Phosphate conjugation may be a perculiarity of the sheep, or, perhaps 
ruminants in general. This clearly merits further investigation. In 
vivo investigation in the sheep using 2-naphthylamine which in the dog has 
been shown to give rise to phosphate conjugates (Troll et al 1959, 
Boyland, et al, 1961) may prove to be interesting. Considering the 
plentiful supply of "high energy phosphate" (e. g. ATP, creatine phosphate) 
in all mammalian species and the importance of phosphorylation of OH 
groups of endogenous compounds, it is perhaps surprising that phosphate 
conjugation of foreign compounds is such an apparent rarity. It may be 
that it is the necessity to conserve these high energy components which 
has lead to their very restricted use in detoxication. If this is 
the case the nature and physiological function of the enzyme involved 
in phosphorylation of phenol in the sheep may be of considerable 
biochemical relevance. The use of isolated cell preparations may be a 
valuable model for studying formation of unusual conjugates. Contrary 
to previous reportsacetylation appears to be an important pathway of 
metabolism of aniline in all three species. Besides conjugation by 
acetylation, metabolites of aniline are also conjugated with glucuronic 
acid and sulphate and interestingly an apparent species difference between 
the rat and the farm animal is observed at the dose level studied in 
that glucuronide conjugates are the major metabolites of aniline in the 
sheep and the pig while sulphates prodominate in the rat. Benzoic acid, 
in contrast to aniline and phenol forms only a very small amount of 
benzoylglucuronide and no sulphate conjugate but is metabolised extensively 
by glycine conjugation. Although all the compounds investigated in the 
present thesis contained a benzene nucleus, only aniline was metabolised 
extensively by aromatic hydroxylation. Aromatic hydroxylation of benzoic 
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acid has also been shown to occur to a small extent by previous 
workers and trace amounts of hydroxy metabolites were found (Acheson 
and Gibbard, 1962). In the present investigation using isolated cells from 
the rat, dog and ferret, small amounts of metabolites of benzoic acid 
which have been designated tentatively as hydroxy metabolites were found 
in kidney cell incubates, but not in liver cell incubates. This 
observation requires further investigation particularly in view of the fact 
that the kidney is generally regarded as being deficient in its ability 
to carry out oxidative metabolism of foreign compounds. Differences in 
the metabolism of these compounds may be partly related to their 
lipophilic properties which may influence their intracellular distribution. 
Thus aniline and phenol will be metabolised by the microsomal enzymes 
(e. g. "aromatic hydroxylase" and glucuronyl transferase) and the 
enzymes of the soluble fraction (e. g. acetylase and sulphotransferase), 
while the more water soluble benzoic acid may partition to a greater 
extent into mitochrondria which are the site of glycine conjugation. 
Although these compounds are relatively "simple" from a chemical point 
of view, their metabolism is extremely complex and the extent to which 
some of these metabolic reactions are interdependent is unclear. 
In the pig, aniline unlike the other compounds studied 
was only eliminated to an extent of about 56% of the dose in the first 
24 hours whereas in the sheep and the rat the 24 hour urinary elimination 
was in excess of 80% of the dose. The slow rate of elimination in the 
pig compared with other species could result from several factors such 
as poor absorption, limited renal excretion, alternative pathways of 
metabolism leading to the same urinary metabolite, extensive entrohepatic 
recirculation of metabolites or possible tissue binding 
in the pig. 
The actual cause(s) is difficult to pin point in the absence of 
kinetic 
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data on the metabolite profile. 
In vivo observations in these species demonstrate that a 
different urinary metabolic profile is obtained at different times 
after administration of each compound. These changes in the urinary 
metabolic profile of a compound with time after dosing may stem from 
different rates of formation of different metabolites, as the result 
of differences in the site of formation of different metabolites, further 
metabolism of metabolites and different rates of renal elimination of 
different metabolites. Preliminary investigations using anaesthetised 
ureter cannulated rats have confirmed that aniline (50% of the dose in 
3 hours) is eliminated much more slowly than phenol or benzoic acid 
(ý 80% of the dose in 2 hours). Also it is possible to demonstrate that 
different metabolites are eliminated at different rates so that the ratio 
of these metabolites changes with time. Furthermore, the in vivo 
metabolism of these compounds at the dose levels investigated indicates 
apparent first order kinetics. By linking these ureter cannulation 
experiments with studies of blood metabolite profile with time useful 
information may be derived regarding the role of the kidney in governing 
the rate of elimination of various metabolites of a given compound. 
The use of anaesthetised animals for such studies has a potential 
disadvantage since such animals may differ from normal animals. This 
aspect requires clarification by accompanying our results with those 
obtained in conscious post-operative ureter cannulated animals. 
Experiments in which blood and urine samples are determined at various 
times in ureter cannulated animals from various species may help to 
pinpoint some of the sources of species differences in drug metabolism. 
Preliminary investigations using isolated cells from 
various species to study metabolism of these "model" compounds have 
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shown that besides the liver, other organs are also capable of 
metabolising these compounds. Thus glycine conjugation of benzoic 
acid is brought about by both the liver and the kidneys of the rat 
whereas in the dog and the ferret it is essentially carried out by the 
kidney. Also liver cells from the dog and the ferret apparently have a 
limited ability to metabolise benzoic acid by other means. Using 
isolated intestinal mucosal cells from the rat it was possible to 
demonstrate that phenol was conjugated to a small extent and aniline 
was converted to acetanilide by the small intestine. Clearly such 
observations may have functional significance in species variation. 
Indeed, the use of isolated cells from different organs may provide a 
useful means to ascertain both the site(s) and the rate of formation of 
different metabolites and provide a more valid model for comparing 
species differences in biotransformations than microsomes or tissue 
homogenates. However, it must be remembered that although the viable 
cells used contained a full complement of biochemical activities, the 
extrapolation directly to in vivo situation must be made with caution 
since physiological factors such as the bloodflow through the organs 
concerned are absent and various cell types may be absent or under 
represented. 
In conclusion, it can be seen that using these "simple" 
monosubstituted benzenes, it has been possible to demonstrate that the 
sheep and the pig metabolise these compounds in a largely similar 
manner to the rat. It is likely that the sheep being a ruminant may 
show new metabolites for orally administered compounds which are poorly 
absorbed and are therefore likely to be exposed to the gut microorganisms. 
4 
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